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Introduction, objectives 
and design

#Hypospadias and undescended testis
‘Hypospadias' refers to a condition in which penile tissues and structures failed to develop 
normally. As a result, the urethral meatus is not found at the tip o f the glans, but some­
where at the ventral surface o f the penis (see Figure i.i). The term is derived from the 
ancient Greek prefix ‘hypo-' (under) and the verb ‘spadonizo' (to tear), indicating a cleft 
in a lower than normal position1. Undescended testis (UDT), also called ‘cryptorchidism', 
from ‘cryptos' (hidden) and ‘orchis' (testis)1, means that one or both testes did not fully 
descend into the scrotum, but remained within the intra-abdominal cavity or the inguinal 
canal, or are found in a high scrotal or ectopic position (see Figure 1.2). So far, very little is 
known about the etiologies o f hypospadias and UDT.
Two common birth defects in boys
Current estimates for the birth prevalence o f hypospadias in Western countries vary 
between 2.8 and 5.2 per 1000 live births2-9. In the Netherlands, a prevalence of 3.8 per 
1000 live births has been reported, which translates into 1 in every 138 boys10. The preva­
lence of hypospadias has been studied quite extensively as a response to reports about 
dramatic increases in the 1970's and 1980's5. However, the findings from different stud­
ies on this suggested upward trend are inconsistent2-4,6’8’11. The comparability of preva­
lence estimates over time and between populations is limited, because these estimates 
often rely on registry data, which show a varying accuracy11,12. Specifically the relatively 
mild anterior or distal forms o f hypospadias, which represent approximately two thirds 
of all cases13, may be underreported in registries. However, improved surveillance of mild 
cases does not seem to explain the reported increases in the prevalence o f hypospadias, 
because these predominantly involved the more severe forms5.
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figure 1.1 Hypospadias figure 1.2 Undescended testis
#In a Dutch study examining boys o f approximately one month of age, the prevalence of 
UDT was estimated to be 1.2 percent14. For three-month-old boys, prevalences between 
1.0 and 2.0 percent have been reported15-17. Because spontaneous descent o f undescended 
testes is common, these estimates are substantially lower than the prevalence o f UDT at 
birth, which varies from 2.4 to even 9.0 percent according to several recent studies16-18. 
The very wide range in prevalence estimates partly results from differences in case defini­
tions between studies18, as clinical findings, such as retractile, high scrotal, and secondary 
ascending testis complicate a uniform diagnosis as well as a uniform treatment o f UDT19.
In summary, findings on the prevalences o f hypospadias and UDT from different stud­
ies are inconsistent Nevertheless, compared to the prevalences o f some other frequent 
disorders, such as congenital hip dislocation or dyplasia (2.7 per 1000), ventricular septum 
defect (2.5 per 1000), orofacial clefts (2.1 per 1000), and Down's syndrome (1.6 per 1000), 
the numbers clearly demonstrate that hypospadias and UDT are the two most common 
birth defects in boys20.
Hypospadias and UDT affect patients’ lives in the short and long run
Most boys with hypospadias or persistent UDT undergo corrective surgery at a young 
age. The correction o f hypospadias is a specialized procedure, which is mostly carried out 
by pediatric urologists or pediatric surgeons in university hospitals. Due to complications 
or unsatisfactory results, multiple surgeries are sometimes necessary. Patients who had 
hypospadias surgery during childhood may encounter specific physical problems in ado­
lescence or adult life, including erection and ejaculation difficulties as well as additional 
discomforts during sexual intercourse21. These functional problems, together with the 
sometimes abnormal cosmetic appearance o f the penis and the stress experienced from 
genital surgery, may also affect psychosocial development and well-being o f patients22.
Compared to hypospadias repair, orchidopexy and orchidectomy, which involve reloca­
tion or removal o f an undescended testis, are less complicated procedures that are car­
ried out in most hospitals. In addition to relieve o f physical discomforts related to UDT, 
surgery aims to reduce the risks o f subfertility and testicular cancer later in life, which 
depend on the preoperative location of the testis and on the age at surgery23-25. At time 
of UDT surgery, testicular biopsies may already show specific morphological abnormali­
ties, including reduced numbers o f germ cells and the presence o f carcinoma in situ (CIS) 
cells23,26,27. These features could be secondary to the abnormal position o f the testis, but 
others argue that they reflect a primary developmental defect o f the testis, meaning that 
the long term consequences o f UDT are not fully reversible by orchidopexy23,26,28.
Development o f  the penis and descent o f  the testes: part o f  becoming a male
Each embryo first goes through an indifferent phase, in which gonadal development 
starts in week 5 after conception with the formation o f two genital ridges that are popu­
lated by primordial germ cells originating from the yolk sac29. Male sexual differentia­
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#tion begins around week 6 with the expression o f the sex determining region o f the Y 
chromosome (SRY) by these genital ridges. W ithout the expression of SRY, development 
o f female reproductive structures proceeds. Therefore, the female is referred to as the 
‘default' sex29.
As a consequence of SRY expression, specific regions within the genital ridges differ­
entiate into Sertoli cells, which will facilitate future spermatogenesis29. In this early stage, 
Sertoli cells reorganize the gonad into tubular testis cords and the interstitial space in 
between as they aggregate around the primordial germ cells30. Sertoli cells also secrete 
anti-Mullerian hormone (AM H) that causes the regression of the Mullerian ducts, which 
would otherwise develop into female reproductive structures, in gestational weeks 8-1029. 
By the end o f week 9, the interstitium gives rise to the testosterone-producing Leydig 
cells30, which play an important role in further masculinization.
Around week 8, the developing testes are situated within the abdominal cavity and 
suspended by two opposing ligaments: the gubernaculum and the cranial suspensory 
ligament (CSL). Descent o f the testes into the scrotum involves two distinct phases: intra­
abdominal descent in gestational weeks 8-15 followed by inguino-scrotal descent between 
weeks 26 and 3531’32. The gubernaculum, meaning ‘helm' or ‘ruder', as it was believed to 
steer the testis into the scrotum, plays a central role in this entire process. The gubernacu­
lum first appears as a thin cord connecting the developing testis to the inguinal region of 
the abdominal wall33. During the first phase o f testicular descent, however, the gubernac­
ulum undergoes a dramatic change in which it enlarges up to the size o f the testis due to a 
swelling reaction. At the same time, regression o f the CSL occurs. The swollen gubernacu­
lum anchors the testis to the abdominal wall while the abdominal cavity enlarges33. Dur­
ing inguino-scrotal descent, the gubernaculum with the testis attached moves through 
the inguinal canal towards the base of the scrotum. In this phase, the processus vaginalis 
is formed: a peritoneal diverticulum within the gubernaculum34. The mechanism through 
which inguino-scrotal descent takes place is controversial, but it seems to involve several 
factors, including intra-abdominal pressure, genito-femoral nerve signaling, and contrac­
tion of the gubernaculum31,33.
Development of the external genitalia also starts around the 5th week o f gestation29. 
At this point, the cloacal membrane is divided into the urogenital and anal regions. The 
genital swellings are formed and the genital tubercle emerges at the urogenital midline. 
The membrane then breaks down to form the urogenital folds that border the urogenital 
ostium29,35. Sexual differentiation of these structures proceeds around 12 weeks o f gesta­
tion. In males, the genital swellings migrate caudally where they merge to form the scro­
tum35. The genital tubercle elongates and forms a groove on its ventral surface, which is 
defined by the urogenital folds that also surround the ostium. As these folds fuse, which 
occurs in a proximal to distal direction, the urogenital groove is converted into a tubular 
penile urethra35. The fusion o f the urogenital folds in the midline o f the penile shaft is 
complete at 14 weeks o f gestation29. The glanular urethra, however, has been reported
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#not to appear until week i6 36. Its development is less well understood and has been the 
subject o f different theories37.
It all depends on hormones
Testicular hormones are key factors in testicular descent and the development of the 
penis. In the first trim ester o f pregnancy, testosterone production by the Leydig cells is 
regulated by placental human chorionic gonadotropin (HCG), which gives the placenta 
an important role in early sexual differentiation29. Thereafter, this function is assumed 
by luteinizing hormone (LH) from the fetal pituitary. Within the urogenital tubercle, tes­
tosterone is converted into the more potent dihydrotestosterone (DHT) by the enzyme 
5-alfa reductase. DHT in particular seems to be responsible for male sexual differentia­
tion of the external genitalia30. The inguino-scrotal phase o f testicular descent was also 
shown to be androgen dependent. Probably acting via the genito-femoral nerve, andro­
gens play an important role in migration o f the gubernaculum when it leads the testis into 
the scrotum31,33,38. The intra-abdominal phase o f testicular descent, however, is largely an 
androgen-independent process that is regulated by Insulin like factor 3 (INSL3), a second 
hormone excreted by the Leydig cells31,32. In general, it is assumed that any disturbances 
in the interplay between testicular hormones and their receptors in target tissues could 
arrest testicular descent and penile development, leading to UDT or hypospadias.
Testicular dysgenesis: a common etiology o f  hypospadias and UDT?
The essential role o f testicular hormones in prenatal development o f the penis and 
descent o f the testes, but also in postnatal testicular function, forms the basis of the ‘Tes­
ticular Dysgenesis Syndrome (TDS)' hypothesis (see Figure 7.3)28-40. This hypothesis states 
that maldevelopment, or dysgenesis, o f the testes in early gestation may lead to hypo­
spadias and/or UDT due to impaired Leydig cell function, while affected Sertoli cells may 
increase the risks o f reduced semen quality and testicular cancer in adult life.
figure 1.3 Schematic presentation of the TDS hypothesis40
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#The TDS hypothesis is founded on several empirical findings. These include observations 
o f poorly differentiated Sertoli cells, underdeveloped seminiferous tubules, spermato- 
genic arrest, and carcinoma in situ (CIS) cells in patients with testicular cancer, which 
indicate a primary testicular maldevelopment of prenatal origin. As mentioned earlier, 
potential signs o f testicular dysgenesis have also been observed in cases o f UDT. The 
hypothesis finds additional support in the increased risk of testicular cancer after UDT 
and in the reduced sperm quality associated with UDT and testicular cancer. Further­
more, geographical clustering and co-occurring time trends o f the four disorders have 
been reported, which is in line with a common etiology28,40.
Looking at hypospadias, UDT, testicular cancer, and reduced semen quality as ‘symp­
toms' o f an underlying testicular dysgenesis has several implications. For clinical practice, 
this means that a patient with one symptom should be considered to have an increased 
risk o f also harboring or developing the other symptoms40. In addition, TDS as a single 
entity occurs more frequently than the four ‘symptoms' separately, indicating a much 
larger health problem28. Linking the four disorders together may also provide clues about 
causative factors, which according to the hypothesis should be sought in both genes and 
environment, and especially in prenatal exposure to endocrine disrupting substances.
In the past two decades, the attention o f many research groups has been drawn to the 
potential harmful effects o f endocrine disruptors (EDs), which are defined as exogenous 
substances that alter functions of the endocrine system, thereby causing adverse health 
effects41. This broad definition captures a large and increasing number o f substances, with 
very different chemical properties and mechanisms o f effect. The ubiquity and persistence 
of some chemicals in the environment has made endocrine disruption a global concern.
Wildlife contamination and DES: first warnings fo r  endocrine disruption
Awareness of the potential health risks o f EDs arose in the 1960's. In these years, the bio­
accumulation and hormonal effects o f dichlorodiphenyltrichloroethane (DDT) in wildlife 
came to light, which led to the ban o f DDT in most W estern countries42-44. Many additional 
reports on harmful effects in wildlife followed, including feminization of male embryos in 
a DDT-exposed gull population45, unsuccessful hatching and development o f micrope­
nis in Lake Apopka alligators after an accidental pesticide spill by an adjacent chem i­
cal company42, ‘intersex' fish in English rivers in the proximity o f sewerage discharges44, 
and female pseudohermaphrodetic polar bear offspring at the Arctic46, which is heav­
ily exposed to organochlorines. These wildlife observations demonstrated the exposure 
hazards o f industrial chemicals within our environment and stirred questions about the 
consequences for human reproductive health.
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Endocrine disruptors
#A very different finding that contributed to today's concern about hormonally active sub­
stances was the disastrous effect o f Diethylstilbestrol (DES), a synthetic estrogen that 
was widely administered to pregnant women between the early 1940's and late 1970's. 
DES was assumed to prevent miscarriages and premature deliveries, but was shown to 
be ineffective in a large randomized placebo controlled trial in 195347. It took almost two 
decades more until the drug was taken off the market, when six young women between
14 and 21 years o f age were diagnosed with vaginal clear-cell adenocarcinoma. This very 
rare condition previously affected only elderly women and was soon linked to prenatal 
DES exposure48. Subsequent studies revealed additional health risks for DES-daughters, 
including vaginal epithelial changes (adenosis), reproductive tract abnormalities, reduced 
fertility, ectopic pregnancies, miscarriages, and premature deliveries48-50. The conse­
quences o f DES exposure for male offspring were much less apparent. Some researchers 
reported an increased occurrence o f UDT in DES sons, as well as indications for increased 
risks o f epidydemal cysts, hypotrophic testes, reduced sperm quality, and possibly tes­
ticular cancer48,51-53. More recently, DES was linked to an increased risk o f hypospadias in 
grandsons, which was first reported by Klip et al. in 200254 and possibly indicates trans­
generational effects of DES.
Like Thalidomide a few years earlier, DES showed that exogenous factors that seem 
save or harmless for adults, may have detrimental effects during specific stages o f prena­
tal development. In addition, DES indicated the dangers o f interfering with the delicate 
balance of hormones during these critical times44,55. In subsequent years, DES has been 
used as a model for xeno-estrogens in numerous molecular and animal experiments, 
which provided important insights into the mechanisms through which estrogen-like 
substances interfere with the human endocrine system and the development o f male and 
female reproductive structures43.
Endocrine disruptors may have numerous target points
Normal functioning o f processes involving estrogens and androgens relies on the inter­
action o f these endogenous hormones with estrogen and androgen receptors (ER and 
AR) located within the nucleus o f the target cells. When the hormones bind to their 
receptors, ligand-receptor complexes are formed, which activate estrogen and androgen 
responsive elements (EREs and AREs) on the DNA causing gene transcription. However, 
like endogenous hormones, several EDs have the ability to bind to estrogen and/or andro­
gen receptors41, causing a similar, but often weaker56, cell response. O ther EDs do not 
activate gene transcription upon ER or AR binding, but block these receptors for their 
endogenous ligands instead41.
Several additional receptors were also shown to be a target point for EDs, such as the 
arylhydrocarbon receptor (AhR)57, the progesterone receptor (PR)58,59, and the perixome 
proliferator activated receptor (PPAR)60. The AhR is known to bind dioxin-like substances 
and to mediate their toxicity. The mechanism through which AhR activation disturbs
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#the endocrine system is not completely understood, but may involve interference with 
ER-induced gene-transscription57 or disturbances in hormone metabolism through the 
release o f detoxification enzymes58. Activation o f PPAR plays an important role in the 
intra-cellular transport o f cholesterol, which forms the basis o f steroid synthesis60.
EDs may also interfere directly with the synthesis and metabolism o f endogenous 
estrogens and androgens. Some chemicals have been shown to inhibit aromatase or 
5-alpha reductase, which convert testosterone to estradiol and DHT41. O ther substances 
may interfere with the hormone metabolism by acting as substrates for sulfotransferases, 
which regulate the inactivation and excretion o f steroid hormones through sulfate con­
jugation61. EDs may also interact with androgen binding proteins (ABP) and sex hormone 
binding globulins (SHBG), thereby influencing the bioavailability o f endogenous estro­
gens and androgens62.
The mechanisms described concern the disruption o f estrogen and androgen func­
tions, which involve the hypothalamic-pituitary-gonadal axis o f the endocrine system. 
Through similar mechanisms, EDs may disturb the hypothalamic-pituitary-adrenal and 
hypothalamic-pituitary-thyroid axes and affect functions o f glucocorticoid and thyroid 
hormones41. Between the axes, cross-talk takes place, which allows different endocrine 
systems to interact with one another. Within one axis, target cells are programmed to 
send feedback signals to regulating cells in order to maintain a homeostatic condition. 
Due to these cross-talk and feedback mechanisms, observations from molecular investi­
gations cannot readily be extrapolated to the entire organism. Therefore, the ‘net-effect' 
o f most EDs in the human body is difficult to predict41.
The potential human health risks o f  endocrine disruptors warrant epidemiologic research
The past 30-40 years o f research provided important insights into the potential mecha­
nisms through which exogenous substances may interfere with the endocrine system. 
In addition, many substances were ‘screened' for their endocrine disrupting potential, 
resulting in a large and increasing list o f candidate EDs63. Yet, the health risks o f exposure 
to these substances largely remain to be elucidated, which underlines the need for epide­
miologic research.
Theoretically, EDs could play a role in the etiology o f any disorder with a hormonal 
component. Researchers especially focused on disorders o f the reproductive system, such 
as male and female subfertility, testicular cancer, and the development of hypospadias 
and UDT. Additional areas o f research include breast cancer64, prostate cancer65, and 
endometriosis66. For EDs, the exposure window o f interest may include any time period 
from early childhood through adult life. Prenatal life, however, is believed to be extremely 
vulnerable to the adverse effects o f EDs, due to the immature endocrine system41. Inter­
ferences with organogenesis may lead to birth defects or, as reflected in the TDS hypoth­
esis, disorders o f the reproductive system that present later in life.
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#Overall, only a few associations have been reported between ED exposure and the afore­
mentioned adverse outcomes and findings from different studies are often inconsistent. 
This may partly be due to the fact that many studies rely on questionnaire or registry data, 
generally resulting in crude exposure classification with limited validity. In fact, expo­
sure assessment o f EDs in epidemiologic studies is referred to as the Achilles heel o f ED 
research67. Efforts to better reconstruct ED exposures include a job exposure matrix (JEM) 
that was developed in 2002 and provides an objective, although crude, classification of 
a wide range o f occupationally encountered EDs68. Some studies also include measure­
ments o f specific ED exposures in e.g. serum69-71, breast milk72-74, and placental tissue75. 
In addition, several reporter-gene bioassays have been developed, which are designed to 
measure hormone-receptor activation and to indicate the endocrine disrupting potential 
of chemical exposures in biological samples76. Although these bioassays seem promising 
for biological monitoring purposes, their applicability in epidemiologic studies requires 
further research.
Objectives
The need to obtain more insight into the etiologies o f hypospadias and UDT and specifi­
cally into the potential role o f ED exposures therein, form the basis for this thesis in which 
the following objectives were pursued:
1 To add knowledge on risk factors for hypospadias and UDT, focusing on:
(a) familial occurrence o f TDS component disorders
(b) parental intra-uterine exposure to DES
(c) fertility treatments, pregnancy complications, and obstetric factors
(d) exogenous factors related to parental life style, prescription drug use, and occupa-
2 To identify whether prenatal exposure to EDs increases the risks o f hypospadias and 
UDT, focusing on:
(a) parental ED exposure at the workplace
(b) parental ED exposure from dietary intake o f specific food products
(c) parental ED exposure during home improvements or leisure time activities
3 To contribute to the development and evaluation o f exposure assessment methods for 
EDs in epidemiologic studies, specifically:
(a) a job exposure matrix for EDs
(b) measurements o f estrogenic and androgenic activities with a reporter-gene bioassay
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#4 To evaluate the TDS hypothesis through the recognition o f similarities and/or differ­
ences in risk factor patterns for hypospadias and UDT
The ultimate goal is to give direction to future preventive measures for the development 
o f hypospadias and UDT and, if possible, for additional health risks o f EDs.
Design of the study and outline of the thesis
In 2002, we first conducted an explorative case-referent study on hypospadias, in which 
we assessed a wide range o f potential risk factors. A specific subquestion we aimed to 
answer was whether we could confirm the findings o f Klip et al. on an increased risk of 
hypospadias among sons of DES-daughters54. The study population consisted o f boys who 
were treated for hypospadias at the Pediatric Urology Centre o f the Radboud University 
Nijmegen Medical Centre in The Netherlands and were born in 1987-1997. Data were col­
lected with postal questionnaires for both parents. As referents, we included neighbors 
or school friends o f similar age whose parents were recruited via the parents o f cases. The 
results o f this case-referent study, and specifically the association between hypospadias 
and parental DES-exposure, are presented in Chapters 2 an d3.
The 2002 study formed the basis for two subsequent case-referent studies set up in 
2005 to replicate or refute the abovementioned findings and to identify additional risk 
factors for hypospadias and UDT. These studies involved more extensive data collection 
in which we focused specifically on exposure to potential EDs. In addition, clinical infor­
mation was included in order to assess potential etiological differences between sub­
groups o f cases with either one o f these disorders. Cases were boys who had surgery for 
hypospadias or UDT at the departments o f Urology and Pediatric Surgery of five hospitals 
in the Eastern part o f The Netherlands. These boys were compared to a single referent 
population o f boys who received ear ventilation tubes at the departments o f Otorhino­
laryngology o f the same hospitals. All subjects were born in the period 1996-2004. Data 
were collected with postal questionnaires, o f which we assessed the reproducibility in 
2006. Chapters 4 and 5 display the main findings from these case-referent studies for 
hypospadias and UDT, respectively.
With retrospective questionnaires, the possibilities to obtain reliable information on 
ED exposure were limited. Therefore, we decided to use a Job Exposure Matrix (JEM) for 
the assessment of occupational exposure to EDs. Based on the 2002 JEM o f Van Tongeren 
and colleagues, we developed a new JEM, which we assumed to be a more accurate and 
comprehensive exposure assessment method for EDs in our studies. We also looked at 
opportunities to increase the performance o f the JEM, by incorporating subject-specific 
information on tasks and working environment in the exposure assessment. The develop­
ment o f the JEM and its implementation in our studies on hypospadias and UTD are 
described in Chapters 6 a n d 7.
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#A further contribution to the development o f exposure assessment methods for EDs was 
made by studying the applicability o f specific reporter-gene bioassays in an epidem io­
logic setting. A cross-sectional study was performed among the fathers of a subset of 
cases and referents, in which exposure data were compared to measurements o f estro­
genic and androgenic activities in blood plasma. The findings o f this study are presented 
in Chapter 8.
A general discussion o f our findings and future perspectives for research on hypos­
padias and UTD are included in Chapter 9.
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Risk factors for hypospadias
#Abstract
Despite being one o f the m ost com m on congenital defects in boys, the e tio l­
ogy o f hypospadias rem ains largely unknow n. In this case-referent study, we 
evaluated a w ide spectrum  o f potential risk factors for hypospadias. C ases w ere 
identified from  the hospital inform ation system  and referents w ere recruited 
through the parents o f the cases. Both parents o f cases and referents com pleted 
w ritten q uestio nn aires that they received through the mail. Logistic regression 
analyses w ere used to assess the ind epen dent con trib u tio n o f different factors to 
the risk o f hypospadias. The final database included 583 cases and 251 referents. 
H ypo spadias m ore often occurred  in children w hose father had hypospadias: O R 
9.7 (95%CI 1.3-74.0) and in children w ith a low birth w eight: O R  2.3 (95%CI 1.2-4.2). 
In dications for elevated risks w ere found w hen m others w ere DES-daughters: O R 
3.5 (95%CI 0.8-15.6), fathers w ere subfertile: O R  1.8 (95%CI 0.7-4.5), the parents 
had undergone fertility  treatm ent: O R  2.3 (95%CI 0.9-5.8), and in twin or triplet 
pregnancies: O R  2.0 (95%CI 0.8-5.1). M aternal use o f iron supplem en ts: O R  2.2 
(95%CI 0.8-6.0), m aternal sm oking: O R  1.5 (95%CI 1.0-2.4), paternal prescrip ­
tive drug use: O R  2.6 (95%CI 1.1-6.6), and paternal e xpo su re to pesticides: O R  2.1 
(95%CI 0.6-7.1) d urin g the three m onths im m ediately prior to con ceptio n or in 
the first trim ester o f p regnancy also appeared to increase the risk o f hypospa­
dias. The associatio ns found in this stud y su p p o rt the hypothesis that genetic 
predisposition, placental insufficiency, and su bstances that interfere w ith natural 
horm ones play a role in the etio logy o f hypospadias.
#Introduction
Hypospadias is one o f the most common congenital defects in boys, affecting approxi­
mately 30 to 4 0 children out o f 10,000 live births1,2. According to some studies, the birth 
prevalence increased rapidly during the 1970s and 1980s, but these trends do not appear 
to persist in recent evaluations3-6. Hypospadias results from an incomplete fusion o f the 
urethral folds between the seventh and fourteenth week o f gestation7, but the exact etiol­
ogy o f the disorder remains largely unknown.
The association between growth retardation and hypospadias is well established. One 
possible explanation is that placental insufficiency in providing the fetus with nutrients 
and gonadotropins may lead to both growth retardation and hypospadias8-11. Placental 
insufficiency may also explain the increased occurrence o f hypospadias in tw ins8,10,11. How­
ever, familial clustering suggests a genetic component in the etiology of hypospadias12. 
Higher maternal age13,14, assisted reproductive techniques (ART)15-17, paternal subfertility18, 
maternal exposure to diethylstilbestrol (DES) in utero19-21, maternal vegetarian diet and 
iron supplementation22, and paternal smoking and exposure to solvents and pesticides23-25 
have also been put forward as risk factors for hypospadias. As male sexual differentia­
tion in general depends on testosterone, its metabolite dihydrotestosterone (DHT), and 
the expression o f androgen receptors by target cells7, disturbances in the balance o f this 
endocrine system by either endogenous or exogenous factors may lead to hypospadias.
In the past two decades, attention has focused on the potential adverse effects of 
environmental endocrine disruptors on male reproductive health. These substances 
include numerous industrial chemicals as well as dietary phyto-estrogens. Exposure dur­
ing early gestation has been hypothesized to affect the developing Sertoli cells and Leydig 
cells, thereby increasing the risk o f hypospadias, cryptorchidism, testicular cancer, and 
reduced semen quality later in life; all o f these are conditions that have been described as 
different expressions o f the Testicular Dysgenesis Syndrome26-28. Although the evidence 
for adverse effects of endocrine disruptors on human reproduction is limited, data from 
animal studies as well as observations on wildlife after environmental pollution are con­
vincing29,30.
The origin o f hypospadias thus appears to be multifactorial. Although previous research 
has provided evidence for some risk factors, more knowledge is required in order to pre­
vent future cases. The majority o f studies carried out to date have focused on distinct 
components in the etiology o f hypospadias; the result has been a fragmented body of 
knowledge on risk factors. Consequently, there is an urgent need to study the full spec­
trum o f potential risk factors and to assess the independent contribution o f each factor as 
this may lead to more insight into the etiology. The aim o f the investigation reported here 
was to identify a wide range of risk factors for hypospadias in a large case-referent study 
in which we focused on both maternal and paternal exposure.
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#Recruitment o f  cases and referents
Data of 937 boys who were treated for hypospadias at the Pediatric Urology Centre o f the 
Radboud University Nijmegen Medical Centre, were retrieved from the hospital infor­
mation system. Approximately 80 hypospadias corrections are performed each year at 
the Pediatric Urology Centre, with most of these patients presenting with a mild defect 
(glandular or coronal hypospadias, 60 percent). Intermediate (penile) and severe (scrotal 
or perineal) manifestations o f hypospadias are seen in approximately 25 percent and 15 
percent o f the patients, respectively. The selection o f cases was restricted to children who 
were born in the period 1987 through 1997 and who were residents o f the Netherlands. 
Among the cases were 14 boys of whom an older brother was also included in the study 
population; these boys were excluded in order to avoid bias in the effect parameters. In 
addition, only one child was included from four twins and one triplet. In October 2002, 
written questionnaires were mailed to the parents o f all selected cases. Due to unknown 
address changes, however, the parents o f at least 98 boys did not receive the question­
naires. Two boys had foster parents and were therefore not eligible. As a result, the total 
number o f eligible boys with hypospadias was 817. In order to recruit a referent group, 
we mailed an extra set o f questionnaires to the parents o f the eligible boys with the 
request that they give these questionnaires to the parents o f a boy o f approximately the 
same age as their son -  for example, a school friend -  who was then included in the 
referent group. The aim o f this recruitment strategy was to realize a referent group that 
reflects the hospital's catchment area from which the cases originated. Consequently, the 
final study population consisted o f a mixture o f ‘case-referent pairs' and ‘single' cases for 
whom no referent was recruited.
Data collection
Both parents o f cases and referents were asked to fill out the same written questionnaires. 
First and second reminders were sent to the parents o f the cases in order to increase the 
response rate. The questionnaires for both sets of parents contained questions about 
age, ethnicity, education, prenatal exposure to DES, and medical history. Information was 
requested on the three months immediately prior to conception and the first trimester 
of pregnancy with respect to illnesses, medication, life style, and occupational exposure 
to various agents. Additionally, mothers were questioned about oral contraceptive use, 
assisted reproductive techniques, the course o f pregnancy, their son's birth weight, and 
the diagnosis o f hypospadias or other congenital defects. Finally, the mothers were asked 
to provide information on their other children and pregnancies. The study was approved 
by the Regional Committee on Research Involving Human Subjects.
Methods
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#Statistical analyses
Data were entered into an MS Access database and converted to SPSS 12.0.1 and SAS V8.2 
for statistical analyses. All potential risk factors, with the exception o f birth weight and 
maternal age, were dichotomous (yes vs. no). Crude associations with hypospadias were 
estimated by odds ratios (OR) with 95 percent confidence intervals (95%CI) in univariable 
analyses. Odds ratios greater than one indicate increased risks for hypospadias, especially 
when the lower bound of the 95%CI excludes unity. Educational level (three levels) and 
native country (Netherlands vs. other) o f both parents were considered to be potential 
confounders. Educational level was defined as low (elementary school or lower vocational 
education), intermediate (intermediate secondary school or intermediate vocational edu­
cation), and high (higher secondary school, higher vocational education, or university). 
Effect-measure modification was assessed through bivariable stratified analyses, involv­
ing all combinations between risk factors as well as combinations with educational level 
and native country o f the parents and was evaluated using both the Breslow-Day test for 
homogeneity across strata and strata-specific point estimates. Subsequently, all potential 
risk factors and confounders were simultaneously included in logistic regression models 
in order to assess their independent contribution to the risk o f hypospadias. In a stepwise 
manner, risk factors with minimal effect estimates (OR < 1.5 and/or lower bound o f 95%CI 
< 0.7) were manually excluded from the model if exclusion did not have a substantial effect 
on the coefficients o f other risk factors (<10%). Additionally, conditional logistic regres­
sion analyses were performed on the subset o f case parents for whom referent parents 
were available (‘case-referent pairs') to control for potential confounding by unmeasured 
factors as a result o f the recruitment strategy. The same inclusion and exclusion criteria 
were applied as in the analyses on the complete study population.
The parents o f 613 o f the 817 hypospadias cases completed the questionnaires, resulting 
in a response rate o f 75 percent. Additionally, completed questionnaires were received 
from the parents o f 264 referents. For 30 cases and 13 referents information could only be 
obtained from one parent; these data were excluded from further analysis. The final data­
base included 583 cases and 251 referents, in which 232 ‘case-referent pairs' were identi­
fied. Cases and referents resided throughout the country and showed a similar distribu­
tion of the 61 regional postal area codes that were reported. Descriptive statistics o f the 
cases and referents in the complete study population and in the case-referent pairs are 
shown in Table 2.1. Cases and referents were all approximately 10 years old at the time of 
study. In the complete study population, parents o f cases tended to have a lower educa­
tional level compared to the parents o f referents. They also reported more often to have
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Results
#table 2.1 Descriptive statistics of cases and referents in 
the complete study population and in the case-referent pairs
Cases in complete 
population (n= 583)b
Cases in case-refer- 
ent pairs (n=232)b
Referentsa
(n=251)b
Age of case/referent
-  mean (sd) 10.2 (3.6) 9.7 (3.5) 9.6 (3.5)
Educational level of parents 
-  frequency (%)
Mother Low 143 (24.6) 32 (13.8) 28 (11.2)
Intermediate 243 (41.8) 105 (45.3) 101 (40.6)
High 195 (33.6) 95 (4 0 .9) 120 (48.2)
Father Low 173 (29.8) 48 (20.7) 50 (20.2)
Intermediate 192 (33.1) 84 (36.2) 80 (32.3)
High 215 (37-1) 100 (43.1) 118 (47-6)
Native country of parents 
-  frequency (%)
Mother Netherlands 545 (93.5) 228 (98 .3) 244 (97.6)
Other 38 (6 .5) 4 (1.7) 6 (2.4 )
Father Netherlands 545 (93.6) 226 (97.4 ) 243 (96.8)
Other 37 (6 .4) 6 (2.6) 8 (3.2)
a Descriptive statistics o f the 232 referents in the case-referent pairs are sim ilar to the statistics o f all referents 
tha t are presented here. 
b Numbers do not add up to tota l group size due to missing values.
been born in a foreign country, which was a European country in about 50% percent o f the 
responses. Among the case-referent pairs, parents' educational level and native country 
were more alike.
The crude odds ratios (OR) and 95 percent confidence intervals (CI) for the analyses 
in the complete study population are presented in Tables 2.2 and 2.3. Table 2.2 shows 
potential risk factors for hypospadias that are associated with the parent's health and 
fertility status and pregnancy characteristics. O ur data did not support an association 
with increased maternal age (>35 years). An assessment o f the effect o f maternal age on 
a continuous scale or in multiple age categories did not lead to different findings. The 
most profound result was the increased risk o f hypospadias for boys whose fathers had 
hypospadias (n=23): OR 9.8 (95%CI 1.3-73.0). Strong indications for an increased risk of 
hypospadias were also found when mothers were exposed to DES in utero: OR 2.6 (95%CI 
0.8-9.0) and when subfertility was reported by mothers: OR 1.9 (95%CI 1.0-3.9) or fathers: 
OR 2.2 (95%CI 0.9-5.4). In addition, parents o f cases more often achieved pregnancy fol­
lowing fertility treatment: OR 2.6 (95%CI 1.1-6.3), which mostly involved ovulation stim u­
lants (19 cases and three referents). Three fathers and one mother o f cases used other 
fertility-enhancing drugs prior to pregnancy. Ten cases and one referent were born after 
in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatments, and two
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#table 2.2 Associations between hypospadias and potential risk factors related to 
parent's health and fertility status and pregnancy characteristics
Number o f cases 
(n=583)a
Number of 
referents (n=251)a
Crude OR 
(95%CI)
Increased maternal age at time of 
delivery (>35 years)
58 21 1.2 (0.7-2.1)
Hypospadias in father 22 1 9.8 (1.3-73.0)
Intra-uterine DES-exposure
Mother 18 3 2.6 (0.8-9.0)
Father 8 3 1.2 (0.3-4.4)
Subfertility
Mother 43 10 1.9 (1.0-3.9)
Father 30 6 2.2 (0 .9 -5.4 )
Pregnancy achieved with fertility 
treatmentb
35 6 2.6 (1.1-6.3)
Twin or triplet pregnancy 34 6 2.5 (1.1-6.1)
Low birth weight (<2500g)c 114 19 2.3 (1.2-4.2)
a Maximum numbers o f missing values per risk fac to r were 27 and 10 fo r  cases and referents, respectively 
b Including Assisted Reproductive Techniques 
c Adjusted fo r  duration o f gestation (in weeks)
cases and one referent were born following intra-uterine insemination. Associations with 
twin or triplet pregnancies: OR 2.5 (95%CI 1.1-6.1) and with low birth weight OR 2.3 (95%CI
1.2-4.2) were also found.
Potential risk factors concerning life style, drug use and occupational exposures in 
the three months immediately prior to conception and/or during pregnancy are shown 
in Table2.3. Increased risks were found when mothers smoked during pregnancy: OR 1.8 
(95%CI 1.2-2.8) or fathers smoked before pregnancy: OR 1.4 (95%CI 1.0-1.9). No associa­
tions were observed between hypospadias and maternal alcohol consumption, vegetarian 
diet, and the use o f folic acid or other vitamin supplements. However, we found some 
indication that oral contraceptive use after conception might be associated with hypospa­
dias: OR 2.0 (95%CI 0.7-5.9). Also, there appeared to be an increased risk when mothers 
used iron supplements in the three months immediately prior to conception and/or dur­
ing the first trim ester of pregnancy: OR 2.1 (95%CI 0.9-5.2). The use o f other prescriptive 
drugs by mothers did not seem to be associated with hypospadias, but our findings do 
suggest an increased risk when fathers used prescriptive drugs: OR 1.9 (95%CI 0.8-4.4). A 
wide variety o f drugs were listed, o f which the five mostly used were anti-inflammatory 
drugs, antihypertensives, antipsychotics, respiratory drugs, and drugs for gastritis. With 
respect to occupational exposures, the parents were asked about pesticides, paint, var-
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#table 2.3 Associations between hypospadias and potential risk factors concerning 
parent's life style, drug use, and occupational exposures
Number of 
cases (n=583)a
Number of 
referents (n=251)a
Crude OR 
(95%CI)
Smoking
Mother b 133 35 1.8 (1.2-2.8)
Father 234 81 1.4 (1.0-1.9)
Mother drank alcoholic beveragesb 117 63 0.8 (0.5-1.1)
Mother had a vegetarian diet 10 7 0.6 (0.3-1.6)
Mother used folic acid 56 24 1.0 (0.6-1.7)
Oral contraceptive use after conception 18 4 2.0 (0 .7-5.9)
Mother used iron supplements 29 6 2.1 (0 .9 -5.2)
Prescriptive drug use
Mother 42 14 1.3 (0 .7-2.5)
Father 30 7 1.9 (0.8-4.4)
Occupational exposure to pesticides
Mother 6 3 0.9 (0 .2-3.5)
Father 24 8 1.3 (0.6-2.9)
Occupational exposure to paint, varnish 
or thinners
Mother 35 12 1.3 (0 .7-2.5)
Father 78 42 0.8 (0.5-1.2)
N.B.: Maternal exposures concern the three months before conception and/or the firs t trimester o f pregnancy, 
unless otherwise specified. Paternal exposures concern the three months before conception. 
a Maximum numbers o f missing values per risk fac to r were 10 and 6 fo r  cases and referents, respectively 
b Specified as smoking or drinking alcohol during pregnancy only
nish or thinners, cleaning agents, heavy metals, and exhaust fumes. We found no associa­
tions between hypospadias and any o f these exposures.
We also attempted to identify whether the retrospective assessment of risk factors 
affected the results by comparing the univariable effect estimates presented in Tables 2.2 
an d2.3 between boys who were younger and older than 10 years o f age at time o f data col­
lection, respectively. The population size did not allow evaluation o f other cut-off points 
yielding unequally sized groups. The association with subfertility o f the mother appeared 
to be only present for boys under 10 years of age: OR 3.5 (95%CI 1.2-10.3) but not among 
older boys: OR 1.1 (95%CI 0.4-2.7). Likewise, a much larger effect estimate was found for 
the maternal use o f iron supplements among younger boys: OR 4.0 (95%CI 0.9-17.5) ver­
sus OR 1.3 (95%CI 0.4-4.1). For older boys, however, an increased risk of hypospadias was 
found when mothers were occupationally exposed to paint, varnish or thinners: OR 4.1
32 c h a p t e r  2
table 2.4 Multivariable analyses of risk factors for hypospadias using logistic regression models 
for the complete study population and the case-referent pairs separately
Risk factors
Complete population 
OR (95%CI) n=769b
Case-referent pairs8 
OR (95%CI) n=440b
Educational level of motherc 
Low vs. high 
Intermediate vs. high
2.9
1.5
(1.7-4 .7)
(1.1-2.1)
2.0
1.8
(0 .9 -4 .4 )
(1.1-3.1)
Native country of motherc
Other vs. Netherlands 2.9 (12-71) 0.5 (0.1-2.9)d
Hypospadias in father 9.7 (1.3-74.0) 9.2 (1.0-84.1)
Fertility treatmentse 2.3 (0.9-5.8) 1.3 (0 .4 -4 .2)d
Twin or triplet pregnancy 2.0 (0.8-5.1) V (0 .5-5.6)
Mother exposed to DES in utero 3.5 (0.8-15.6) 3.7 (0 .8-17.4 )
Mother smoked during pregnancy 1.5 (1.0-2.4) 1.5 (0.8-2.8)
Mother used iron supplements 2.2 (0.8-6.0) 2.6 (0 .7-9.7)
Father used prescriptive drugs 2.6 (1.1-6.6) 2.7 (0.8-9.0)
Father exposed to pesticides 1.2 (0 .5-2.7)d 2.1 (0.6-7.1)
a Including cases fo r  whom a referent was available. This analysis involved a conditional logistic regression model 
in which the tie between cases and referents was treated as a matching variable and was included in the model. 
b Numbers do not add up to to ta l population sizes (n=834 and n=464, respectively), due to missing values. 
c Educational level and native country o f  mother were considered to be confounders in both models 
d These risk estimates met the criteria to be excluded fro m  the model (OR < 1.5 and/or lower bound 
o f 95%CI < 0.7), but were included in order to obtain two consistent, models 
e Including Assisted Reproductive Techniques
(95%CI 0.9-17.7) (older boys) versus OR 0.7 (95%CI 0.3-1.6) (younger boys). The effect esti­
mates of other risk factors did not substantially differ between the two age groups.
Table2.4 shows the independent effect estimates for the risk factors that contribute to 
an increased risk of hypospadias as obtained from the multivariable analyses on the com­
plete study population and on the population o f case-referent pairs. The latter analysis 
was performed by using a conditional logistic regression model in which the tie between 
cases and referents was included as a matching variable. In both analyses, the full models 
contained all risk factors that showed an indication for an association with hypospadias in 
the previous analyses (see Tables 2.2 and 2.3), with the exception of low birth weight as it 
shares certain causal factors with hypospadias. Educational level and native country of the 
parents were included as potential confounders. Increased maternal age, maternal veg­
etarian diet, and paternal exposure to pesticides or solvents were added as well because 
these are potential risk factors according to previous studies. Following the exclusion of 
factors that did not contribute to the risk o f hypospadias, the final models contained the 
risk factors as shown in Table 2.4. Some risk factors that should be excluded from one of 
the models according to our criteria were maintained, so both models contained the same 
risk factors and their effect estimates can be compared.
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#Overall, the effect estimates for the complete study population correspond with the 
univariable analyses, although some risk factors did appear to be somewhat stronger 
(maternal DES exposure, paternal drug use) or weaker (fertility treatments, twin or trip­
let pregnancy) in the multivariable analysis. Oral contraceptive use and paternal smok­
ing dropped out o f the model completely, whereas subfertility o f mother or father could 
not be included in the multivariable model because o f strong correlations with fertility 
treatment. An alternative model which included subfertility instead o f fertility treatments 
showed that maternal subfertility did not contribute substantially to the risk o f hypospa­
dias, but the effect estimate for paternal subfertility was OR 1.8 (95%CI 0.7-4.5) in the 
complete study population. An additional analysis excluding children who were born after 
fertility treatment did not yield essentially different findings. The risk estimates for the 
case-referent pairs (see Table 2.4, right-hand column) deviate from those for the complete 
study population in a few respects. The indications for increased risks o f hypospadias in 
twin or triplet pregnancies or following fertility treatment were much less convincing: OR 
1.7 (95%CI 0.5-5.6) and OR 1.3 (95%CI 0.4-4.2), respectively. In contrast, the risk estimate 
for paternal subfertility from the alternative model was stronger: OR 2.6 (95%CI 0.9-7.2). 
Surprisingly, some indication for an association between hypospadias and paternal pesti­
cide exposure was revealed among case-referent pairs: OR 2.1 (95%CI 0.6-7.1). Sub-analyses 
in which cases and referents whose father had hypospadias were excluded, did not lead to 
different findings in either model.
Discussion
In this large case-referent study we assessed the contribution of a wide spectrum of 
potential risk factors in the development o f hypospadias, including the parents' health 
and fertility status, fertility treatments, DES-exposure, and pregnancy characteristics 
as well as parents' life style, drug use, and occupational exposures to various agents in 
the three months immediately prior to conception and during the first trim ester o f preg­
nancy. By simultaneously including all potential risk factors in the multivariable models, 
our aim was to identify their independent contributions to the risk o f hypospadias. Before 
these results can be reliably interpreted, however, it is necessary to consider the potential 
shortcomings in study design and analysis that may have affected the findings.
By recruiting referents through the parents o f the cases, we attained a referent popu­
lation that properly reflected the hospital's catchment area from which the cases origi­
nated, as shown by the similar distribution o f postal area codes. However, this recruit­
ment strategy may also raise concern about selection bias, especially because our data 
suggest that the willingness of case parents to approach other parents was associated 
with their educational level and native country. Therefore, we performed additional analy­
ses focusing only on those cases for whom a referent was available. The risk estimates for
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#these case-referent pairs may be considered to be the most valid. However, the somewhat 
different findings may also result from a loss o f precision due to the reduced population 
size. Therefore, we feel that both analyses are informative for the purpose o f exploring 
risk factors for hypospadias. We treated parents' educational level and native country as 
confounders under the assumption that the differences between the parents o f the cases 
and those o f the referents resulted from the referent recruitment strategy. However, edu­
cational level and native country may also be associated with hypospadias through, for 
example, exposures related to life style or occupation. In that case, some odds ratios may 
be underestimated due to overcorrection. An underestimation of some risk factors may 
also have occurred due to the similarities in, for example, residential area between cases 
and referents, which would have resulted from the recruitment of referents through the 
parents o f cases.
Potential information bias should be considered as well, especially since all exposure 
data were self-reported and collected retrospectively as far back as on average 10 years 
prior to the study. Non-differential misclassification o f exposure may have led to an 
underestimation o f effects. However, risk estimates may also have been overestimated 
due to recall bias, as parents o f cases may have tried to find an explanation for their 
child's defect. A comparison o f the effect estimates between boys younger and older than
10 years o f age at time o f data collection revealed a weaker association between hypo­
spadias and maternal use o f iron supplements in the older age group. This may be due to 
recall difficulties with respect to the use o f iron supplements among the mothers o f both 
cases and referents. The lack o f an association with maternal subfertility for older boys 
may be explained by changes in medical practice regarding subfertility (e.g. availability of 
fertility treatment) in the past 10-20 years. A possible explanation for the increased risk 
o f hypospadias found in this study when mothers o f older children were occupationally 
exposed to paint, varnish or thinners is that 10 years ago paints more often contained high 
levels o f organic solvents. However, overestimation due to differential recall cannot be 
ruled out either, although the effect estimates o f other risk factors did not differ substan­
tially between older and younger boys. Furthermore, many o f our findings are consistent 
with previous literature, which adds support to the validity of our results.
The most profound association revealed in this study was the increased risk o f hypo­
spadias among boys whose father had hypospadias himself. Among the fathers o f the 
cases in our study, 4% reported hypospadias, which seems to be compatible with previ­
ous studies which reported that hypospadias affects about 7% o f first, second and third 
degree relatives of cases12. The familial occurrence of hypospadias indicates an important 
genetic component in the etiology o f hypospadias, although family members may share 
environmental risk factors as well. Also consistent with previous literature, we found an 
increased occurrence o f hypospadias in children with a low birth weight or born out o f a 
multiple pregnancy. In these pregnancies, the placenta may have been insufficient in pro­
viding the fetus with nutrients and gonadotropins, o f which Human Chorionic Gonado-
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#tropin (H CG ) appears to play a specific role in male sexual differentiation. This may have 
led to both growth restriction, to which twins and triplets are more susceptible, and 
hypospadias8.
A strong indication for an increased risk o f hypospadias was found among boys whose 
mothers were exposed to DES in utero -  ‘DES-daughters' -  an association reported in a 
previous article by our research group31. In 2002, Klip et al. reported the prevalence ratio 
for hypospadias in sons of DES-daughters to be 21.3 (95%CI 6.5-70.1), which was the first 
suggestion o f a transgenerational effect o f DES in humans19. However, the association 
between intra-uterine DES-exposure and hypospadias was assessed in a cohort o f women 
with fertility problems, who do not reflect DES-daughters in general. According to our 
findings, the excess risk o f hypospadias appears to be of much smaller magnitude. This 
may be explained by the differences in study design, and in the study population in par­
ticular, and probably results in a more valid risk estimate that is concordant with findings 
from a recent study in France20. It is possible that DES-related pathology o f reproductive 
structures in DES-daughters interferes with normal fetal development during pregnancy, 
but other explanations have been suggested as well19. We found no indication that DES­
sons ‘transmit' a predisposition to hypospadias to their sons.
Our results also point towards an association between paternal subfertility and hypo­
spadias. According to the Testicular Dysgenesis Syndrome hypothesis, hypospadias and 
male subfertility may share the same origin, with genetic and environmental compo­
nents26. Hence, subfertile fathers may transmit a certain predisposition to their sons. Fur­
thermore, we found indications that fertility treatment increased the risk o f hypospadias. 
In previous studies, an increased occurrence o f hypospadias was reported following IVF 
and ICSI treatments15,16, and these risks were reflected in our data as well. We also found 
that mothers o f cases used ovulation stimulants relatively more often, which corresponds 
with the recently reported increased risk o f hypospadias following clomiphene treat­
ment17. One possible explanation is that hormones administered as part o f fertility treat­
ment interfere with male sexual hormones in early gestation and thereby disturb normal 
genital development. Progesterone used to support pregnancies achieved with ART, in 
particular, may impair testosterone production or its conversion to DHT15,32.
Our data suggest a slightly increased risk o f hypospadias when mothers smoked during 
pregnancy. This finding should be interpreted with caution, however, as smoking behavior 
is probably associated with the parents' educational level and native country and residual 
confounding by these cofactors cannot be ruled out. On the other hand, the suggestion 
that placental malfunctioning plays an important role in the origin o f hypospadias sup­
ports an increased risk when mothers smoked during pregnancy. The strongly increased 
risk o f hypospadias when fathers smoked prior to pregnancy reported by Pierik et al.24, 
was not reflected in our data.
An increased risk o f hypospadias was found when mothers used iron supplements 
immediately prior to conception and/or in the first trim ester o f pregnancy. North et al.
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#also mentioned such an association22. Iron Deficiency Anemia (IDA) in early pregnancy 
has been associated with preterm delivery, possibly due to long-term hypoxia and oxida­
tive stress33. Furthermore, it has been suggested that iron supplementation in mothers 
who are not iron deficient may cause toxic reactions or increase blood viscosity, which 
subsequently impairs placental blood flow34. No association with hypospadias was found 
when mothers used other prescriptive drugs. However, we did observe an increased risk 
when fathers used prescriptive drugs during the three months immediately prior to con­
ception. Because we pooled all drugs in this study, thereby disregarding their pharma­
cological characteristics, this unexpected finding is difficult to interpret. Unfortunately, 
the population size did not allow us to distinguish drugs that are biologically plausible to 
cause hypospadias. As past drug use is often hard to remember, the possibility that recall 
bias influenced the association between drug use and hypospadias cannot be ruled out.
The analyses on the case-referent pairs revealed an indication for an elevated risk 
when fathers were exposed to pesticides. Previous studies have reported inconsistent 
results on the association between pesticides and hypospadias, while there appears to be 
more agreement about an association with cryptorchidism23-25,35,36. Pierik and colleagues 
also reported a slightly increased risk o f hypospadias when fathers were occupationally 
exposed to solvents; this association, however, was not reflected in our data24. Exposure 
to pesticides, solvents, and other chemicals can be work-related, but may also occur 
through leisure time activities, diet, or personal care products. Future research projects 
should take into account all potential sources in order to clarify the role of these endo­
crine-disrupting chemicals in the development o f hypospadias. Some other associations 
have been described in the literature, but did not appear in our data; these include the 
association with increased maternal age13,14 and the strongly increased risk o f hypospadias 
in mothers with a vegetarian diet during pregnancy previously reported by North et al.22. 
However, the number o f vegetarian mothers in our study was extremely small.
In conclusion, we found that hypospadias more often occurred in children whose 
father had hypospadias, in children with a low birth weight, and in twins or triplets. The 
use o f iron supplements by mothers and other prescriptive drugs by fathers also appeared 
to be associated with hypospadias. We found indications for an increased risk o f hypospa­
dias when mothers were DES-daughters, when fathers were subfertile, and when preg­
nancy was achieved by means o f a fertility treatment. Some indication was found for an 
increased risk when mothers smoked during pregnancy and when fathers were exposed 
to pesticides. These risk factors support the idea that genetic predisposition, placental 
insufficiency, and substances that interfere with natural hormones before conception or 
during fetal development play a role in the etiology o f hypospadias. However, the popula­
tion size did not allow us to identify effects o f rare or weak risk factors. Larger studies 
could facilitate the identification o f these risk factors as well and provide opportunities 
for further in-depth investigation o f the associations found to date.
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Hypospadias: 
a transgenerational effect 
of diethylstilbestrol?
#Abstract
In 2 002 , an increased risk o f hypospadias was reported for sons o f w om en ex­
posed to d iethylstilb estrol (DES) in utero, suggesting transgenerational effects o f 
DES. The aim  o f this stud y w as to fu rth e r assess the association betw een parental 
DES e xpo su re and hypospadias in a case-referent study. Cases w ith hypospadias 
w ere retrieved from  the hospital inform ation system . Referents w ere recruited via 
the parents o f cases. Both parents com pleted postal questionn aires. A ssociations 
w ere estim ated by odds ratios (O R ) w ith 95 percent con fid en ce intervals (CI). 
A dditionally, con d itio nal logistic regression analyses w ere perform ed for a 
m atched subset o f parents. The final database included 583 cases and 251 
referents. In the initial analyses, an indication w as found for an increased risk of 
hypospadias w hen m others w ere exposed to DES in utero: O R  2.3 (95%CI 0.7-7.9). 
C o nd itio nal logistic regression resulted in a stro n ge r risk estim ate: O R  4.9 
(95%CI 1.1-22.3). Raternal e xpo sure to DES did not increase the risk. The results 
confirm  an increased risk o f hypospadias w hen m others w ere exposed to DES in 
utero. How ever, the excess risk appears to be o f m uch sm aller m agnitude than 
in the 2 0 0 2  study. Further research on the potential health risks for the third 
generation is o f great im portance.
#Introduction
In 2002, Klip et al. reported an increased risk o f hypospadias for sons of women who 
were exposed to diethylstilbestrol (DES) in utero1. Hypospadias is a common congenital 
birth defect in boys, which involves a dysplasia of the ventral penis and urethra and often 
requires several operative procedures2. The disorder affects approximately 30 to 4 0 chil­
dren out o f 10.000 live births, which implies 1 in 150 live-born males3. The increased preva­
lence found in offspring o f DES-daughters was the first suggestion o f a transgenerational 
effect of DES in humans1.
In the years 1938 through 1975, approximately 220.000 women in the Netherlands and 
a few million women around the world were prescribed DES during pregnancy in order to 
prevent a threatening miscarriage or premature birth. Unfortunately, this synthetic oes­
trogen was not only found to be ineffective, but also to have harmful effects. Daughters 
born out o f DES-related pregnancies often show abnormalities of reproductive structures 
and have elevated risks o f vaginal and cervical clear-cell adenocarcinoma, fertility prob­
lems, ectopic pregnancies, miscarriages, and premature births. There also appears to be 
an increased risk o f breast cancer for DES-mothers and o f reproductive tract abnormali­
ties for DES-sons4. Moreover, the question emerged whether the harmful effects o f DES 
may be ‘transmitted' to subsequent generations. Findings from animal studies suggest 
that DES causes certain genetic or epigenetic changes, which may be transmitted to sub­
sequent generations leading to increased susceptibility for tumours o f the reproductive 
tract5,6.
Hypospadias results from an incomplete fusion of the urethral folds between the 
eight and 14th week o f gestation. Male sexual differentiation in general depends on tes­
tosterone, dihydrotestosterone (DHT), and the expression of androgen receptors by tar­
get cells7. Disturbances in the balance o f this endocrine system by either endogenous 
or exogenous factors may lead to hypospadias. Well-established is the familial clustering 
o f hypospadias and the association with low birth-weight8-11. Indications for some other 
risk factors have also been reported12-16. However, the aetiology o f hypospadias remains 
largely unknown.
Klip et al. estimated the risk o f hypospadias in sons o f DES-daughters in a cohort of 
women diagnosed with fertility problems. This cohort counted 205 sons o f DES-daugh- 
ters, four of whom had hypospadias. In the remaining 8729 boys, only eight cases o f hypo­
spadias were reported, resulting in a prevalence ratio of 21.3 (95%CI 6.5-70.1)1. However, it 
is questionable whether these results can be extrapolated to the general population. The 
study exclusively involved women with fertility problems, who reflect a specific subset of 
DES-daughters. A recently published study o f registered data from France confirmed the 
increased occurrence of hypospadias in sons o f DES-daughters, but presented a probably 
more realistic prevalence ratio of 5.0 (95%CI 1.2-16.8)17. In another recent investigation in
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the United States, an inconclusive prevalence ratio o f 1.7 (95%CI 0.4-6.8) was observed18. 
All three studies focussed on maternal DES exposure only. In contrast, we conducted a 
population-based case-referent study in order to further evaluate the possible association 
between hypospadias and intrauterine DES exposure o f both parents.
Methods
Data of 937 patients diagnosed with hypospadias and born in the Netherlands between 
1987 and 1997 were retrieved from the hospital information system o f the Radboud Uni­
versity Nijmegen Medical Centre in the Netherlands. Mainly due to unknown address 
changes or misdiagnosis, 120 patients were non-eligible for the study. Both parents of 
the remaining 817 patients were asked to fill out a postal questionnaire addressing vari­
ous potential risk factors for hypospadias, including DES exposure. In order to recruit the 
referent population, these parents were asked to give an extra set o f questionnaires to 
the parents o f a boy o f about the same age as their son. Regarding paternal and maternal 
exposure to DES in utero, response options were ‘yes', ‘probably', ‘no', and ‘unknown'. 
Parents who listed probable exposure to DES were asked to clarify this. All data were self­
reported. Associations were estimated by odds ratios (OR) with 95 percent confidence 
intervals (95%CI) and were adjusted for confounding in logistic regression analyses. In 
addition, conditional logistic regression analyses were performed on the subset of case 
parents for whom referent parents were also available, to control for potential confound­
ing by unmeasured factors as a result o f the referent recruiting strategy. The study was 
approved by the Regional Committee on Research Involving Human Subjects.
Results
From the 817 eligible patients, the parents o f 613 patients completed the questionnaires, 
resulting in a response rate o f 75%. Additionally, completed questionnaires were received 
from the parents o f 264 referents. For 30 cases and 13 referents information could only be 
obtained from one parent, so they were excluded. The final database included 583 cases 
and 251 referents. The mean age o f cases and referents at time o f data collection was 
10.2 and 9.5 years respectively. Six mothers o f cases reported DES-related pathology and 
fertility problems, o f whom one achieved pregnancy with in vitro fertilization. Table 3.1 
presents the intrauterine exposure to DES for the parents o f cases and referents. When 
mothers were probably or certainly exposed to DES in utero, their sons appeared to have 
an increased risk o f hypospadias: OR 2.6 (95%CI 0.8-9.0). Educational level was considered 
to be a confounder, because it differed substantially between case and referent parents 
and might have been a proxy for other risk factors related to life style or occupation.
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#table 3.1 Parental exposure to DES in utero and the risk of hypospadias in offspring
Cases 
(n=583) 
yes/noa (%)
Referents 
(n=251) 
yes/noa (%)
Odds Ratio 
(95% CI)
Adjusted 
odds Ratiob 
(95%  CI)
Mothers probably or certainly 
exposed to DES in utero
18/565 (3.1) 3/248 (1.2) 2.6 (0.8-9.0) 2.3 (0.7-7.9)
Fathers probably or certainly 
exposed to DES in utero
8/575 (1.4) 3/248 (1.2) 1.2 (0.3-4.4) 1.1 (0.3-4.2)
a Parents with unknown exposure status (71 mothers and 136 fathers) were considered to be non-exposed 
b Adjusted fo r  educational level (3 levels) o f the mother and father, respectively
After adjustment for confounding by educational level, however, an indication for an 
increased risk o f hypospadias remained: OR 2.3 (95%CI 0.7-7.9). Associations were not 
found between hypospadias and exposure o f the father to DES in utero: OR 1.1 (95%CI 
0.3-4.2). The variation o f the potential for DES exposure over time was another possible 
source o f confounding, but adjusting for the parent's year o f birth and additional analyses 
excluding parents born after 1976 did not lead to different findings. Effect-measure modi­
fication or confounding by other factors could not be identified.
Because DES exposure was unknown for many parents (71 mothers and 136 fathers), 
these parents were considered non-exposed. Excluding cases and referents with unknown 
exposure-status from the analyses did not change the effect estimates. The mothers of 
eleven cases and three referents were certain about their exposure to DES in utero. The 
remaining seven mothers o f cases suspected DES exposure, most often because their 
mothers received an unknown medicine for preventing miscarriage or because they suf­
fer from uterine abnormalities typical for intra-uterine DES exposure. Exclusively focus-
table 3.2 Parental exposure to DES in utero and the risk of hypospadias in offspring: 
conditional logistic regression analyses on a ‘matched' subset of cases and referentsa
Cases 
(n=232) 
yes/nob (%)
Referents 
(n=232) 
yes/nob (%)
Conditional 
Odds Ratio 
(95% CI)
Adjusted 
Odds Ratioc 
(95% CI])
Mothers probably or certainly 
exposed to DES in utero
12/220 (5.2) 3/229 (1.3) 5.5 (1.2-24.8) 4.9 (1.1-22.3)
Fathers probably or certainly 
exposed to DES in utero
2/230 (0.9) 2/230 (0.9) 1.0 (0.1-7.1) 0.9 (0.1-6.7)
a Analyses were performed on the subset o f case parents fo r  whom referent parents were also available 
b Parents with unknown exposure status (28 mothers and 63 fathers) were considered to be non-exposed 
c Adjusted fo r  educational level (3 levels) o f the mother and father, respectively
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#sing on mothers who were certain about their DES-exposure weakened the association 
with hypospadias substantially: OR 1.6 (95%CI 0.2-4.7). The fathers of four cases and two 
referents were certain about exposure to DES in utero, while the fathers of the other four 
cases and one referent suspected exposure.
On a subset o f the parents o f 232 cases for whom both referent parents were also avail­
able, conditional logistic regression analyses were performed in which the tie between 
cases and referents was considered a matching variable. As is shown in Table 3.2, the 
association between hypospadias and maternal DES exposure was much stronger in this 
analysis compared to the initial analyses: OR 4.9 (95%CI 1.1-22.3). The same was observed 
when the analyses were restricted to mothers certainly exposed to DES: OR 3.0 (95%CI 
0.6-14.9). Risks estimates concerning paternal DES exposure did not change.
Discussion
O ur findings indicate an increased risk o f hypospadias in offspring o f women who were 
exposed to DES in utero. However, the excess risks estimated in our population appear 
to be of much smaller magnitude than in the previous findings in the Netherlands1. This 
may be explained by a different study design and study population, probably resulting in 
a more valid risk estimate, that is concordant with recent findings in France17. In the USA, 
Palmer et al. found no evidence for an increased risk of hypospadias in a combination of 
existing cohorts o f DES-daughters and their referents, but the broad confidence interval 
is compatible with our risk estimate18. In both the US study and the previous Dutch study, 
the occurrence o f hypospadias in offspring was self-reported and assessed in a manner 
that raises concern about underreporting. In contrast, Pons and colleagues studied the 
prevalence o f hypospadias in children who were born in a hospital in France and their 
data-collection showed many similarities with ours. Mothers who gave birth were system­
atically asked about their intra-uterine DES exposure and diagnoses o f hypospadias were 
confirmed by medical files17. The fact that their risk estimate (prevalence ratio 5.0 (95%CI
1.2-16.8)) is concordant with ours, adds support to the validity and reliability o f the results 
in the current study.
However, the self-reported nature of DES exposure may have biased these results. 
Both case and referent parents may not have been aware of their mother's use o f DES 
during pregnancy, possibly leading to nondifferential misclassification o f exposure status 
and underestimation o f the effect o f DES. Since the link between DES and hypospadias 
in grandchildren is not very obvious and certainly not common knowledge, it seems less 
likely that the effect estimates were overestimated due to recall bias, although this can­
not be ruled out either. A strong argument against recall bias, however, is that the odds 
ratios for fathers centre around unity.
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#As mentioned before, Klip et al. assessed DES exposure in a cohort of women with fertil­
ity problems (prevalence ratio 21.3 (95%CI 6.5-70.1)). Reduced fertility and infertility treat­
ment may be intermediate factors in the causal pathway in which DES increases the risk 
o f a son with hypospadias12,13. These women may therefore not reflect DES-daughters in 
general, unlike the DES-exposed mothers in our study. Furthermore, the low prevalence 
o f hypospadias in the control group is reason for concern that selective underreporting 
affected the risk estimated by Klip et al.19. The authors comment that mild cases were 
less well represented in both groups1, but this does not mean that mild cases were in fact 
underreported in both groups. Possibly, DES or DES-related causal factors lead to a more 
severe manifestation o f hypospadias, so that mild cases are not to be expected in the 
exposed group.
Due to the referent recruitment strategy in our study, data were collected for a ref­
erent boy for less than half o f the cases only. This resulted in a non-random sample of 
referents in which the referent parents on average seemed to be higher educated than 
the parents in the case population. That is why we performed additional analyses focus­
sing only on the cases for whom referent parents were also available. In this ‘matched' 
subset, the association between maternal exposure to DES and hypospadias appeared to 
be stronger. We feel that this risk estimate (OR 4.9 (95%CI 1.1-22.3)) is probably more valid 
than the estimate based on the total study population. Nevertheless, it remains uncertain 
whether the referents were an accurate reflection o f the source population of the cases 
and to what extent this influenced the results.
The mechanism through which DES could cause adverse effects in the third generation 
is unclear. According to our findings, DES-sons are unlikely to ‘transmit' a predisposition 
to hypospadias to their sons. DES-related pathology o f reproductive structures in DES- 
daughters, however, may interfere with normal foetal development during pregnancy. 
Additionally, DES-daughters could suffer from a disturbed hormonal balance during adult 
life. A third suggestion is that certain genetic or epigenetic defects are transmitted, which 
increases the risk o f hypospadias for their sons1. The latter hypothesis is supported by 
findings from animal studies and implies that other health risks may also be expected 
in the third generation5,6. In 2003, Blatt et al. described a 15-year-old girl with small cell 
ovarian carcinoma whose mother was exposed to DES in utero20. Although it concerned 
only one case, this finding seems to be as alarming as the independent findings on hypo­
spadias in this study and the previous studies. Further research, with a more thorough 
assessment of both exposure and outcome, should clarify the ability o f DES to affect 
grandchildren, as it is o f great importance to identify their potential health risks at pres­
ent as well as in the future.
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Hypospadias: 
risk factor patterns and 
different phenotypes
#Abstract
Objective To obtain m ore insight into the origin o f hypospadias by e xplo rin g  a 
w ide range o f potential risk factors in a case-referent stud y in w hich a distin ctio n 
w as m ade betw een d ifferent phenotypes.
Patients and methods C ases and referents w ere 305 boys w ith hypospadias and 
629 boys w ith m iddle ear effusion w hose parents com pleted postal q u e stio n ­
naires. H ypo spadias phenotype w as classified as distal (n=i95), m iddle (n=67), and 
proxim al (n=43). A djusted odds ratios (O R) w ith 95% con fid en ce intervals (CI) 
w ere estim ated using logistic regression.
Results Low birth w eight, being a twin or triplet, m other being a DES-daughter, 
fertility  treatm ents, paternal subfertility, obesity, and prescriptive drug use, and 
fam ilial occurren ce  o f hypospadias or testicu lar can ce r w ere associated w ith hy­
pospadias in general. For fam ilial o ccu rren ce  o f hypospadias, there w ere high risk 
estim ates for the distal and m iddle phenotypes w ith an O R  (95% CI) o f 10.4 (4.5­
24.1) and 9.0 (3.1-26.0), but not for the proxim al type: 1.8 (0.2-14.9). By contrast, 
the associatio n w ith low birth w eight (a proxy for placental d ysfu nction ) seem ed 
m uch stron ger for proxim al hypospadias w ith an O R  (95% CI) o f 9.1 (3.4-24.2) 
com pared to distal and m iddle hypospadias at 2.6 (1.4-5.0) and 2.3 (0.8-6.5). There 
w ere sim ilar estim ates for preeclam psia.
Conclusion These findings indicate aetiological heterogen eity o f hypospadias 
and provide ind icatio ns for the possible m echanism s through w hich specific risk 
factors may interfere w ith penile developm ent.
#Introduction
Hypospadias is a common urogenital birth defect that originates from a disturbed penile 
development between gestational weeks seven and 141. There is a large diversity in mani­
festations o f hypospadias, in which the location o f the urethral meatus can vary from the 
penile glans to the scrotum or perineum. Hypospadias affects approximately one in 150 
boys2. Causal explanations are limited to only a few patients3, which stresses the need for 
further aetiological research.
Previous studies have consistently demonstrated familial clustering o f hypospadias 
with approximately 7% o f the patients reporting hypospadias in first- or second-degree 
relatives4. Familial occurrence has been noticed to be more common for patients with 
glanular hypospadias, while patients with penoscrotal or perineal hypospadias are most 
often sporadic cases5. An increased occurrence o f hypospadias in children with low birth 
weight has also been well established and this association appears to be stronger in more 
proximal manifestations o f hypospadias6,7. Low birth weight may reflect placental insuf­
ficiency in providing the foetus with both nutrients and gonadotrophins, which is also a 
plausible explanation for increased occurrence o f hypospadias in twins and triplets and 
for the association with preeclampsia8-10. Other factors that have been linked to hypospa­
dias include increased maternal age6,11, maternal intra-uterine exposure to Diethylstilbes- 
trol (DES)12-14, fertility treatment15-18, paternal subfertility19,20, smoking21, prescriptive drug 
use20, and maternal obesity22 and iron supplementation20,23.
According to the Testicular Dysgenesis Syndrome (TDS) hypothesis, hypospadias 
partly shares its aetiology with undescended testes (UDT), testicular cancer, and reduced 
semen quality24. The hypothesis indicates prenatal exposure to endocrine disruptors 
(EDs) and genetic predisposition as common causes for the four disorders. EDs include a 
growing list of industrial chemicals such as pesticides, dioxins, and phthalates, but also 
synthetic hormones and natural phytoestrogens. Examples of reproductive defects in 
w ildlife after environmental pollution and findings from experimental animal and in vitro 
models with EDs are cause for concern. However, there is little epidemiological evidence 
for a role o f EDs in the aetiology of hypospadias21,23,25,26.
In summary, several potential risk factors for hypospadias have been reported, but 
these require confirmation. The role o f other factors, and especially exposure to EDs, 
remains largely unclear. In addition, some suggestions for aetiological heterogeneity of 
hypospadias have been described, although this had not extensively been studied. For 
these reasons, we conducted a case-referent study in which we explored a wide range of 
potential risk factors. We distinguished between distal, middle, and proximal hypospa­
dias phenotypes, with the expectation that these more homogeneous subgroups could 
reveal novel associations and could give more insight into the pathological mechanisms 
involved.
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#Subjects and methods
Population
Cases and referents were recruited at one university hospital and three general hospitals 
in The Netherlands. All subjects were born between 1996 and 2004. Cases were boys 
who had surgery for hypospadias at departments o f Urology. Referents were found at 
the departments of Otorhinolaryngology and were boys who received ear ventilation 
tubes for persistent middle ear effusion. This is a very common surgical procedure, so 
we expected these referents to be a good representation of the general population. By 
including children who had early childhood surgery as referents, we also aimed to mini­
mize recall bias. Most o f the cases and some o f the referents were treated at the Rad­
boud University Nijmegen Medical Centre (RUNMC), which serves as a referral hospital 
for hypospadias for a large population in the eastern part o f The Netherlands. To recruit 
additional referents from the same catchment area, three general hospitals located in this 
area were also involved.
The total numbers o f eligible cases and referents identified from the hospitals' infor­
mation systems were 494 and 2911, respectively. The cases were restricted to 465 boys 
who resided within the catchment areas o f the participating hospitals. Seventy-four of 
these already participated in a case-referent study on hypospadias in 200220. Based on 
the distribution o f the postal area codes among the cases, 1125 referents were randomly 
selected. The personal data o f all subjects were screened in order to identify twins and 
triplets (from which one sibling was randomly selected), other siblings (from which the 
oldest sibling was selected), and double records, resulting in a final selection of 460 cases 
and 1091 referents.
Data collection
In February 2005, the parents o f cases and referents were sent identical sets o f question­
naires, followed by two reminders after three and seven weeks to increase the response 
rate. The questionnaires included items on socioeconomic characteristics, familial history 
of birth defects and illnesses, and the medical history o f their son. Referring to the time 
just before and during the index pregnancy, parents were asked about health status, preg­
nancy details, life style, various exposures at work or during leisure time activities, and 
diet. These items included questions about the use o f personal care products and expo­
sure to pesticides, solvents, or other chemicals at work and during home improvements 
or hobbies as potential sources o f exposure to EDs. For the dietary intake variables, we 
focused on soy replacements for meat or dairy (as rich sources o f phytoestrogens) and 
seafood (as a rich source o f persistent endocrine disrupting pollutants). We also included 
a question included about being a ‘DES-daughter' or ‘DES-son', and parents who sus­
pected or were certain about prenatal DES exposure were asked to clarify this.
58 c h a p t e r  4
#To avoid selective non-response and information bias, parents were informed that the 
study was designed to investigate associations between life style, diet, illnesses, and 
complications around pregnancy and children's health in general, not focusing on uro­
genital birth defects. About 150 parents were contacted by phone to complete their ques­
tionnaire information. Clinical data o f the cases were collected from medical files. The 
location o f the urethral opening was classified in the nine levels that are presented in 
F igu re4.1. Cases with a glanular or coronal urethral opening but with a poorly developed 
membrane-like penile urethra were classified as proximal penile hypospadias. The study 
was approved by the Regional Committee on Research Involving Human Subjects.
Outcome and exposure classification
Based on the questionnaire data, referents with a major birth defect as defined in the 
EUROCAT registry protocol27 were excluded from the study population. Referents with 
UDT, a minor abnormality according to EUROCAT, were excluded as well, because this 
disorder shares several risk factors with hypospadias. Only cases with syndromal hypo­
spadias or chromosome abnormalities were excluded, but sub-analyses were performed 
to see whether exclusion o f cases with other major birth defects affected the main study 
results. The hypospadias phenotypes were divided in distal, middle, and proximal hypo­
spadias, according to the location o f the urethral opening as shown in Figure4.1. ‘Hypospa­
dias sine hypospadia', i.e. a ventral lack o f prepuce but a normal location o f the urethral 
opening, was classified as distal hypospadias in the primary analyses, but sub-analyses 
were performed excluding this phenotype.
Regarding the risk factor data, adjustments were made to the input for specific occu­
pational exposures, as the data indicated that occupational exposure was sometimes 
confused with private use o f chemical products. For instance, only parents who were 
employed in the cosmetic industry (e.g. beauticians and hairdressers) or in health care 
(e.g. nurses and geriatric helpers) were considered likely to work with cosmetics. For 
the private use o f cosmetics, parents listed all products they had used daily at time of 
the index pregnancy. These products were classified into different product groups, e.g. 
‘deodorant', ‘hairstyling products', and ‘body lotion'. Following, a summary variable was 
made with three categories based on the number o f product groups used per day.
Data analyses
In the case-referent comparisons, crude odds ratios (ORs) with 95% confidence intervals 
(CI) were calculated for all potential risk factors. Next, multivariable logistic regression 
analyses were performed for factors with crude ORs > 1.5 and a lower bound o f the 95%CI 
> 0.7 and for less elevated ORs with more precision, to adjust for confounding. In these 
analyses, parental educational level, ethnic origin, and all other identified or previously 
reported risk factors for hypospadias (approximately 20 variables), were treated as poten­
tial confounders, except for those factors that shared their causal pathway with the risk
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#factor of interest (e.g. low birth weight was not included as a confounder in the analy­
sis o f preeclampsia). Confounders that changed the crude ORs with at least 10% were 
included in the multivariable analyses simultaneously. All associations were adjusted for 
year o f birth to account for potential trends in exposure levels or probabilities over time. 
To obtain an indication for the influence o f misclassification in case of a long recall inter­
val, sub-analyses were performed to assess differences in ORs in case o f short (1-5 years) 
or long (6-9 years) time periods between delivery and data collection.
Effect estimates for the distal, middle, and proximal phenotypes were calculated with 
multinomial logistic regression analyses. These analyses included potential risk factors 
identified in the present data, previously reported risk factors, and factors reflecting ED 
exposure, but were restricted to variables with at least three exposed subjects in the ref­
erent group and in each of the three case subgroups. All ORs were adjusted for the same 
confounders as in the case-referent analyses described above. Additionally, we assessed 
confounding by other risk factors for which there were heterogeneous associations with 
distal, middle, and proximal hypospadias.
Results
Completed questionnaires were received from the parents o f 328 cases and 741 referents, 
which corresponds to response rates of 74% and 70%, respectively, taking into account 17 
cases and 37 referents with unknown address changes. For two cases and seven referents 
essential questionnaire data were missing. An additional 105 referents were excluded, 
because of UDT (12 boys) or major birth defects (93 boys), including 37 orofacial clefts 
and seven Down syndromes, which are associated with persistent middle ear effusion.
figure 4.1 Prevalence and classification of hypospadias phenotypes In the present study
0 ‘sine hypospadia' (n=i8)
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2 (sub)coronal (n=ii4)
3 distal penile (n=38)
4 midshaft (n=22)
5 proximal penile (n=7)
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8 perineal (n=o)
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#table 4.1 Parental educational level and ethnic background of cases and referents
Referents (n=629) 
No. (%)
Cases (n=305) 
No. (%)
Educational level of parents:
Mother Low 153 (24.6) 77 (25.7)
Intermediate 306 (49.1) 154 (51.3)
High 164 (26.3) 69 (23.0)
Father Low 164 (28.2) 94 (33.1)
Intermediate 227 (39.1) 98 (34.5)
High 190 (32.7) 92 (32.4)
Ethnic background of parents:
Mother European Caucasian 609 (97.9) 283 (93.7)
Other 13 (2.1) 19 (6 .3)
Father European Caucasian 568 (97.4) 270 (94 .4 )
Other 15 (2.6) 16 (5.6)
N.B. There were no questionnaire data available from  2 mothers and 19 fathers o f cases and 4 mothers and 46 
fathers o f referents. Proportions o f missing data were < 1% per variable.
We also excluded seven cases with syndromal hypospadias or chromosome abnormalities 
and 14 ‘cases' who did not have hypospadias, but were treated for epispadias (five boys), 
phimosis (eight), or complications o f a previous circumcision (one). Thus, the data analysis 
included 629 referents and 305 cases, of whom 195 cases were classified as distal (64%), 67 
cases as middle (22%), and 43 cases as proximal hypospadias (14%) (Figure 4.1).
Cases were approximately 10 months younger than referents, their mean age at time 
o f data collection was 4.7 (SD 2.0) and 5.5 (SD 2.1) years, respectively. Additionally, parents 
o f cases more often reported a non-European ethnic origin, including Turkish, Moroccan, 
Surinamese, Antillean, Asian, and other origins (Table 4.1). A Turkish origin in particular 
was more common among parents o f cases (nine mothers and nine fathers) compared to 
parents o f referents (two mothers and two fathers). No substantial differences in parental 
education were identified. Due to the population recruitment strategy, the two popula­
tions had similar geographical distributions.
Crude and adjusted ORs for potential risk factors for hypospadias are presented in 
Tables 4.2 and 4.3, which show generally little influence o f confounding. The highest risk 
estimate for hypospadias was associated with occurrence o f the disorder in first- or sec­
ond-degree relatives: OR 8.8 (95%CI 3.9-19.7) (Table4.2). There was also an association with 
familial occurrence o f testicular cancer: OR 5.0 (95%CI 1.2-20.2), although cell counts were 
low. The data also reflected associations with low birth weight: OR 3.2 (95%CI 1.8-5.7), twin 
and triplet pregnancies: OR 2.0 (95%CI 1.0-3.9), and preeclampsia: OR 3.2 (95%CI 1.6-6.4).
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t a b l e  4.2 Associations between hypospadias and familial predisposition, gestational and obstetric risk factors, and factors associated with subfertility
No. referents 
(n=629)
No. cases 
(n=305)
Odds ratio (95%CI) 
Crude Adjusted3
Familial history (ist or 2nd degree) of:
Hypospadias 8 31 8.3 (3.8-18.3) 8.8 (3-9 -19-7)
Cryptorchidism 45 26 i.i (0.7-1.9) i.i (0.7-I.9)
Testicular cancer 3 6 4.1 (1.0-16.6) 5.0 (1.2-20.2)
Gestational and obstetric characteristics:
Low birthweight (< 2500g)b 43 59 2.9 (1.6-5.0) 3.2 (1.8-5-7)
Twin or triplet 20 18 1-9 (1.0-3.7) 2.0 (1-0 -3-9)
Pre-eclampsia during index pregnancy 15 22 3.2 (1.6-6.2) 3.2 (1.6-6.4)
Gestational hypertension during index pregnancy 77 51 1.4 (1.0-2.1) 1.4 (1.0-2.1)
Increased maternal age (> 35 years) 99 50 i.i (0.7-1.5) i.i (0.7-1.6)
Prenatal DES exposure:
Mother is probably DES-daughter 16 12 1.6 (0.8-3.4) 1.6 (o.7-3-4)
Father is probably DES-son H 8 i.i (0.5-27) 1.2 (0.5-3.0)
Factors associated with subfertility:
TTP > 6 months, excluding fertility treatments 98 65 1.6 (11-2-3) 1.6 (1.1-2.3)
Subfertility of mother 61 25 0.8 (0.5-14) 0.8 (0.5-14)
Subfertility of father 17 22 2.8 (1-5-5-3) 2.9 (1.4-5.8)c
Index pregnancy achieved with fertility treatment (any) 42 32 1.6 (1.0-2.7) 1.2 (o.7-2.2)d
Index pregnancy achieved with IVF/ICSI 10 H 3.0 (1.36.8) 2-3 (o.9 -5.8)d
N.B. There were no questionnaire data available from  2 mothers and 19 fathers o f  cases and 4 mothers and 46  fathers o f referents. Proportions o f missing data were < 5% per variable, 
except fo r familial history o f hypospadias (8%) and cryptorchidism (15%) and prolonged TTP (10%). 
a All risk estimates were adjusted fo r year o f birth b Adjusted fo r gestational age (in weeks)
c Adjusted fo r year o f birth, low birth weight, and gestational age (in weeks) d Adjusted fo r year o f birth and familial occurrence o f hypospadias
#Correspondingly, there were associations with gestational hypertension and with antihy­
pertensive drug use: OR 2.2 (95%CI 0.9-5.1) (Table4.3). Other pregnancy complications (e.g. 
gestational diabetes or anaemia) and increased maternal age were not associated with 
hypospadias. However, there appeared to be a slightly elevated risk of hypospadias when 
the mother thought or was certain that she was a DES-daughter, because her mother had 
used DES or an unknown drug to prevent miscarriage: OR 1.6 (95%CI 0.7-3.4). In addition, 
hypospadias occurred more often after a prolonged time to pregnancy: OR 1.6 (95%CI 1.1­
2.3), after in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment: 
OR 2.3 (95%CI 0.9-5.8), and when fathers reported subfertility: OR 2.9 (95%CI 1.4-5.8).
There was some indication for an association with obesity o f the father (but not of 
the mother): O R 1.5 (95%CI 0.8-2.9) (Table 4.3). Fathers o f cases also slightly more often 
reported prescriptive drug use, particularly antipsychotic drugs, in the three months 
before the index pregnancy: OR 1.5 (95%CI 0.9-2.4). Mothers o f cases less often reported 
the use o f antibiotics just before or during pregnancy: OR 0.5 (95%CI 0.3-0.8), but there 
were no associations with other prescription drugs or vitamin supplements (including 
folic acid). Also, hypospadias could not be associated with smoking or private use o f cos­
metics by either parent. Against expectations, mothers o f cases less often reported occu­
pational exposure to cosmetics at time o f pregnancy: OR 0.4 (95%CI 0.2-1.0). Both case- 
parents were more likely to respond positively to an open-ended question on occupational 
exposure to dusts, which was difficult to interpret because different types o f dust were 
listed, such as dust from hay, grain, construction processes, and plastic manufacturing. 
Only fathers o f cases more often reported exposure to dusts from grinding metals: OR 
4.3 (95%CI 1.0-18.4). Additionally, fathers more often described occupational exposure to 
gasoline fumes in the three months before pregnancy: OR 1.9 (95%CI 0.9-4.0). There were 
no associations with other occupational exposures. A vegetarian or vegan diet, intake of 
soy replacements for meat or dairy, and intake o f seafood could not be associated with 
hypospadias, either.
In the stratified sub-analyses, no clear differences were found in the ORs for dietary 
intake variables, occupational exposures, prescriptive drug use, and familial history 
between subjects aged 6-9 years and subjects aged 1-5 years at time o f data collection. 
However, the potentially increased risk o f hypospadias in case o f paternal obesity and 
the inverse association with maternal use of antibiotics, seemed to be more pronounced 
in younger subjects compared with the older age group: OR 2.4 (95%CI 1.0-5.3) vs. OR 
0.7 (95%CI 0.2-2.4) and OR 0.3 (95%CI 0.1-0.5) vs. OR 1.6 (95%CI 0.7-3.7), respectively. In 
contrast, there were somewhat stronger associations with low birth weight and paternal 
subfertility in older vs. younger subjects: OR 4.9 (95%CI 0.9-1.1) vs. OR 2.0 (95%CI 0.9-4.5) 
and OR 5.1 (95%CI 1.9-13.6) vs. OR 1.5 (95%CI 0.5-4.1), respectively. There was a similar but 
much larger difference in ORs for IVF/ICSI treatment: OR 7.2 (95%CI 1.8-29.0) vs. OR 0.5 
(95%CI 0.1-2.3).
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t a b l e  4.3 Associations between hypospadias and obesity, prescriptive drug use, vitamin supplem ents, smoking, cosm etics, occupational exposures, and diet
No. referents 
(n=629)
No. o f cases 
(n=305)
Odds Ratio (95%CI) 
Crude Adjusted8
Obesity (BMI > 30 kg/m2)
Motherb 30 18 1.2 (0.7-2.3) 1.0 (0 -5-1-9)
Fatherb 25 19 1.6 (0.8-2.9) i -5 (0.8-2.9)
Prescriptive drug use:
Mother1 Any drug 340 156 0.9 (0.7-1.2) 0.9 (07-1-2)
Iron supplements 238 95 0.7 (0.6-1.0) 0.8 (0.6-1.1)
Antibiotics 64 18 0.6 (0.3-1.0) 0.5 (0.3-0.8)
Antihypertensives 11 12 2.3 (1.05.3) 2.2 (0.9-5.1)
Antipsychotic drugs 7 4 1.2 (°-3"4 -i) i.i (0.3-4.0)
Oral contraceptives: after conception 7 4 1.2 (°-3"4 -i) i.i (0.3-4.0)
Fatherb Any drug 42 33 1.6 (1.0-2.7) 1-5 (0.9-2.4)
Antipsychotic drugs 2 6 6.1 (1.2-30.3) 3-1 (0.6-16.7)e
Maternal intake of folic acid or other vitamin supplementsf 459 229 1.1 (0.8-1.5) 0.9 (0.6-1.2)
Smoking:
Mother11 109 47 0.9 (0.6-1.2) 0.9 (0.6-1.3)
Fatherb 204 93 0.9 (0.7-1.2) 0.9 (07-1-3)
Private use of cosmetics/day:
Mother1 Used 0-2 product groups 85 37 ref8 ref8
Used 3-6 product groups 401 37 1.2 (0.8-1.9) i.i (07-1-7)
Used 7/8 product groups 
Fatherb Used 0/1 product groups
131
162
213
74
0.9
refs
(0.5-1.5) 0.8
ref8
(0.5-1.4)
Used 2-4 product groups 389 202 i.i (0.8-1.6) i.i (0.8-1.5)
Used 5 product groups 20 6 0.7 (0.3-17) 0.7 (0.3-1.8)
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Occupational exposures:
Mother1 Cosmetics 37 8 0.4 (0.2-0.9) 0.4 (0.2-1 .o)h
Pesticides 12 4 0.7 (0.2-2.1) 0.8 (0.2-2.4)
Paints, ink, adhesives, or thinners 
(at least 8h/w eek)
6 2 0.7 (0.1-34) 0.6 (0.1-3.2)
Industrial cleaning agents or solvents 
(at least 8h/w eek)
7 4 1.2 (0.3-4.0) 1.0 (0 -3-3-5)
Dusts (any) 7 8 2-4 (0.9-6.6) 1.8 (0 .6-5.2)1
Fatherb Pesticides 30 11 O.7 (0.4-1.5) 0.8 (0.4-1.6)
Paints, ink, adhesives, or thinners 
(at least 8h/w eek)
27 13 1.0 (0.5-1.9) i.i (0.5-2.2)
Industrial cleaning agents or solvents 
(at least 8h/w eek)
12 7 1.2 (0.5-3.1) 1.2 (0.5-3.1)
Dusts (any) 52 35 1.4 (0.9-2.3) 1-5 (0.9-2.3)
Dusts from grinding metals 3 5 3-4 (0.8-14.5) 4-3 (1.0-18.4)
Gasoline fumes 15 14 2.0 (0.9-4.1) 1-9 (0.9-4.0)
Diet:
Mother11 Vegetarian or vegan diet 12 6 1.0 (0.4-2.8) 1.0 (0.4-2.7)
Soy meat replacements (at least once/w eek) 18 6 0.7 (0.3-17) 0.7 (0-3-17)
Seafood (at least once/w eek) 293 132 0.9 (07-1-2) 0.9 (0.7-1.2)
Fatherb Vegetarian or vegan diet 4 0 - -
Soy meat replacements (at least once/w eek) 17 7 0.8 (0.3-2.0) 0.7 (0.3-1.8)
Seafood (at least once/w eek) 284 123 0.8 (0.6-1.1) 0.9 (0.6-1.1)
N.B. There were no questionnaire data available from  2 mothers and 19 fathers o f  cases and 4 mothers and 46  fathers o f referents. Proportions o f missing data were < 5% per variable, 
except fo r paternal obesity (6%), prescriptive drug use (15%), and intake o f  soy meat replacements (6%).
a All risk estimates were adjusted fo r year o f birth f  In the 3 months before pregnancy and/or in the first 4 months o f pregnancy
b In the 3 months before pregnancy g Reference category
c In the 3 months before pregnancy and/or during pregnancy h Adjusted fo r year o f birth and familial occurrence o f hypospadias
d During pregnancy ' Adjusted fo r year o f birth, low birth weight, and gestational age (in weeks)
e Adjusted fo r year o f birth and familial occurrence o f hypospadias and testicular cancer
o\v-n
#Figure4.2 presents the adjusted ORs for the distal, middle, and proximal phenotypes. The 
analyses were restricted to relatively common factors as defined in the method section, 
except for familial occurrence o f hypospadias because o f its high effect estimate in the 
case-referent comparisons. There were associations of similar strength between familial 
occurrence and the distal and middle phenotypes: OR 10.5 (95%CI 4.5-24.1) and OR 9.0 
(95%CI 3.1-26.0), whereas the OR for proximal hypospadias was much lower, albeit impre­
cise: OR 1.8 (95%CI 0.2-14.9). In contrast, the association with low birth weight seemed 
much stronger for proximal hypospadias: OR 9.1 (95%CI 3.4-24.2) compared with distal 
and middle hypospadias: OR 2.6 (95%CI 1.4-5.0) and OR 2.3 (95%CI 0.8-6.5), respectively. A 
remarkably similar trend in ORs emerged for preeclampsia: OR distal 1.8 (95%CI 0.7-4.3), 
OR middle 2.6 (95%CI 0.8-8.3), and OR proximal 12.4 (95%CI 5.1-30.0). Among the cases 
with proximal hypospadias (43 boys), 20 boys had low birth weight (47%) and 10 boys 
were born after gestational preeclampsia (23%).
The increased risks o f hypospadias when the mother was a DES-daughter or the father 
was obese seemed to be restricted to the middle and proximal phenotypes. Fertility treat­
ment as a group appeared to only increase the risk o f middle hypospadias with an OR of 
2.5 (95%CI 1.1-5.3). The associations with paternal subfertility and IVF/ICSI treatment also 
seemed to be strongest for middle hypospadias, although the prevalence o f IVF/ICSI was 
too low to assess this in a multivariable model. The associations with self-reported pater­
nal exposure to dusts and gasoline fumes were strongest for middle hypospadias: OR 3.0 
(95%CI 1.5-5.8) and distal hypospadias: OR 2.2 (95%CI 1.0-4.8), respectively. There were 
no substantial differences in ORs between phenotypes for being a twin or triplet, pro­
longed time to pregnancy, paternal prescriptive drug use, maternal use o f antibiotics (not 
shown), and maternal occupational exposure to cosmetics (not shown). Additionally, the 
multinomial analyses did not reveal associations between hypospadias phenotypes and 
other suggested risk factors or ED exposures, including increased maternal age, mater­
nal obesity, maternal and paternal smoking, use o f cosmetics, and intake o f seafood, and 
paternal occupational exposure to pesticides or paint, ink, adhesives or thinners.
Exclusion from the analyses o f 31 cases with co-existing birth defects (including UDT, 
n=15) or 18 cases with hypospadias sine hypospadia did not substantially affect any o f the 
reported effect estimates.
Discussion
The present study supports several previously reported associations and gives indications 
for some novel risk factors for hypospadias, including familial occurrence o f testicular 
cancer and paternal obesity. Furthermore, there were indications for aetiological hetero­
geneity of hypospadias. To correctly interpret these results, we will first reflect on some 
methodological issues.
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#figure 4.2 Associations between potential risk factors for hypospadias 
and the distal, middle, and proximal phenotypes
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#We selected boys who received ear ventilation tubes as the referent population, to obtain 
a comparable group o f boys who had early childhood surgery and geographically repre­
sented the source population o f the cases. To our knowledge, persistent middle ear effu­
sion has not been associated with the risk factors that were investigated in the present 
study28. However, the same may not be true for the birth defects that were reported for 
referents, which led to exclusion o f these referents from the analyses. The prevalence of 
birth defects among referents (14%) was much higher than the expected prevalence in 
the general population (2-3%)29; this can partly be explained by the increased occurrence 
of middle ear effusion among children with cranial abnormalities (orofacial clefts, Down's 
syndrome). In addition, some referents may have had only minor malformations that were 
misclassified as major defects due to the self-reported nature of the data. Sub-analyses 
also excluding cases with co-occurring birth defects did not lead to different findings. 
Response rates among cases and referents were quite high. This resulted in a final study 
population with an 80% power to detect statistically significant elevated odds ratios o f >2 
for factors with an exposure prevalence o f at least 5%. The power to detect similar ORs in 
the analyses for the three subgroups of cases ranged from 30-65%, with an 80% power to 
detect ORs o f at least 2.3-4.0.
The self-reported nature o f the data, which were obtained at 2-9 years after delivery, 
is a potentially important limitation o f the study design and may raise concerns about 
exposure misclassification. Because both cases and referents were hospital populations 
and parents were not informed about their case/referent status, we expect that this mis­
classification was mostly non-differential. Although recall bias of some specific determ i­
nants cannot be excluded and requires caution, it is reassuring that many o f the present 
findings correspond with published data. For a subset o f items in the questionnaires, we 
assessed the reproducibility during a telephone interview with 72 mothers and 55 fathers 
in 2006. For most o f these items, moderate to good agreements were calculated between 
the questionnaires and interviews, except for specific questions on home improvement 
activities and occupational exposures at time o f the pregnancy. Therefore, these items 
were probably subject to substantial random misclassification. In the stratified sub-analy­
ses, there was some indication that the effect estimates for paternal obesity and maternal 
use of antibiotics were underestimated due to the sometimes long recall intervals. How­
ever, for low birth weight, paternal subfertility, and IVF/ICSI treatment, stronger ORs were 
calculated if there were >5 years between the delivery and data collection. Because these 
factors are probably accurately remembered, also 6-9 years after delivery, it is unlikely that 
the differences in ORs result from overreporting by parents o f older cases. An alternative 
explanation would be the changes in fertility treatments over time.
The strong association between hypospadias and occurrence of the disorder in first- 
and second-degree relatives corresponds with previous findings and most likely reflects 
transmission o f genetic risk factors4,5,20,30. There was also an association with familial 
occurrence o f testicular cancer, which to our knowledge has not been described before.
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#Together with the association between hypospadias and paternal subfertility, these find­
ings indicate familial clustering o f TDS. However, the present findings do not support an 
association between hypospadias and familial occurrence o f UDT, the fourth disorder that 
is referred to in the TDS hypothesis24. The present data seem to agree with findings from 
Fredell and colleagues, who reported that familial cases less often present with penoscro­
tal and perineal hypospadias than sporadic cases5. Due to power limitations, we could not 
assess if the same holds for familial occurrence of testicular cancer.
Another explanation for the association with paternal subfertility is that fertility treat­
ments increase the hypospadias risk in offspring, which corresponds with present and 
previous findings concerning IVF/ICSI treatment15-18. In addition to the underlying sub­
fertility of the parents, different mechanisms have been proposed. Ovulation stimulants 
and progestines were suggested to increase the risk o f hypospadias by interfering with 
the foetal endocrine system31,32, whereas the in vitro procedures o f IVF/ICSI have recently 
been reported to involve a risk o f epigenetic defects33. Furthermore, in vitro chorion for­
mation was hypothesized to affect placental development, which could be an explana­
tion for the greater occurrence o f low birthweight and preeclampsia after IVF/ICSI treat-
ments34.
Placental dysfunction in early pregnancy is also thought to partly explain the asso­
ciations between hypospadias and low birthweight5, twin or triplet pregnancies8, pre­
eclampsia or hypertension10, and maternal DES-exposure12,14, independent from IVF/ICSI. 
Especially the elevated ORs for proximal hypospadias associated with low birthweight 
and preeclampsia, suggest that early placental dysfunction may have a large impact on 
penile development. There was a similar pattern for the associations with maternal DES 
exposure and fertility treatments, as the risks were highest for the middle and proximal 
phenotypes.
The findings for maternal and paternal prescriptive drug use are more difficult to inter­
pret. The increased risk of hypospadias after maternal iron supplementation that we pre­
viously reported20, was not reflected in the present data. The lack of biological plausibility 
of the associations with paternal prescriptive drug use and maternal use of antibiotics, 
however, casts doubts on the validity o f the present data on prescriptive drugs in general. 
For the latter finding, we speculate that mothers o f boys with persistent middle ear effu­
sion may have used antibiotics more often because o f an increased familial predisposition 
to infections.
The case-referent comparisons and the phenotype-specific analyses provided little 
evidence for an increased risk o f hypospadias due to maternal and paternal ED expo­
sure. There was an unexpected inverse association with maternal occupational exposure 
to cosmetics, a potential source o f phthalates and parabens35. Private use o f cosmetics 
was not associated with hypospadias. The present findings for occupational exposure to 
dusts and gasoline fumes were based on data collected with open ended questions, which 
raises further concern about recall bias36, especially because there were no associations
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#between hypospadias and other occupational o r leisure time exposures to EDs, such as 
pesticides, organic solvents, and industrial cleaning agents. However, these null-findings 
could be affected by severe random misclassification, as indicated by the reproducibility 
study described before. More extensive exposure assessment seems necessary to draw 
conclusions about occupational exposure.
As it is also difficult to accurately quantify dietary intake by means o f retrospective 
questionnaires, we may not have been able to detect the increased risk o f hypospadias 
associated with maternal intake o f phytoestrogens in soy as has been reported23. Simi­
larly, we could not identify an association with intake o f fish and seafood, as a rich source 
of dioxin-like substances37. However, increased dietary intake or storage capacity for such 
chemicals could be an explanation for the association between obesity of the father and 
hypospadias, which seemed to be restricted to the middle and proximal phenotypes.
Overall, the results indicated a role for genetic risk factors, factors associated with 
placental insufficiency, paternal subfertility and fertility treatment, and other risk factors 
in the aetiology o f hypospadias. In addition, there were indications for substantial differ­
ences in effect estimates between the distal, middle, and proximal phenotypes for several 
risk factors. Due to power limitations, confidence intervals for these estimates were broad 
and the analyses were restricted to relatively prevalent risk factors. Larger studies could 
further clarify the risk factor patterns for distal, middle, and proximal hypospadias and 
thereby provide insights into causal mechanisms, which may involve timing, frequency, 
and level o f exposure, as well as diversity in pathogenic effects. Differences in risk fac­
tor patterns between phenotypes may also explain inconsistencies in effect estimates 
between populations. Therefore, aetiological heterogeneity o f hypospadias should be 
considered in future research.
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a n d
Risk factors for
undescended testis
-
#Abstract
Objective To co n trib u te to the know ledge on the etio logy o f undescended testis 
(UDT), by e xplo rin g a w ide range o f potential risk factors in a case-referent study. 
Patients and methods C ases and referents w ere recruited at 5 hospitals and 
included 2 0 0  boys w ith su rg ically  corrected UDT and 629 boys w ith persistent 
m iddle ear effusion. Risk factor data w ere obtained w ith postal q u estio n n aires for 
both parents. C lin ica l data w ere collected  from  m edical files. A djusted odds ratios 
(O R) w ith 95 percent con fid en ce intervals (CI) w ere estim ated using logistic 
regression.
Results The main findings include associatio ns betw een UDT and fam ilial 
occurren ce  o f the disorder: O R  3.1 (95%CI 1.9-4.9), low birth w eight: 2.2 (1.1-4.3), 
tw inning: 2.2 (0.9-5.4), gestational preeclam psia: 1.9 (0.8-4.4), use o f oral co n tra ­
ceptives after conceptio n: 3.6 (1.0-12.5), IV F /IC S I treatm ent: 2.2 (0.8-6.0), paternal 
subfertility: 1.8 (0.8-4.1), and m aternal occup atio nal e xp o su re to cosm etics: 3.0 
(0.9-10.0). Subgroup analyses indicated differences in O Rs for several factors 
betw een cases w ith (n=92) and w ith o u t (n=103) inguinal hernia or hydrocele. 
Conclusion The findings point tow ards a role o f genetic predisposition, placental 
insufficiency, and possibly expo sure to specific e n d ocrine d isru ptin g substances 
in the e tio logy o f UDT. Further research should take into accou nt potential etio- 
loglc differences betw een subgroups o f cases w ith UDT.
#Introduction
Undescended testis (UDT) is a common birth defect in boys, with a prevalence of around
1.2 percent according to a recent Dutch investigation1. Because the inguinoscrotal phase 
of testicular descent normally takes place in the last trimester of pregnancy2, UDT is espe­
cially common in boys who are born preterm3. In these cases, the testes often descent 
spontaneously before or shortly after the expected time of delivery. Spontaneous post­
natal descent may also occur in at term infants, resulting in substantial differences in the 
prevalence of UDT between age groups3.
UDT has been hypothesized to partly share its etiology with other disorders of male 
reproductive health, including hypospadias, reduced semen quality and testicular cancer, 
collectively referred to as the Testicular Dysgenesis Syndrome (TDS). TDS and its compo­
nent disorders may result from prenatal exposure to endocrine disruptors (EDs), possibly 
combined with a genetic susceptibility4. A role of EDs in the etiology of UDT finds some 
support by reports of increased risks after occupational exposures to pesticides5-7 and 
diesel exhaust fumes8, and increased levels of several persistent endocrine disrupting 
chemicals in maternal breast milk and placenta tissue9-12.
Well-established is the association between UDT and low birth weight, which can 
been interpreted as placental insufficiency in providing the fetus with both nutrients 
and gonadotropins3,13-15. In addition, several studies demonstrated familial clustering of 
UDT15-17. Knowledge on other risk factors for UDT is restricted to indications for asso­
ciations with specific obstetric conditions8,18, pregnancy complications8,18,19, intra-uterine 
insemination20, increased maternal age21, and parental life style factors8,18,20,22-24, with 
sometimes contradictory study results.
Our aim was to contribute to the knowledge on the etiology of UDT, including the role 
of maternal and paternal exposure to EDs, by exploring a comprehensive set of risk fac­
tors in a case-referent study.
Patients and methods
Recruitment o f  cases and referents
Cases and referents were recruited at one university medical centre and four general 
hospitals in the eastern part of The Netherlands, of which two hospitals provided either 
cases or referents, and three hospitals provided subjects for both study populations. 
Cases were recruited at departments of Urology and Pediatric Surgery and were boys 
who underwent an orchidopexy or orchidectomy, which is indicative of a persistent mani­
festation of UDT. Referents were boys who received ear ventilation tubes for a middle 
ear infection at the departments of Otorhinolaryngology. This is a very common surgical 
procedure, so we expected these referents to be a good representation of the general
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#population. By including children who had early childhood surgery as referents, we also 
aimed to minimize recall bias. The study population was restricted to boys who were born 
between 1996 and 2004 and residents from the catchment area of the participating hospi­
tals. These criteria were met by 376 cases and 2,911 referents who were identified from the 
hospitals' information systems. From these, we randomly sampled 1,125 referents based on 
the geographical distribution of the cases. Personal data of all subjects were screened in 
order to identify twins and triplets (from which one sibling was randomly selected), other 
siblings (from which the oldest sibling was selected), and double records. Through these 
procedures, we selected 368 cases and 1,091 referents.
In February 2005, we invited the parents of these children to participate by filling out 
a set of postal questionnaires. Two reminders were sent to increase response rates. The 
questionnaires included items on socioeconomic characteristics, familial occurrence of 
illnesses and birth defects, and the medical history of their son. Referring to the time 
just before and during the index pregnancy, parents were questioned about health status, 
pregnancy details, life style, various exposures at work or during leisure time activities, 
and diet. These items included questions about private and occupational use of personal 
care products and exposure to pesticides, solvents, or other chemicals at work and during 
home improvements or hobbies as potential sources of exposure to EDs. Occupational 
exposure to other potential reproductive toxicants (X-rays, cytostatics, anesthetics) was 
assessed as well. Regarding dietary intake, we focused on soy replacements for meat or 
dairy (as rich sources of phytoestrogens) and seafood (as a rich source of persistent endo­
crine disrupting pollutants). Parents were first asked to list their current intake of food­
stuffs, to help them recall their intake at time of the index pregnancy.
To avoid selective non-response and information bias, parents were informed that the 
study was designed to investigate the association between life style, occupation, illnesses, 
and complications at time of pregnancy and children's health in general, not focusing on 
the specific disorder under study. Approximately 150 parents were contacted by phone 
to complete their questionnaire information. From the medical files of the cases, we 
collected information on testis position at surgery and previous physical examinations 
and on the presence of an inguinal hernia or hydrocele. The study was approved by the 
Regional Committee on Research Involving Human Subjects.
Referents with UDT or a major birth defect as defined in the EUROCAT registry proto­
col25 were excluded from the study population. Cases with scrotal or retractile testes dur­
ing surgery, with iatrogenic UDT due to an earlier hernia surgery, and cases with syndro- 
mal UDT or chromosome abnormalities were excluded as well. In addition, we performed 
subanalyses to see whether exclusion of cases with other major birth defects affected 
the main study results. Regarding the risk factor data, adjustments were made to the 
reported occupational exposures, particularly concerning cosmetics, paints, adhesives, 
and thinners, as the data indicated that occupational exposure was sometimes confused 
with private use of these products. For instance, only parents who were employed in the
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#cosmetics industry (e.g. beauticians and hair dressers) or in health care (e.g. nurses and 
geriatric helpers) were considered likely to work with cosmetics.
Statistical analyses
The data were analyzed with SPSS version 14.0. In the primary analyses, crude odds ratios 
(ORs) with 95% confidence intervals (CI) were calculated for all potential risk factors. 
Next, multivariable logistic regression analyses were performed for factors with crude 
ORs > 1.5 and a lower bound of the 95%CI > 0.7 as well as for weaker ORs with more preci­
sion. Potential confounders included parental educational level, ethnic origin, and other 
identified or previously reported risk factors for UDT, except variables that shared their 
causal pathway with the risk factor of interest (e.g. low birth weight was not included in 
the analysis of preeclampsia). Potential confounders that changed the crude ORs with 
at least 10% were included in the regression models simultaneously. For variables with 
at least 30 cases and referents, homogeneity of strata-specific ORs was checked using 
contingency tables to exclude effect measure modification, but none was found. All effect 
estimates were adjusted for year of birth to account for potential trends in exposure lev­
els or probabilities over time. To obtain indications for the influence of misclassification in 
case of long recall intervals, stratified subanalyses were performed to identify differences 
in effect estimates between short (1-5 years) and long (6-9 years) time periods between 
delivery and data collection.
Completed questionnaires were received from the parents of 230 cases and 741 referents, 
which corresponds to response rates of 66% and 70%, respectively, taking into account
19 cases and 37 referents with unknown address changes. For 2 cases and 7 referents, 
essential questionnaire data were missing. An additional 105 referents were excluded, 
because parents reported UDT (n=12) or major birth defects (n=93). These included 37 
boys with orofacial clefts and 7 boys with Down syndrome, which are associated with 
persistent middle ear infections. W e also excluded 3 cases with syndromes, 4 cases with 
iatrogenic non-scrotal testes, and 21 cases with scrotal or retractile testes during surgery, 
in which one testis had often atrophied due to testicular torsion. As a result, the primary 
analyses included 200 cases and 629 referents.
UDT was most often unilateral and located within or just below the inguinal canal 
(Table 5.1). Ectopic and intra-abdominal testes were found in 9 and 14 cases, respectively. 
Secondary ascending testes were assumed in 34 cases, for which a urologist or other 
health care professional observed the testes within the scrotum at an earlier examination. 
In 92 cases UDT was accompanied by inguinal hernia or hydrocele, for which subgroup 
analyses were performed.
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Results
#table 5.1 Clinical breakdown of cases with UDT
Cases (n=200)a
Unilateral or bilateral UDT
Unilateral 162
Bilateral 33
Location of UDT
Inguinal or high scrotal 166
Intra-abdominal 14
Ectopic 9
Unclassifiableb 1
Absent testisc 5
Secondary UDT
No 161
Yes 34
UDT accompanied by inguinal hernia or hydrocele
No 103
Yes 92
a Totals due not add up to 200 because the medical files o f  5 cases were not accessible 
b Location was unclassifiable due to severe inguinal hernia 
c Absent testis most often indicates atrophy due to testicular torsion
table 5.2 Descriptive statistics of cases and referents
Referents (n=629) Cases (n=200)
Mean age at time of data collection (SD) 5.6 (2.1) 5.4 (2.0)
Educational level of parents (%)
Mother Low 153 (24.6) 54 (27-1)
Intermediate 306 (49.1) 96 (48.2)
High 164 (26.3) 49 (24.6)
Father Low 164 (28.2) 62 (32.6)
Intermediate 227 (39.1) 62 (32.6)
High 190 (32.7) 66 (34.7)
Ethnic background of parents (%)
Mother European Caucasian 609 (97.9) 184 (92.5)
Other 13 (2.1) 15 (7.5)
Father European Caucasian 568 (97.4) 174 (91.1)
Other 15 (2.6) 17 (8.9)
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#Mean age at time of data collection was around 5.5 years for both cases and referents 
(Table5.2). Parents of cases and referents reported similar educational levels, but the par­
ents of cases were more often of non-European ethnic origin, such as Turkish, Moroccan, 
Surinamese, Antillean, or Asian.
Table5.3 displays crude and adjusted associations between UDT and potential risk fac­
tors, which were generally little influenced by confounding. Occurrence of the disorder 
in 1st or 2nd degree relatives was associated with a three times increased risk of UDT: OR
3.1 (95%CI 1.9-5.0), but no associations were found with familial occurrence of hypospadias 
or testicular cancer. An increased occurrence of UDT in children with low birth weight 
was also reflected in our data: OR 2.2 (95%CI 1.1-4.3), and similar associations were found 
with being a twin or triplet: OR 2.2 (95%CI 0.9-5.5) and with preeclampsia: OR 1.9 (95%CI 
0.8-4.5). W e found no associations with gestational diabetes or other pregnancy compli­
cations, mother being a DES-daughter, and increased maternal age.
UDT appeared to occur more often after IVF/ICSI treatment: OR 2.2 (95%CI 0.8-5.9), 
which seemed to correspond with the findings for paternal subfertility: OR 1.8 (95%CI 0.8­
4.1), whereas subfertility of the mother was not associated with UDT. Mothers of cases 
more often reported the use of oral contraceptives: OR 3.5 (95%CI 1.0-12.3) and antiemetic 
drugs: OR 2.0 (95%CI 1.0-3.9) during pregnancy, while an inverse association was found 
with the use of antibiotics: OR 0.5 (95%CI 0.3-1.0). For fathers, use of any prescriptive 
drug in the three months prior to pregnancy appeared to be associated with UDT: OR 1.8 
(95%CI 1.0-2.9), but the population size did not allow us to identify associations with spe­
cific drugs. Fathers of cases also slightly more often reported daily use of body lotion: OR
1.6 (95%CI 0.9-2.8). W e identified no associations with any other personal care products 
(e.g. deodorant, make-up, perfume, or sunscreens), different combinations of these prod­
ucts, parental life style factors, obesity, or use of folic acid or other vitamin supplements.
Regarding occupational exposures, a three times increased risk of UDT was found if 
mothers worked with cosmetics: OR 3.0 (95%CI 0.9-10.0). Mothers of cases also more 
often reported exposure to domestic cleaning agents: OR 1.5 (95%CI 0.9-2.7) and dusts:
OR 5.2 (95%CI 1.6-16.4), although the latter finding was difficult to interpret due to the 
large diversity in dusts that were listed (e.g. dust from hay, grain, hair dressing products, 
and textile manufacturing). Our data did not reflect an increased risk of UDT if parents 
worked with pesticides, nor for exposure to paints, adhesives, inks, thinners, industrial 
cleaning agents, metals, exhaust fumes, X-rays, anesthetics, or cytostatics, although the 
latter generally involved small numbers. The same was true for exposures during leisure 
time activities, including home improvements, gardening, and hobbies. No associations 
were detected either between UDT and a vegetarian or vegan diet, intake of soy meat 
replacements, and frequent consumption of fish or seafood by the parents in and around 
pregnancy. Exclusion of 24 cases with major birth defects or 34 cases with secondary 
ascending testes did not substantially affect any of the reported effect estimates, except 
that in the latter subanalyses the adjusted OR for maternal occupational exposure to cos­
metics was less strong: OR 2.1 (95%CI 0.5-8.5).
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t a b l e  5.3 Effect estim ates o f potential risk factors for UDT
Referents
(n=629)
Cases
(n=200)
Crude OR
(95% Cl)
Adjusted ORa 
(95% Cl)
Familial history (1st or 2nd degree)
UDT 45 39 3-1 (1.9-4.9) 3-1 (1.9-5.0)
Hypospadias 8 2 0.7 (0.2-3.5) 0.8 (0.2-3.6)
Testicular cancer 3 2 2.0 (0.3-12.3) 2.1 (0.3-12.4)
Gestational and obstetric characteristics
Low birthweight (< 2500g) 43 23 2.4 (i-3-4-7)b 2.2 (i-i-4-3)c
Twin or triplet 20 12 1-9 (0.9-4.0) 2.2 (o-9-5-5)d
Preeclampsia 15 9 1-9 (0.8-44) 1-9 (0.8-4.5)
Gestational diabetes 10 4 1-3 (0.4-4.0) 1-3 (0.4-4.0)
Increased maternal age (> 35 years) 99 28 0.9 (0.6-1.4) 0-9 (0.6-1.4)
Mother is probably DES-daughter 16 2 0.4 (0.1-1.8) 0.4 (0.1-1.8)
Factors associated with subfertility
TTP > 6 months, excluding fertility treatments 98 30 0.9 (0.6-1.5) 0-9 (0.6-1.5)
Subfertility of mother 61 15 0.8 (0.4-14) 0.8 (0.4-14)
Subfertility of father 17 10 1.8 (0.8-4.1) 1.8 (0.8-4.1)
Pregnancy achieved with IVF/ICSI 10 7 2.2 (0.8-6.0) 2.2 (0.8-5.9)
Obesity (BMI > 30 kg/m2)
Mother 30 11 1.1 (0.6-2.4) 1.1 (0.6-2.3)
Father 25 4 0.5 (0.2-1.4) 0-5 (0.2-1.4)
Prescriptive drug use
Mother Any drug 340 104 0.9 (0.7-1.3) 0-9 (0.7-1.3)
Antiemetic drugs 23 14 2.0 (1.0-3.9) 2.0 (1.0-3.9)
Antibiotics 64 11 0.5 (0.3-1.0) 0-5 (0.3-1.0)
Oral contraceptives: after conception 7 6 2-7 (0.9-8.2) 3-5 (l.O-12.3)e
Father Any drug 42 23 i-7 (1.0-2.9) 1.8 (1.0-2.9)
Maternal intake of folic acid or other vitamin supplements 459 145 1.0 (0.7-14) 1.0 (0.7-14)
Life style
Mother Smoking during pregnancy 109 39 1.1 (0.8-1.7) 1.1 (0.8-1.7)
Alcoholic beverages during pregnancy 94 27 0.9 (0.5-14) 0-9 (0.5-1.5)
Father Smoking 204 62 0.9 (0.6-1.3) 0-9 (0.6-1.3)
Private use of cosmetics
Mother Body lotion 302 89 0.9 (0.6-1.2) 0.9 (0.6-1.2)
Any product 603 192 0.9 (0.3-2.2) 0.9 (0.3-2.2)
Father Body lotion 38 19 1.6 (0.9-2.8) 1.6 (0.9-2.8)
Any product 503 168 1-3 (0.7-2.2) 1-3 (0.7-2.2)
Occupational exposures (at least 8 hours per week) 
Mother Cosmetics 9 6 2.1 (0-7-5-9) 3.0 (o.9-io.o)d
Domestic cleaning agents 39 19 1-5 (0.9-2.7) 1-5 (0.9-2.7)
Industrial cleaning agents 7 1 0.4 (0.1-3.6) 0.4 (o.i ■-3.6)
Paints, inks, adhesives, or thinners 6 2 1.0 (0.2-5.2) 1.0 (0.2-5.1)
Exhaust fumes 6 4 2.1 (0.6-7.5) 2.1 (0.6-7.4)
Pesticides (also less than 8 hours per week) 12 4 1.0 (0.3-3.2) 1.0 (0.3-3.3)
Dusts (any) 7 7 3.2 (1.1-9.2) 5-1 (i.6-i6.4)d
Father Domestic cleaning agents 7 6 2.6 (0.9-8.0) 1.0 (o.2-5.o)f
Industrial cleaning agents 12 6 1.6 (0.6-4.2) 1.6 (0.6-4.2)
Paints, inks, adhesives, or thinners 27 8 0.9 (0.4-2.0) 0.9 (0.4-2.0)
Exhaust fumes 41 15 i.i (0.6-2.1) i.i (0.6-2.1)
Pesticides (also less than 8 hours per week) 30 9 0.9 (04-2.0) 0.9 (0.4-2.0)
Dusts (any) 52 19 1.2 (0.7-2.0) 1.2 (0.7-2.0)
Diet
Mother Vegetarian or vegan diet 12 2 O.5 (0.1-2.3) 0.5 (0.1-2.4)
Soy meat replacements (at least once per week) 18 7 1.2 (0.5-3.0) 1.2 (0.5-3.0)
Fish or seafood (at least three times per week) 21 8 1.2 (0.5-2.8) 1.2 (0.5-2.7)
Father Vegetarian or vegan diet 4 2 1-5 (0.3-8.5) 1-5 (0.3-8.6)
Soy meat replacements (at least once per week) 17 3 O.5 (0.2-1.9) 0.5 (0.2-1.8)
Fish or seafood (at least three times per week) 6 4 2.1 (0.6-7.7) 2.1 (0.6-7.7)
N.B. Maternal exposure referred to 3 months prior to and/or during pregnancy, while paternal exposure referred to 3 months prior to pregnancy only Proportions o f missing values were 
less than 5 percent per variable, except fo r familial occurrence ofUDT (16%) and hypospadias (9%), paternal prescriptive drug use (14%) and BMI (7%), maternal alcohol consumption (6%), 
and paternal intake o f soy meat replacements (6%) and seafood (6%).
a All associations were adjusted fo r year o f birth d A djusted fo r year o f birth and familial occurrence o f cryptorchidism
b Adjusted fo r gestational age e Adjusted fo r year o f birth, low birth weight, and gestational age
c Adjusted fo r year o f birth, gestational age, and ethnic background o f mother f  Adjusted fo r year o f birth, ethnic background o f father, and familial occurrence o f UDT
table 5.4 Effect estimates of potential risk factors for the total case-population and subgroups 
of cases with and without inguinal hernia or hydrocele
All cases (n=200) 
Adj OR (95%CI)a
With hernia or 
hydrocele (n=92) 
Adj OR (95%CI)a
Without hernia or 
hydrocele (n=103) 
Adj OR (95%CI)a
Twin or triplet 2.3 LH
C\
4.3 (1.6-11.2)b 0.9 (0 .2-3.9)b
Gestational preeclampsia 1.9
CO 2.4 (0.8-6.7) 1.2 (0 .4-4 .3)
Pregnancy achieved with IVF/ 
ICSI
2.2 (0.8-5.9) 2.7 (0.8-9.0) 1.2 (0.3-5.6)
Subfertility of father 1.9 (0 2.4 (0.9-6.4) 1.1 (0 .3-3.7)
Oral contraceptives after 
conception
3.5 (1.0-12.3)° 5.9 (1.5-22.7)° 1.4 (0.2-12.1)°
Mother used antiemetic drugs 2.0 .9)1.0- 0.9 (0.3-3.0) 3.1 (1.5-6.6)
Father used any prescriptive 
drug
1.8 (1.1-3.0) 2.1 (1.1-4.1) 1.4 (0 .7-2.9)
Father used cosmetics 
(any product)
1.3 (0.7-2.2) 1.0 (0.5-2.1) 1.5 (0 .7-3.2)
Mother worked with domestic
cleaning agents
(at least 8h per week)
1.5 (0.9-2.7) 1.0 (0 .4 -2.5) 1.9 (1.0-3.9)
N.B. The table is restricted to factors fo r  which the ORs in the subgroups differed at least 10 percent from  the OR 
fo r  the tota l case population 
a A ll associations are adjusted fo r  year o f birth 
b Adjusted fo r  year o f birth and fam ilia l occurrence o f UDT 
c Adjusted fo r  year o f birth, low birth weight, and gestational age
For some risk factors, stronger ORs were calculated if the data referred to a more recent 
time period (1-5 years vs. 6-9 years ago), including being a twin or triplet: OR 4.9 (95%CI 
1.2-20.6) vs. OR 1.3 (95%CI 0.4-4.6), maternal use of antibiotics: OR 0.3 (95%CI 0.1-0.7) vs. 
OR 1.1 (95%CI 0.4-2.7), and occupational exposure to cosmetics of the mother: OR 2.8 
(95%CI 1.0-7.8) vs. OR 0.3 (95%CI 0.1-1.5). An opposite pattern, however, was seen for sev­
eral other factors, including familial occurrence of UDT: OR 2.2 (95%CI 1.1-4.6) vs. OR 4.0 
(95%CI 2.1-7.6), gestational preeclampsia: OR 0.4 (95%CI 0.1-3.1) vs. OR 3.8 (95%CI 1.4-10.3), 
IVF/ICSI treatment: OR 1.6 (95%CI 0.5-5.5) vs. OR 3.6 (95%CI 0.7-18.2), paternal subfertility: 
OR 1.3 (95%CI 0.4-4.5) vs. OR 2.4 (95%CI 0.9-7.1), and maternal occupational exposure to 
household cleaning agents: OR 1.0 (95%CI 0.4-2.3) vs. OR 2.4 (95%CI 1.1-5.3).
Table 5.4 displays a breakdown for the co-occurrence of UDT with inguinal hernia or 
hydrocele based on multinomial logistic regression analyses, only showing effect esti­
mates with substantial subgroup differences. In general, stronger effect estimates were 
calculated for the subgroup of UDT with inguinal hernia or hydrocele, whereas the esti­
mates for UDT alone centered around one. An opposite pattern in subgroup-specific 
effect estimates was seen for maternal antiemetic drug use and occupational exposure to
8 4 c h a p t e r  5
#domestic cleaning agents, with stronger risk estimates in cases without inguinal hernia 
or hydrocele.
The population size did not allow subgroup analyses that distinguished between uni­
lateral and bilateral UDT or between specific locations of the UDT (inguinal, ectopic, or 
intra-abdominal). When the 33 bilateral cases were excluded, the effect estimates for 
maternal antiemetic drug use and occupational exposure to dusts were reduced to OR 
1.5 (95%CI 0.7-3.3) and OR 3.5 (0.9-13.4), respectively, whereas for being a twin or triplet: 
OR 2.8 (1.1-6.7), gestational preeclampsia: OR 2.3 (1.0-5.4), and IVF/ICSI treatment: OR
2.7 (1.0-7.2) slightly stronger ORs were found. Exclusion of 23 cases with ectopic or intra­
abdominal testes resulted in a somewhat weaker effect estimate for maternal dust expo­
sure as well: OR 4.2 (1.2-14.9).
Discussion
This study demonstrated familial clustering of UDT and associations with low birth weight, 
being a twin or triplet, and gestational preeclampsia. Additionally, increased risks of UDT 
were found after IVF/ICSI treatment, if fathers reported subfertility, and if mothers used 
oral contraceptives during pregnancy. Associations with other prescriptive drugs used by 
the parents were found as well. Mothers of cases were more often occupationally exposed 
to domestic cleaning agents, dusts, and cosmetics, whereas slightly more case-fathers 
reported daily use of body lotion. W e did not detect associations with other occupational 
or leisure time exposures, dietary intake of soy or seafood, pregnancy complications, 
life style factors, or familial occurrence of hypospadias and testicular cancer. Subanaly­
ses revealed differences in the effect estimates of specific risk factors between cases 
with and without inguinal hernia or hydrocele, which, to our knowledge, have not been 
described earlier. Before interpreting these results, we will discuss some methodological 
aspects of our study.
Our case population was restricted to boys who underwent an orchidopexy or orchi- 
dectomy to represent persistent manifestations of UDT, as opposed to cases that are 
ascertained by means of a physical examination, after which the testis may spontaneously 
descent in up to 70 percent3. Additionally, physical examinations are prone to misdiagno­
sis, which is illustrated by the 21 cases with scrotal or retractile testes diagnosed during 
surgery that we excluded from the analyses. However, surgical cases also include cases 
with secondary ascending testes of which the pathogenesis is not clear26,27, but subanaly­
ses excluding these cases did not substantially change our findings.
By including boys who received ear ventilation tubes as referent population, we aimed 
to obtain a comparable group of surgical patients of similar age and from the same geo­
graphical area. To our knowledge, persistent middle ear effusion is not associated with 
the risk factors that were studied in the present study28. This may not be true for the
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the analyses. The prevalence of birth defects among referents (14%) was much higher 
than expected (2-3%)29, partly due to the increased occurrence of middle ear infections 
among children with orofacial clefts and Down's syndrome. Subanalyses in which we also 
excluded cases with co-occurring birth defects did not lead to different findings.
The parents of referents and cases were not informed about the hypotheses for this 
study to prevent selective non-response and information bias, resulting in response rates 
of 70 percent for referents and 66 percent for cases. Therefore, an association between 
participation and exposure status seems unlikely. W e cannot exclude random misclas- 
sification, however, as risk factor data were collected retrospectively with postal ques­
tionnaires. W e assessed the reproducibility of a subset of items by means of telephone 
interviews with 72 mothers and 55 fathers a year later. Moderate to high agreements were 
found for questions on low birth weight (kappa 0.8), prolonged time to pregnancy (kappa 
0.6), various pregnancy complications (kappas between 0.5 and 0.8), and maternal and 
paternal smoking (kappa 0.9 and 0.8, respectively). Poorer agreements were calculated for 
some questions on home improvements and occupational exposures at time of the index 
pregnancy (kappas 0.0 - 0.7). The latter may explain why only a few associations with UDT 
were found. In the stratified subanalyses, we found some indications that specific effect 
estimates were affected by misclassification due to long recall intervals.
Parents of cases more often reported the occurrence of UDT in 1st or 2nd degree relatives, 
which corresponds with previous reports15-17. Familial clustering may indicate a genetic 
component in the etiology of UDT, although family members may share environmental 
risk factors as well. Contrary to our expectation based on the TDS hypothesis, we did not 
identify familial clustering of hypospadias or testicular cancer in cases with UDT4. But the 
association between UDT and paternal subfertility is in line with the TDS hypothesis.
Placental insufficiency is considered to be a plausible underlying mechanism for the 
increased occurrence of UDT in children with low birth weight and may also explain the 
associations with preeclampsia and being a twin or triplet For these factors, similar risk 
estimates were found for hypospadias30, pointing towards a shared etiologic pathway for 
the two disorders, which has been suggested in previous literature as well13-15. The data 
also reflected similar risks of UDT and hypospadias in case of paternal subfertility and 
after IVF/ICSI treatment, which to our knowledge has not been described before. Inter­
estingly, in vitro chorion formation during IVF/ICSI treatments has also been linked to 
placental insufficiency31, but other mechanisms through which IVF and ICSI may interfere 
with fetal development have been described as well, including disturbance of the fetal 
endocrine system by the administered ovulation stimulants32 or progestins33 or epigen­
etic defects induced by the in vitro procedures34.
An approximately three times increased risk of UDT was found for mothers using oral 
contraceptives during pregnancy, although confidence intervals were broad due to low 
cell counts. Possibly, estrogens or progestins in oral contraceptives interfere with testicu-
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pregnancies in general. The findings for antiemetic drug use by the mother seems to cor­
respond with the earlier reported increased risk of UDT in case of severe gestational vom­
iting8. The biologically implausible associations with paternal prescriptive drug use and 
maternal use of antibiotics, however, casts doubts on the validity of the present data on 
prescriptive drugs. We speculate that mothers of boys with persistent middle ear effusion 
may have used antibiotics more often because of an increased familial predisposition to 
infections.
Mothers of cases more often worked with cosmetics (e.g. hair sprays, hair-dyes, nail 
polish, lotions, and ointments) during pregnancy, whereas fathers slightly more often 
reported daily use of body lotion. Most cosmetics, including body lotion, contain a mix­
ture of phthalates, siloxanes, parabens, and UV screens, which have all been reported 
to have endocrine disrupting properties35-38. Domestic cleaning agents, which were also 
more often reported by mothers of cases, may also contain some level of endocrine dis­
rupting chemicals, although we would expect more relevant exposures from the various 
industrial agents for which no associations with UDT were found. The strong association 
with exposure to dusts is also difficult to interpret. However, as indicated by the repro­
ducibility study, the data on occupational exposures in general warrant extra caution 
about misclassification.
In almost 50 percent of the cases, UDT was accompanied by inguinal hernia or hydro­
cele due to incomplete closure of the processus vaginalis. The processus vaginalis is 
thought to play an active role in testicular inguinoscrotal descent, but the etiological sig­
nificance of an inguinal hernia or hydrocele in UDT is unclear2,39,40. The subgroup analyses 
revealed that several risk factors (e.g. being a twin or triplet, gestational preeclampsia, 
IVF/ICSI, oral contraceptives during the pregnancy), appear to be associated with the 
combination of UDT and inguinal hernia or hydrocele, but not with UDT alone. This could 
indicate that these factors are predominantly associated with the risk of inguinal hernia 
or hydrocele and do not interfere with testicular descent. Another explanation would be 
that the subgroup with UDT and co-occurring hernia or hydrocele represents a specific 
manifestation of the disorder, related to the timing or duration of risk factor interference 
with testicular descent Distinguishing between bilateral and unilateral cases or between 
different locations of the UDT could be informative as well, especially because inguinal 
testes, intra-abdominal testes, and ectopic testes, are thought to involve different causal 
mechanisms2. The population size did not allow to assess the effect of risk factors for 
these subgroups separately, however.
In conclusion, we found indications for several risk factors for UDT, which point 
towards a role of genetic predisposition, placental insufficiency, and possibly exposure 
to specific endocrine disrupting substances in its etiology. The differences in effect esti­
mates between cases with and without inguinal hernia or hydrocele are yet difficult to 
explain, but seem interesting. W e propose that further research should differentiate
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#between subgroups of cases and include more extensive exposure assessment of EDs in 
order to obtain more insight into the etiology of UDT.
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#Occupational exposure
to potential endocrine
disruptors:
further development of
a Job Exposure Matrix
*
#Abstract
Objectives The aim  w as to develop a new  up-to-date and co m prehensive Job 
Exposure M a trix  (JEM ) for estim ating exp o sure to potential e nd ocrine  d isrup to rs 
in epidem iological research.
Methods Ch e m icals w ith e n d o crin e  d isru p tin g  properties w ere identified from  
the literature and classified into 10 chem ical groups: polycyclic arom atic hyd ro­
carbons (PAHs), polychlo rinated  organic com pounds, pesticides, phthalates, 
organic solvents, b isphenol A, alkylp heno lic com pounds, brom inated flam e 
retardants, metals, and a m iscellaneou s group. M o st chem ical groups w ere 
divided into three to six subgroups. Focusing on the years 1996 - 2 0 0 6 , three 
experts scored the probability  o f e xpo sure to each chem ical group and subgroup 
for 353 job  titles as ‘unlikely' (0), ‘possible' (1), and ‘probable' (2). Job titles with 
positive exp o sure probability  scores w ere provided w ith e xp o su re scen arios that 
described the reasoning behind the scores.
Results Exposure to any chem ical group w as unlikely for 238 jo b  titles (67%), 
w hereas 102 (29%) job  titles w ere classified as possibly (17%) or probably (12%) 
exposed to one or several e n d ocrine d isruptors. The rem aining 13 jo b  titles 
provided too little inform ation to classify  exposure. PAHs, pesticides, phthalates, 
organic solvents, a lkylp heno lic com pounds, and m etals w ere often linked to a job 
title in the JEM. The rem aining chem ical groups w ere found to involve very few  
occupations.
Conclusions D espite som e im portan t lim itations, this JEM  can be a valuable tool 
for exp o sure assessm ent in studies on health risks o f e n d o crin e  disrupto rs, esp e ­
cially  w hen task-specific inform ation is incorporated. The d ocum ented  exposure 
scenarios are m eant to facilitate  furth e r adjustm ents to the JEM to allow  m ore 
w idespread use.
#Introduction
Endocrine Disruptors (EDs) have been described as exogenous substances that alter 
endocrine system functions and thereby cause adverse health effects1. EDs have been 
hypothesized to interfere with the foetal development of the male reproductive system2. 
More specifically, exposure in early gestation is believed to increase the risks of hypo­
spadias and cryptorchidism (two birth defects in boys) and the risks of testicular cancer 
and male subfertility in adulthood. Besides disrupting male foetal development, EDs are 
suspected of playing a role in the pathogenesis of various diseases, including endometrio­
ses3, breast cancer4, and prostate cancer5. However, the potential of current exposure lev­
els to affect human health has been questioned by some researchers6-8 and lacks detailed 
epidemiological evidence. Potential EDs include a growing list of industrial chemicals, 
such as pesticides, dioxins, and phthalates, but also synthetic hormones and naturally 
occurring phytoestrogens. Diet is probably the most important source of EDs for the gen­
eral population. Other sources include the environment, cosmetics, and other consumer 
productsi. In addition, relatively high exposure levels may occur in specific occupations.
In 2002, van Tongeren and colleagues published a Job Exposure Matrix (JEM ) for the 
assessment of occupational exposure to potential EDs in the UK9. In this JEM , 348 job titles 
were linked to ED exposure probability scores: unlikely, possible, or probable. A total of 
seven chemical groups were distinguished, which were pesticides, polychlorinated com­
pounds, phthalates, alkylphenolic compounds, bi-phenolic compounds, heavy metals, and 
a miscellaneous category. In constructing the JEM , three occupational hygienists indepen­
dently assigned exposure scores to each of the occupations, after which consensus was 
reached. The JEM  was developed in order to study the risk of hypospadias after maternal 
exposure to EDs using data of the UK Office for National Statistics. Little evidence was 
found for an association between occupational exposure of the mother and hypospadias, 
although there was some indication for an increased risk when mothers were exposed 
to phthalates before adjustment for social class: OR 1.5 (95%CI 1.1-2.2), but not after: OR
1.3 (0.8-2.0)10. This JEM  was also used in a Dutch case-control study aiming to identify 
maternal and paternal risk factors for cryptorchidism and hypospadias. An increased risk 
of cryptorchidism was observed when fathers were exposed to pesticides according to the 
JEM : OR 3.8 (95%CI 1.1-13.4)11.
Our objective was to use a similar JEM  for exposure assessment of EDs in another 
Dutch case-referent study on hypospadias and cryptorchidism, carried out at the Rad­
boud University Nijmegen Medical Centre in 2005-2007. In this study, parents of cases 
and referents provided data on job title, tasks, and occupational exposures via postal 
questionnaires. The reason for extending the exposure assessment strategy with a JEM  is 
that various potential EDs, such as phthalates, metals, and dioxins, are difficult to capture 
with questionnaires. Moreover, JEM  exposure estimates are generally less influenced by 
recall bias as they are solely based on job titles, which are usually more reliably recalled
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#than specific chemical exposures12. The validity of JEMs, however, has been shown to vary 
greatly from study to study and JEM s are unable to account for variability in exposures 
within occupations12. Additional difficulties may arise when a JEM  is applied to popula­
tions different from that originally targeted13.
Dosemeci and colleagues demonstrated that the performance of a JEM  could be con­
siderably improved by efforts to obtain more accurate exposure estimates, in particular 
by (i) replacing dichotomous exposure scores (yes vs. no) with exposure probabilities 
(low, medium, high), (ii) using a more suitable occupational classification scheme, and 
(iii) taking into account differences in exposures over time14. Kauppinen and colleagues 
pointed out that the applicability of a JEM  could be improved by documenting the reason­
ing for the exposure scores, which would facilitate continuous improvement of the JEM  
and adjustments necessary for more widespread use15. In addition, studies performed by 
Kennedy et al. and Semple et al. indicate that the general problem of JEM  exposure mis- 
classification can be partly resolved by refining JEM  exposure estimates with task specific 
information from questionnaires or interviews16,17.
Taking into account the above findings, our aim was to adjust the 2002 JEM  for EDs 
in order to improve its performance. This was motivated by the fact that the original JEM  
was based on a by now outdated occupational classification and that some of the expo­
sure probability scores were not valid for current working conditions due to changes in 
legislation. There was also a need for incorporation of new knowledge on chemicals with 
endocrine disrupting properties in the JEM . Instead of the rather broad chemical groups 
in the original JEM , we made the new JEM  more specific by assigning exposure probability 
scores for chemical sub-categories. Furthermore, we decided to provide documentation 
about the reasons for the exposure probability scores, which can be used to make further 
improvements or adjustments to the JEM  and to facilitate refinement of the exposure 
scores with task specific information. With these modifications, we aimed to develop a 
new JEM  that would allow a more accurate exposure assessment of EDs to be used both 
in our case-referent study on hypospadias and cryptorchidism and in many other com­
munity based studies that involve occupational exposure to EDs.
Methods
The development of the JEM  was carried out according to the following general strat­
egy, in which the 2002 JEM  was used as a starting point. First, chemicals with known 
or suspected endocrine disrupting properties were identified from the literature. Next, 
information was gathered about occupations at risk. The job titles of the original JEM  
were replaced by the UK Standard Occupational Classification 2000 (SOC2000)18. Finally, 
exposure probability scores were revised or added by means of expert assessments and 
positive scores were accompanied by exposure scenarios that described the reasoning
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#table 6.1 Characteristics of the job exposure matrix
Selected chemicals Evidence or indications for endocrine disrupting effects 
Occupational exposure relevant compared to other sources
Time frame 
Focus population 
Exposure scores
1996 to 2006
Workers in the UK
Exposure probability in three levels 
Assigned by means of expert assessments 
Do not reflect exposure level
behind the scores. Table 6.1 summarises the specific characteristics of the new JEM. Like 
the original JEM , it is based on the UK situation, but an effort was made to focus the expo­
sure probability scores on the 10 years before the expert assessments.
In order to select potential EDs for inclusion in the JEM, information was obtained from 
the report ‘Chemicals purported to be endocrine disruptors' by the Institute for Environ­
ment and Health in the UK19, the website ‘www.ourstolenfuture.org' by Golborn et al.20, 
and the World Health Organisation report ‘Global assessment of the state-of-the-science 
of endocrine disruptors'1. Additional information was identified from research articles, for 
which secondary literature sources were used in some cases. In selecting substances for 
the JEM , we considered whether occupational exposure was expected to have a relevant 
contribution to a person's body burden in comparison to other sources of exposure, such 
as diet, living environment, and consumer products. For that reason, phytoestrogens were 
not included in the JEM. This resulted in a total of 10 chemical groups and 33 subgroups, 
which are displayed in Table 6.2. The right hand column lists some reported properties for 
the chemical groups and subgroups that indicate their endocrine disrupting potential, but 
this should not be considered a complete overview.
Literature was then gathered about the occupational settings in which the selected 
chemicals are encountered. This reference material served as a tool for the expert assess­
ment. The Toxicological Profiles of chemical substances of the US Agency for Toxic Sub­
stances and Disease Registry (ATSDR) were important literature sources47, as were the 
European Union Risk Assessment Reports (EURAR) provided by the European Chemicals 
Bureau48. An effort was made to focus the reference material on the UK and on the time 
period from 1996 onwards. For example, information was obtained from the UK Chemicals 
Stakeholder Forum about current uses of alkylphenols and alkylphenol ethoxylates in var­
ious industries and about efforts to reduce human exposure and release in the environ­
ment in the past49. Additionally, the national pesticide registry was searched to identify 
the purposes of specific pesticides used in the UK50,51.
The 353 job titles in the SOC2000 were manually matched with the 348 job titles in 
the 2002 JEM , which were derived from the 1980 UK Categories of Occupations, so that 
the original exposure probability scores could be taken into account during the expert
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table 6.2 Chem ical groups and subgroups o f substances with endocrine-disrupting potential that were selected for the JEM
Chemical group Subgroups Description Some reported endocrine disrupting effects
l Polycyclic aromatic 
hydrocarbons
None Formed by incomplete combustion of 
carbon containing fuels 
Constituents in tar
Anti-estrogenic effects in vitro2'
2 Polychlorinated 
organic compounds
2.1 Polychlorinated biphenyls (PCBs)
2.2 Dioxins, furans, polychlo-rinated 
naphthalene (PCN)
2.3 Hexachlorobenzene (HCB)
2.4 Octachlorostyrene (OCS)
Produced as byproducts during waste 
incineration and industrial processes 
involving carbon and chlorine (e.g. during 
metal, solvent, or pesticide manufactur­
ing)
PCBs: until 1970s widely used as insulat­
ing and cooling fluids
PCBs, dioxins, furans, PCN: interfere with 
steroid synthesis through aryl hydrocarbon 
receptor binding (CDC)22,23 
HCB: affects male and female fertility in 
animal studies24
OCS: metabolites possibly interfere with 
thyroid homeostasis through binding with 
plasma proteins25
3 Pesticides 3.1 Organochlorines
3.2 Carbamates
3.3 Organophosphates
3.4 Tributyltin
3.5 Pyrethroids
3.6 Other pesticides
Used in agriculture
Other purposes include wood preserva­
tion, anti-fouling, parasite treatment, and 
public hygiene
Include among others estrogenic or anti- 
androgenic effects in vitro, reproductive 
toxicity in animal models, and subfertility or 
endocrine alterations in human studies26,27
4 Phthalates 4.1 Di-2-ethylhexyl phthalate (DEHP), 
di-isononyl phthalate (DNP), di-n- 
hexyl phthalate (DHP)
4.2 Benzyl butyl phthalate (BBP)
4.3 Dibutyl phthalate (DBP)
4.4 Diethyl phthalate (DEP)
Many industrial applications 
High molecular weight phthalates (DEHP, 
DNP, DHP) primarily used a plasticizers in 
polyvinyl chloride (PVC)
Low molecular weight phthalates (BBP, 
DBP, DEP) used as solvents and plasticiz­
ers in cosmetics, adhesives, ink, dyes, and 
plastic packaging
DEHP, DNP, DHP, BBP, DBP: affect develop­
ment of male reproductive organs in animal
studies2®32
DEP, DBP, BBP: possibly interfere with male 
reproductive hormone levels in children33
w5 Organic solvents 5.1 Ethylene glycol ethers (EGEs)
5.2 Styrene
5.3 Toluene
5.4 Xylene
5.5 Trichloroethylene (TCE)
5.6 Perchloroethylene (PCE)
EGEs, toluene, xylene: widely used in e.g. 
paints, adhesives, thinners, lacquers, and 
resins
Styrene: used for producing polystyrene 
plastics and resins
TCE, PCE: used for metal degreasing and 
other industrial cleaning purposes
EGEs: reproductive toxicity in animal studies 
and possibly reduced fertility and menstrual 
length variability in women34 
Styrene: styrene dimers and trimers bind to 
estrogen receptor in vitro35 
Toluene, xylene, TCE: possibly interfere with 
reproductive hormone levels in humans36 38 
PCE: dry cleaning has been associated with 
menstrual disorders, infertility, and delayed 
conception in women34
6 Bisphenol A None Used for production of polycarbonate 
plastic and epoxy resins
Estrogenic effects according to various in 
vitro and in vivo studies39
7 Alkylphenolic com­
pounds
7.1 Alkylphenolic ethoxylates (APEs)
7.2 Alkylphenols (APs)
APEs: commonly used surfactants in e.g. 
detergents, pesticides, and cosmetics 
APs: primarily used to produce APEs
APE metabolites, which include APs and 
short chain APEs, interact with the estrogen 
receptor in vitro40
8 Brominated flame 
retardants
8.1 Tetrabromobisphenol A (TBBPA)
8.2 Hexabromocyclodecane (HBCD)
8.3 Polybrominated disphenyl ethers 
(PBDEs)
Widely used in polymer industry, e.g. in 
production of PVC, epoxy resins, polyes­
ter, and rubber
TBBPA, HBCD, PBDEs: interfere with thyroid 
hormone Ievels4i
TBBPA, PBDEs: possibly interfere with estro­
gen metabolism through estrogen sulfotrans- 
ferase inhibition4'
9 Metals 9.1 Arsenic
9.2 Cadmium
9.3 Copper
9.4 Lead
9.5 Mercury
Used in e.g. electrical/electronics indus­
try, for construction, in batteries, dyes, 
pesticides, and dental amalgam, and as 
chemical intermediates
Arsenic: inhibits glucocorticoid gene tran­
scription in vitro and thought to have similar 
effects on other steroid receptors42 
Cadmium, coppers, lead, mercury: testicular 
toxicity in animal models or altered hormone 
levels and/or male subfertility in humans43
10 Miscellaneous 10.1 Benzophenones
10.2 Parabens
10.3 Siloxanes
Benzophenones: UV screens used in 
cosmetic and plastic industries 
Parabens: widely used preservatives in 
cosmetic and pharmaceutical industries 
Siloxanes: intermediates in polymer in­
dustry and ingredients in personal care 
products and precision cleaning agents
Benzophenones: bind with estrogen receptor 
in vitro and exert estrogenic effects in animal 
studies44
Parabens: estrogenic activity in vitro and in 
animal studies45
Siloxanes: estrogenic and antiestrogenic 
activity in animal studies46
#table 6.3 Definitions of the exposure scores
0 Exposure is unlikely to occur (or does not exceed general population background levels)
1 Exposure is possible for some workers, but probability is low (involves less than 10% of 
workers with this job title)
2 Exposure is likely to occur (in more than 10% of workers with this job title)
9 Job title provides too little information to classify exposure
assessments. This was not possible for seven job titles that did not correspond with any 
job title in the original JEM .
A panel of three experts (MB, AH, MvT) assigned exposure probability scores for all 
chemical groups to each of the 353 job titles. Similar to the original JEM , the exposure 
probability counted three levels, which were ‘unlikely', ‘possible', and ‘probable' (Table
6.3). In addition, an ‘unclassifiable' score was assigned to job titles which were very broad 
and non-specific. For many chemicals, most people experience a certain level of exposure 
through diet, environment or widely used consumer products. The JEM  exposure score 
refers to the probability that the occupational exposure level exceeds this background 
level in the general population. For example, exposure to PAHs may result from environ­
mental tobacco smoke and traffic exhaust fumes, sources that affect the most people to 
at least some level. Therefore, only full-time occupational exposure to PAHs from indoor 
tobacco smoke was considered in the JEM  and positive exposure scores associated with 
traffic exhaust fumes only applied to workers who spend nearly all of their time driving or 
working outside on or beside a busy road. No distinction was made between the various 
routes of exposure (inhalation, ingestion, or dermal).
The exposure probability scores were assigned by means of consensus discussions in 
which the original scores were taken into account where possible, but no prior individual 
assessments were performed. In preparation of the discussion meetings, the experts 
studied the reference material and reviewed the job descriptions. Furthermore, the 
expert panel's exposure estimates were based on their knowledge of tasks and work­
ing environments in various occupations in the UK, considering the relevant time period. 
First, the complete list was screened to identify job titles that were highly unlikely to 
involve any exposure and job titles that were unclassifiable. The remaining occupations 
were scored for each of the chemical groups and 33 subgroups, taking into account the 
original exposure scores where possible. The exposure probability scores for subgroups 
(e.g. ‘cadmium', ‘arsenic', ‘copper', ‘lead', and ‘mercury') were summarised in the group 
score (‘metals'), so that the group score equalled the highest exposure probability score 
in the subgroups. Likewise, the 10 group scores were summarised in the overall exposure 
probability score. During the consensus meeting, the reasons for the positive exposure 
scores (score 1 or 2) were documented and used to define 57 different exposure scenarios,
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#such as ‘exposure to fumes from burning buildings', ‘exposure to refuse contaminated 
with PCBs', ‘exposure to indoor exhaust fumes', ‘working with spray paints', and ‘applying 
pesticides against insects and rodents'.
After completing the expert assessments, 24 job titles which had not been identi­
fied as unexposed in the first screening, were left as unexposed. These occupations were 
double checked, as well as the occupations that received an ‘unclassifiable' score. For 
each chemical group, both the group score and the subgroup scores were checked for 
consistency over all exposed job titles. W e also ensured that job titles with a similar expo­
sure scenario received the same exposure probability scores. The few inconsistencies that 
were detected were corrected in the final JEM.
The final makeup of the JEM  is illustrated in Table 6.4. ‘Senior officials in national govern­
ment' is an example of a job title for which exposure to any chemical group is classified 
as unlikely. For the second job title ‘electricians, electrical fitters', exposure is classified 
as possible, because some workers may reach relevant exposure levels for lead during 
soldering. Glass and ceramics makers, decorators, and finishers are classified as prob­
ably exposed to arsenic, cadmium, and lead, because arsenic and lead are used for glass 
making and cadmium and lead are constituents in glass and ceramics dyes. They are also 
possibly exposed to organic solvents from coatings. ‘Beauticians and related occupations' 
involves working with cosmetics, which are considered to be an exposure source for many 
chemicals, although the probability of exposure to organic solvents, alkylphenolic com­
pounds, benzophenones, and siloxanes is considered to be low. ‘Chemical and related 
process operatives' is an example of a job title that is too broad to classify the exposure 
probability.
Some examples of exposure scenarios are listed in Table 6.5, which shows some sce­
narios and exposures that were considered for the glass and ceramics industry, for people 
working with metals or metal end products, and for jobs in agriculture settings.
O f the 353 job titles, 237 (67%) were classified as not exposed to any chemical group 
and 13 (4%) were ‘unclassifiable'. O f the remaining 103 job titles (29%), 60 (17%) were 
classified as possibly exposed and 43 (12%) as probably exposed to one or more chemical 
groups in the JEM . The unexposed job titles mostly concerned managers, professionals 
in science, technology, teaching, business, and public services, administrative and sec­
retarial occupations, and sales and costumer service occupations. The exposed job titles 
were predominantly skilled trade occupations and process, plant, and machine operatives.
Table 6.6 shows the frequencies of the exposure probability scores among the job 
titles in the JEM  for each chemical group separately. Metals and organic solvents are 
most often linked to an occupation in the JEM. Regarding organic solvents, the positive
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Results
t a b l e  6.4 Illustration o f  the JEM for five different jo b  titles
Code SOC2000 job  t it le
Overall exposure 
score3 Chemical groups'1
Group
scores3 Chemical subgroups'1
Subgroup
scores3 Exposure scenarios
1111 Senior officials in national 
government
0 - - - • -
5241 Electricians, electrical fitters 1 Meta Is (9) 1 Lead (9.4) 1 Lead solder
5491 Glass and ceramics makers, 
decorators, and finishers
2 Organic solvents (5) 
Meta Is (9)
1
2
EGEs (5.1) 
Toluene (5.3) 
Xylene (5.4)
Arsenic (9.1) 
Cadmium (9.2) 
Lead (9.4)
i
i
i
2
2
2
Glass making chemicals; 
dyes for glass and ce­
ramics; coatings
6222 Beauticians and related 
occupations
2 Phthalates (4)
Organic solvents (5)
Alkylphenolic com­
pounds (7)
Miscellaneous (10)
2
1
1
2
DEHP, DNP, DHP (4.1) 
BBP (4.2)
DBP (4.3)
DEP (4.4)
EGEs (5.1)
APEs (7.1)
APs (7.2)
Benzophenones (10.1) 
Para bens (10.2) 
Siloxanes (10.3)
1
2 
2 
2
1
1
1
1
2 
1
Cosmetics
8114 Chemical and related process 
operatives
9 - - - • -
a Exposure scores refer to the exposure probabilities formulated In Box 2 
b Only chemical groups and subgroups to which exposure is possible (1)  or probable (2)  are shown
#table 6.5 Several examples of exposure scenarios that describe the reasons 
for assigning exposure probability scores in the JEM
Exposure scenarios
JEM chemical groups 
involved
JEM chemical subgroups 
involved
Exposures during manufacturing and 
processing of glass and ceramics
Examples:
Glass making chemicals Metals (9) Arsenic (9.1) 
Lead (9.4)
Dyes for glass and ceramics Metals (9) Cadmium (9.2) 
Lead (9.4)
Exposures during processing of metals and 
using metal end products
Examples:
Lead solder Metals (9) Lead (9.4)
Ammunition for firearms Metals (9) Lead (9.4)
Metal cleaning and degreasing 
agents
Organic solvents (5) EGEs (5.1) 
TCE (5.5) 
PCE (5.6)
Exposure to pesticides
Examples:
Pesticides for general agricultural 
purposes
Pesticides (3) Organochlorines (3.1) 
Carbamates (3.2) 
Organophosphates (3.3) 
Pyrethroids (3.5)
Other pesticides (3.6)
Phthalates (4) DEHP,DNP, DHP (4.1) 
DBP (4.3)
DEP (4.4)
Organic solvents (5) EGEs (5.1) 
Toluene (5.3) 
Xylene (5.4)
Alkylphenolic 
compounds (7)
APEs (7.1) 
APs (7.2)
Metals (9) Copper (9.3)
Sheep dipping pesticides Pesticides (3) Organophosphates (3.3) 
Pyrethroids (3.5)
Other pesticides (3.6)
Phthalates (4) DEHP,DNP, DHP (4.1) 
DBP (4.3)
DEP (4.4)
Organic solvents (5) EGEs (5.1) 
Toluene (5.3) 
Xylene (5.4)
Alkylphenolic 
compounds (7)
APEs (7.1) 
APs (7.2)
#
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#table 6.6 Prevalence of exposure scores among the 353 UK SOC2000 job titles in the JEM
No. of job No. of job No. of job titles with
titles titles score 1 or 2 plus
Chemical group with score 1 with score 2 percentage of total
1 Polycyclic aromatic hydrocarbons 27 5 32 (9.i%)
2 Polychlorinated organic compounds 3 i 4 (i.i%)
2.1 PCBs i i 2 (o.S%)
2.2 Dioxins, furans, PCN 3 i 4 (i.i%)
2.3 HCB 3 i 4 (i.i%)
2.4 OCS 3 i 4 (i.i%)
3 Pesticides i 3 7 2o (5.7%)
3.1 Organochlorines 7 S i3 (3.7%)
3.2 Carbamates i2 7 i9 (5.4%)
3.3 Organophosphates 9 7 iS (4 .5%)
3.4 Tributyltin o o o (o.o%)
3.5 Pyrethroids i2 7 i9 (5.4%)
3.6 Other pesticides i 3 7 2o (5.7%)
4 Phthalates iSa S 24 M % )
4.1 DEHP, DNP, DHP i2 2 24 M % )
4.2 BBP 9 S i7 (4 .S%)
4.3 DBP i9 5 24 M % )
4.4 DEP 9 5 i4 (4 .o%)
5 Organic solvents 33 i3 " I T (i3.o%)
5.1 EG Es 32 o 32 (9.i%)
5.2 Styrene 2 o 2 (o.S%)
5.3 Toluene i2 iS 3o (s.5%)
5.4 Xylene 23 7 3o (S.5%)
5.5 tce ii o ii (3.i%)
5.6 PCE io i ii (3.i%)
6 Bisphenol A i o i (o.3%)
7 Alkylphenolic compounds i9 o i9 (5.4%)
7.1 APEs i9 o i9 (5.4%)
7.2 APs ii o ii (3.i%)
8 Brominated flame retardants 4 o 4 (i.i%)
8.1 TBBPA 2 o 2 (o.S%)
8.2 HBCD 3 o 3 (o.9%)
8.3 PBDEs 4 o 4 (i.i%)
9 Meta ls 3i i4 45 (i53%)
9.1 Arsenic S 2 S (2.3%)
9.2 Cadmium i 5 S (i.7%)
9.3 Copper 2i 7 2S (7.9%)
9.4 Lead 2i S 27 (7.7%)
9.5 Mercury i 3 4 (i.i%)
10 Miscellaneous 2a 3 5 (i.4%)
10.1 Benzophenones 4 o 4 (i.i%)
10.2 Parabens o 3 3 (o.9%)
10.3 Siloxanes 5 o 5 (i.4%)
#
a Exposure probability scores fo r  the chemical groups correspond w ith the highest score o f  the chemical sub­
groups. Therefore, frequencies o f  subgroup scores can exceed the frequency o f  corresponding group scores.
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#exposure scores most often refer to ethylene glycol ethers (EGEs), toluene, and xylene, 
although EGE exposure was not considered to be very likely in any occupation. Exposure 
to metals most often concerns copper or lead. Other frequently scored chemical groups 
include PAHs, pesticides, phthalates, and alkylphenolic compounds, but the latter group 
only scored in the ‘possible' category. The remaining chemicals (polychlorinated organic 
compounds, bisphenol A, brominated flame retardants, benzophenones, parabens and 
siloxanes) involve very few occupations in the JEM.
The most commonly documented exposure scenarios were exposure to exhaust fumes 
(27 times), copper fumes (10 times), and lead fumes (seven times), and working with lead 
solder (five times), metal cleaning and degreasing agents (seven times), pesticides for 
general agricultural purposes (13 times), adhesives (nine times), and coatings (five times). 
The remaining exposure scenarios mostly applied to a single job title.
Differences between the exposures scores in the 2002 JEM  (available for pesticides, 
dioxins, phthalates, bisphenol A, alkylphenolic compounds, and metals) and the corre­
sponding new exposure scores demonstrate some improvements in working environ­
ments. For example, 10 job titles that were considered exposed to polychlorinated com­
pounds according to the 2002 JEM  were not exposed in the new JEM . Many of these job 
titles involve handling electronic goods, which used to be a source of PCB exposure but 
has not been so for the last 10 years. For four job titles, the original exposure probability 
scores for metals were adjusted because of the reduction of lead in paint and petrol. Three 
job titles that involved domestic cleaning were no longer considered to be exposed to 
alkylphenolic compounds. In nine other cases, exposure scores were adjusted because of 
disparities between the job descriptions and chemical groups used the 2002 JEM  and in 
the new JEM, and 12 job titles were now judged to be ‘unclassifiable'. Additionally, several 
exposure scores were adjusted because the experts did not find them appropriate and 
the motivation for the original scores was not clear. The original JEM  scores remained 
unaltered for 254 job titles.
Discussion
Based on a JEM  developed by van Tongeren et al. in 2002, we constructed a new JEM  
for estimating occupational exposure to EDs in epidemiological studies. In this JEM , 353 
job titles were linked to an exposure probability for 10 chemical groups and 33 chemical 
subgroups. W e updated the original JEM  by incorporating the current knowledge about 
chemicals with endocrine disrupting properties and by focusing the exposure estimates 
on the previous 10 years. Additionally, the reasons for the exposure probability scores 
were documented as 57 exposure scenarios to facilitate further adjustments. These 
changes are intended to increase the performance of the JEM  and encourage its wide­
spread use. Nevertheless, the JEM  has some limitations, which are discussed below.
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#We aimed to identify as many potential EDs for the JEM  as possible from the literature. 
This resulted in a large selection of chemical groups and subgroups with varying strengths 
of evidence for endocrine disrupting potential and with very diverse industrial purposes. 
It was difficult to classify exposure for some specific chemicals, especially if little back­
ground information was available. It might be possible to achieve more accurate exposure 
estimates by extending the literature search or by consulting other experts for additional 
information on occupations at risk. The exposure scenarios that describe the reasoning 
for the exposure scores are meant to be helpful for improving the JEM  and for making 
adjustments to account for differences in exposure probabilities over time and between 
countries. For example, in applying the JEM  to our Dutch case-referent study on hypo­
spadias and cryptorchidism we adjusted the exposure probability scores for the scenario 
‘working with sheep dipping pesticides', as sheep dipping is much less common in The 
Netherlands than in the UK. W e also considered ‘exposure to lead fumes' by pipe fitters 
and plumbers to be less likely than in the UK. New regulations on, for example, the uses of 
organic solvents, metals and alkylphenolic compounds, may require specific adjustments 
to the JEM  for younger subjects. In general, we recommend other researchers not to use 
the JEM  ‘blindly', but to first consider the generalisibity of the exposure probability scores 
to their specific study population.
The vast majority of the job titles in the JEM  were classified as unexposed. Most of 
these were easily recognized by managerial and administrative job descriptions. For 
applying the JEM, this has the practical advantage that an efficient coding strategy can be 
used in which unexposed occupations are coded with less detail. However, the restricted 
number of exposed occupations also means that, depending on the distribution of job 
titles within a specific study population, studying associations between ED exposure and 
adverse health effects at the chemical group or subgroup level may require a very large 
sample size.
The cells of our matrix represent exposure probabilities, which are only a crude mea­
sure of exposure. W e considered the possibility to assess the level of exposure as well, 
but concluded that we had too little information to produce such estimates. In some 
cases, however, the exposure scenarios can be used as an indication of the level of expo­
sure. For example, the scenario ‘working with tar' can be expected to involve higher levels 
of PAHs compared to the scenario ‘exposure to environmental tobacco smoke'. Taking 
into account the exposure scenarios may therefore give more insight into the association 
between specific chemical groups and subgroups and the outcome of interest.
As stated earlier, a major drawback of all JEM s is that they do not account for vari­
ability in tasks and working environments within job titles. This could result in substantial 
misclassification, especially when a JEM  is based on a broad occupational classification 
system developed for socio-economic purposes rather than exposure assessment, which 
is often the case. Strategies to refine JEM  exposure estimates have been described by 
Semple et al. and Kennedy et al. for exposure assessment in studies on risk factors for
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#Parkinson's disease and asthma16,17. In both studies, a method was developed in which JEM  
exposure estimates were modified based on task specific information from interviews. 
With respect to the asthma JEM, this method resulted in stronger associations between 
risk factors and asthma, indicating a reduction in non-differential misclassification16.
In the current JEM , the documented exposure scenarios describing the reasons for the 
exposure probability scores allow further refinements as well. Task specific information 
from questionnaires, interviews, or diaries can be used to verify the exposure scenarios 
for the subjects in a study population. For example, according to the JEM , all workers 
with the job title ‘farmer' are probably exposed to pesticides. However, from the task 
descriptions, it may become clear that some subjects with this job title have certain odd 
jobs around a farm (e.g. feeding farm animals) where pesticide exposure is less likely. 
Especially with such exercises, we believe that the JEM  can be a valuable tool for exposure 
assessment in community based studies on health risks of the increasing number of EDs.
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#Abstract
Background Parental exposure to end ocrine dlsruptors (EDs) has been suggested 
to increase the risks of undescended testis (UDT) and hypospadias in offspring, 
but con clu sive evidence for such associations is lacking.
Objectives To assess w hether parental ED exposure is associated w ith an 
increased risk o f UDT and hypospadias in offspring using a Job Exposure M atrix 
(JEM).
Methods A case-referent study was perform ed including 2 0 0  cases w ith UDT,
305 cases with hypospadias, and 629 referents (boys with m iddle ear effusion). 
Exposure assessm ent involved the application of a JEM that provides exposure 
probability scores (‘unlikely', ‘possible', or ‘probable') on 10 groups and 33 su b ­
groups of potential EDs for 353 job  titles. Som e JEM exposure p robability scores 
w ere modified based on q u estionn aire  data on tasks and w orking environm ent. 
Results A ssociations w ere observed between UDT and m aternal occupational 
exposure to pesticides: O R 2.0 (95%CI 0.9-4.6), phthalates: OR 2.0 (0.8-5.4), or­
ganic solvents: O R 1.7 (1.0-2.8), alkylphenolic com pounds: O R 2.0 (1.1-3.5), copper: 
O R 1.9 (0.9-4.3), benzophenones: O R 2.9 (1.0-8.7), parabens: O R 2.6 (0.9-7.0), and 
siloxanes: O R 2.2 (0.9-5.4), w hich m ainly involved w orking in agriculture or with 
cosm etic products. M aternal occupatio nal exposure to organic solvents seem ed to 
increase the risk of hypospadias in offspring: O R 10.3 (1.0-101.8). Slightly elevated 
O Rs w ere calculated for paternal exposure to pesticides, phthalates, and copper. 
Conclusions The findings indicate that occupational expo sure to potential EDs 
may increase the risks of UDT an d /o r hypospadias in offspring. The JEM seem s a 
valuable exposure assessm ent m ethod, especially  w hen additional data on tasks 
and w orking environm en t are incorporated.
#Introduction
The potential link between parental occupational exposure to endocrine disruptors (EDs) 
and hypospadias and undescended testis (UDT) in offspring has been assessed in several
job titles or self-reported exposures. For example, UDT was reported to be more common 
among sons of women who worked in gardening1 and agriculture4. Using retrospective 
questionnaire data, UDT was also linked to paternal exposure to diesel exhaust fumes5. 
Self-reported parental occupational exposure to hairsprays6 and organic solvents2 was 
associated with an increased risk of hypospadias.
To date, endocrine disrupting properties have been demonstrated for a large variety 
of industrial chemicals, including several pesticides7, polycyclic aromatic hydrocarbons 
(PAHs)8, dioxins9, phthalates10, organic solvents11,12, parabens13, metals14, and other agents. 
Exposure to these chemicals may occur in occupational circumstances that are difficult to 
capture with questionnaires, especially retrospectively. Therefore, a Job Exposure Matrix 
(JEM ) in which experts assign exposure scores to jobs based on their knowledge of tasks 
and working environments may be a valuable alternative. In case-referent studies, JEM  
exposure estimates are unlikely to be affected by recall bias due to the fact that the scores 
are solely based on job titles, which are generally reliably recalled15. An important limita­
tion of JEM s is, however, that they do not account for differences in exposure between 
workers with the same job title. In 2002, Van Tongeren and colleagues published a Job 
Exposure Matrix (JEM ) for seven groups of potential EDs, assessing the probability of 
exposure for a total of 348 job titles16. Using this JEM , suggestions for an increased risk 
of hypospadias following maternal exposure to phthalates were observed3,6. In two other 
studies that used the same JEM , UDT was linked to parental pesticide exposure2,4.
In 2005, we set up a new case-referent study to investigate the risk factors for UDT 
and hypospadias in The Netherlands. For the assessment of occupational exposure, we 
used an extended JEM  covering 353 jobs that provides exposure estimates for 10 chemi­
cal groups and 33 chemical subgroups of potential EDs17. To optimize the retrospective 
assessment of parental occupational exposures to potential EDs, we systematically modi­
fied some JEM  exposure estimates based on information on tasks and working environ­
ment obtained from self-administered questionnaires.
Materials and methods
Population and data collection
Cases and referents were recruited at five hospitals in the eastern part of the Netherlands 
using the hospital electronic information systems. Cases were boys who underwent cor­
rective surgery for hypospadias or UDT (orchidopexy or orchidectomy) at departments
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studies1-6. Exposure assessment of EDs in these studies was generally based on parental
#of Urology or Pediatric Surgery. Referents were recruited at the departments of Otorhi­
nolaryngology at the same hospitals and were otherwise healthy boys who received ear 
ventilation tubes for persistent middle ear effusion. As this is a very common surgical 
procedure, these referents form a good representation of the general population. The 
study population was restricted to boys who were born between 1996 and 2004 and were 
residents in the catchment areas of the participating hospitals. These criteria were met by 
870 cases and 2911 referents. From the latter, we randomly sampled 1125 boys based on 
the geographical distribution of the cases.
Personal data of all subjects were screened in order to identify twins and triplets (from 
which one sibling was randomly selected), other siblings (from which the oldest sibling 
was selected), and double records. This resulted in a final selection of 368 cases with 
UDT, 460 cases with hypospadias, and 1091 referents. In February 2005, the parents of the 
selected cases and referents were asked to complete a postal questionnaire addressing 
various potential risk factors for UDT and hypospadias. Parents were informed that the 
study was designed to investigate associations between life style, occupation, illnesses 
and complications at time of pregnancy and children's health in general, not focusing on 
urogenital birth defects. Data on the clinical presentation of UDT and hypospadias were 
collected from medical files. Referents with birth defects were excluded from the final 
study population. For power considerations, we only excluded cases with syndromes or 
chromosome abnormalities, while we performed subanalyses to see whether exclusion of 
cases with other major birth defects affected the main study results. Additional details on 
data collection and recruitment of cases and referents are available elsewhere18,19.
Job Exposure Matrix
The development of the JEM  for ED exposure is also described in detail elsewhere17. Briefly, 
the JEM  includes 10 chemical groups and a total of 33 chemical subgroups of potential 
EDs. For each chemical group, exposure scores were assigned to each job title from the 
UK Social Occupational Classification 2000 (SOC2000) by three exposure assessment 
experts. The scores represent three levels of exposure probability:
0: exposure is unlikely to occur for workers in the job title of interest or does not 
exceed general population background levels;
1: exposure is possible for some workers, but the probability is low (involves less 
than 10% of workers with the job title of interest); and
2: exposure is likely to occur (involves more than 10% of workers with the job title 
of interest).
Job titles that provided too little information to assign exposure probabilities were 
labeled as ‘unable to score'. All positive exposure probability scores (1 or 2) are accompa­
nied by an exposure scenario that describes the reason for the particular score. The JEM
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#was developed to assess exposures that occurred in the time period 1996-2006 in the UK. 
For the application of the JEM  to our study population, we assessed potential differences 
in exposure between the UK and The Netherlands. The exposure probability scores for 
arsenic (in wood preservatives) and lead (for pipe fitters and plumbers) were modified, as 
the original exposure scores were not deemed to be appropriate for The Netherlands over 
the past 15 years. In addition, ‘sheep dipping' is much less common in The Netherlands 
than in the UK, and the exposure probability scores for pesticide exposure among cattle 
farmers were adjusted accordingly.
Application of JEM  to study population
Parental jobs were coded according to the SOC2000 based on questionnaire data on 
job title, complemented with information on the organization or company the parents 
worked for and their main tasks at time of the index pregnancy. All jobs were coded manu­
ally by two of the authors (MB and NR) who were blinded to case-referent status. To some 
parents, multiple job codes were assigned in order to capture all aspects relevant for their 
exposure status. The online available Computer Assisted Structured Coding Tool20 was 
used to identify suitable occupational codes. Subsequently, the JEM  was applied to obtain 
exposure estimates in the form of exposure probability scores. In case of multiple job 
codes, the highest exposure probability score for a certain chemical was used.
Exposure assessment
In order to reduce misclassification of exposure, all records and exposure estimates were 
blindly reviewed using the text entry of the parental job description. Examples of records 
for which the JEM  exposure estimates were modified are provided in. Examples 1 through
7 illustrate JEM  exposure estimates which were not appropriate and were changed to ‘0'. 
In case of example 9, the pesticide exposure scores were changed from ‘2' to ‘1', while the 
scores for phthalates, solvents, and copper, which are constituents in some pesticides, were 
changed from ‘1' to ‘0'. Examples 11 through 13 demonstrate situations where the JEM  did 
not assign exposures that were likely to occur in some specific jobs. Probability scores for 
these exposures were then copied from other job titles with similar exposure scenarios.
Data analyses
Statistical analyses were performed with SPSS version 16.0. Associations between case 
status and exposure to the various chemical groups and subgroups of potential EDs were 
expressed in odds ratios (OR) with 95% confidence intervals (95%CI). Subjects whose 
mothers or fathers were unlikely to have been exposed to any chemical group were 
treated as the reference category. The exposure categories ‘possible' (1) and ‘probable' 
(2) were grouped if the OR for ‘probable' exposure could not be calculated because of 
empty cells. In all other cases, separate ORs for the two exposure categories were calcu­
lated. Using multivariable logistic regression analyses, all associations were adjusted for
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#potential confounding factors for which, within the dataset, indications for increased risks 
of UDT or hypospadias were found18,19, and for risk factors obtained from the literature 
for which we expected an association with parental job title. The selected covariables 
included ethnic origin (European or non-European), low birth weight, gestational age (in 
weeks), gestational preeclampsia, twinning, and parental obesity and smoking at time of 
the index pregnancy. All effect estimates were also adjusted for subjects' year of birth in 
order to account for potential differences in exposure levels or probabilities over time. 
In addition, maternal use of oral contraceptives and anti-emetic drugs during pregnancy 
were included as potential confounders in the analyses for UDT. Parental subfertility and 
IVF/ICSI treatment were considered possible intermediate factors in the associations 
between JEM  exposures and hypospadias and UDT in offspring, and were not included in 
the multivariable models. Subanalyses showed that adjustment for familial occurrences 
of hypospadias and UDT, which were not included in the main analyses due to large num­
bers of missing values, did not substantially change the effect estimates. Further analyses 
were performed to identify any differences in effect estimates for subgroups of cases 
with anterior, middle, or posterior hypospadias and UDT with and without inguinal her­
nia, because previous findings suggested heterogeneous etiologies18,19. Elevated ORs were 
recalculated using the original JEM  exposure probability scores that were not modified 
according to the questionnaire data, in order to see the effect of these modifications on 
the final effect estimates.
Completed questionnaires were received from parents of 230 cases with UDT, 328 cases 
with hypospadias, and 741 referents. After excluding cases and referents with unknown 
address changes (n=73), this corresponds to response rates of 66%, 74%, and 70%, respec­
tively. Essential questionnaire data were missing for 11 cases and referents. An additional 
105 referents were excluded, because parents reported UDT (non-treated or treated else­
where, n=12) or other birth defects (n=93), including 37 orofacial clefts and 7 Down syn­
dromes, which are associated with persistent middle ear infections. W e also excluded 10 
cases with syndromes or chromosome abnormalities and 35 ‘cases' with misdiagnoses. As 
a result, the data analyses included 200 cases with UDT, 305 cases with hypospadias and 
629 referents.
The employment status of mothers and fathers at the time of the index pregnancy 
was similar in the two case groups and the referent group with a total of 926 employed 
mothers (82%) and 1027 employed fathers (98%). Almost all parents (917 mothers and 1013 
fathers) provided sufficient information for job coding; 27 mothers and 56 fathers received 
two or three job codes. Exposure probability scores were modified for 31 mothers and 95 
fathers based on the parents' original job descriptions (see examples in Table7.1). The asso-
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table  7.1 Examples of records in which parental job descriptions led to a modification of their exposure probability scores according to the JEM
No. Job titlesinJEM JEM exposure scenario
Job descriptions that led to modifica­
tion of exposures according to JEM
Implications of job descriptions 
for the exposure assessment
1 Floorers and wall tilers Work with adhesives, floor stripping chem­
icals, and coatings
Wall tilers 
(5 fathers)
Do not work with floor stripping 
chemicals and coatings
2 Road construction operatives Exposed to asphalt and outdoor exhaust 
fumes
Street masons 
(5 fathers)
Not exposed to fumes from as­
phalt
3 Metal working machine opera­
tives
Exposed to fumes from copper and lead Workers in steel or aluminum indus­
tries (6 fathers)
Not exposed to fumes from cop­
per and lead
4 Carpenters and joiners Possibly exposed to pesticides for wood 
treatment, paints, and adhesives
Machine operatives in a woodworking 
manufactory (6 fathers)
Do not work with paints and 
adhesives
5 Launderers, dry cleaners, press- 
ers
Possibly exposed to dry cleaning agents Launderers 
(2 mothers)
Not exposed to dry cleaning 
agents
6 Dental nurses Encounter mercury in dental fillings Nurses or assistants in an orthodontic 
practice (2 mothers)
Unlikely to encounter mercury in 
dental fillings
7 Veterinary nurses and assis­
tants
Possibly encounter pesticides at farms Nurses or assistants who work with 
pets but not farm animals 
(2 mothers)
Not exposed to pesticides at 
farms
8 Production, works and mainte­
nance managers; construction 
or process operatives n.e.c.
Classified as ‘unable to score’ Company directors or project leaders 
with exclusively managerial tasks 
(1 mother and 21 fathers)
Unlikely exposed to any chemical 
group
9 Farm workers Work with pesticides for general agricul­
tural purposes
Farmer's wives with odd jobs around 
the farm (6 mothers)
Possibly exposed to pesticides, 
but exposure is less likely
10 Leather and related trades Possibly exposed to leather making chemi­
cals, leather fungicides, and adhesives
Shoe repairmen/women 
(1 mother and 2 fathers)
Not exposed to leather making 
chemicals and leather fungicides, 
probably work with adhesives
11 Assemblers of electrical prod­
ucts; electricians
Possibly exposed to fumes from lead solder Assemblers or repairmen of copiers 
(1 mother and 7 fathers)
Possibly also exposed to print­
ing ink
12 Retail cashiers and check/out 
operators
Classified as unlikely exposed to any 
chemical group
Gasoline station attendants 
(1 mother and 1 father)
Exposed to exhaust fumes
13 Construction trades n.e.c. Classified as 'unable to score' Builders or contractors in construction 
(6 fathers)
Possibly work with paints and 
adhesives, other exposures are 
unlikely
N.B. The examples shown involve 17  mothers and 58 fathers in total, which represent more than half o f  all mothers (31)  and fathers (95)  whose exposure probability scores were completely 
or partly modified based on the original jo b  descriptions
t a b l e  7.2 Associations between maternal occupational exposure to potential EDs according to the JEM and the risks o f undescended testis and hypospadias
Referents
n
Undescended testis 
Crude 
n OR (95°/oCI)
Adjusted8 
O R (95°/oCI)
Hypospadias 
Crude 
n OR (95%CI)
Adjustedb 
O R (95°/oCI)
Summary JEM score
Unlikely 523' 7 68c ref ref 20f ref ref
Possible 44 9 0.6 (0.3-1.3) 0.7 (0.3-1.6) V 0.8 (0.4-1.4) 0.9 (0.5-1.7)
Probable 47 22 1.5 (0.9-2.5) 1.6 (0.9-2.8) 21 0.9 (0.5-1.5) 0.9 (0.5-1.6)
Polycyclic aromatic hydrocarbons
Possible 9 0 - - 2 0.5 (0.1-2.1) 0.5 (0.1-2.9)
Probable 9 2 0.7 (0.2-3.2) 0.7 (0.1-3.3) 6 1.3 (0.5-3.8) 1.2 (0.4-3.7)
Pesticides
Possible 8 0 - - 3 0.8(0.2-2.9) 0.9 (0.2-3.7)
Probable 21 11 1.6 (0.8-3.5) 2.0 (0.9-4.6) 9 0.9 (0.4-1.9) 1.1 (0.4-2.7)
Phthalates - as a group
Possible 21 11 1.6 (0.8-3.5) 2.0 (0.9-4.6) n 1.1 (0.5-2.2) 1.3 (0.5-3.1)
Probable 12 7 1.8 (0.7-4.7) 2.0 (0.8-54) 2 0.3 (0.1-1.5) 0.3 (0.1-1.4)
Di-2-ethylhexyl phthalate, di-isononyl
phthalate, di-n-hexyl phthalate
Possible 30 18 1.8 (i.o-3.3)d 2.2 (i.24.3)d 10 0.7 (o.3-i.3)d 0.7 (o.7-i.7)d
Probable 1 0 0
Butyl benzyl phthalate
Possible 1 0 - - 2 4.0 (0.4-44.4) 4.0 (0.3-55.0)
Probable 11 7 2.0 (0.8-5.2) 2.2 (0.8-5.8) 2 0.4 (0.1-1.7) 0.3 (0.1-1.6)
Dibutyl phthalate
Possible 22 11 1.6 (0.7-3.3) 1.9 (0.84.2) 13 0.8 (o.4-i.5)d 0.9 (o.4-i.8)d
Probable 11 7 2.0 (0.8-5.2) 2.4 (0.9-6.3) 0
Diethyl phthalate
Possible 20 11 1.7 (0.8-3.7) 2.2 (0.9-5.0) 10 0.7 (o.3-i.3)d 0.7 (o.3-i.7)d
Probable 11 7 2.0 (0.8-5.2) 2.4 (0.9-6.3) 0
Organic solvents - as a group
Possible 57 26 1.4 (o.9-2.3)d 1.7 (1.0-2.8)d 20 0.7 (0.4-1.2) 0.8 (0.5-1.5)
Probable 1 0 5 10.0 (1.2-86.2) 10.3 (1.0-101.8)
Ethylene glycol ethers
Possible 48 23 1.5 (0.9-2.5) 1.9 (1.1-34) 20 0.8 (0.5-1.4) 1.0 (0.5-1.9)
Probable 0 0 - - 0 - -
Toluene
Possible 30 14 1.4 (o.7-2.7)d 1.4 (0.7-2.9)d 12 0.8 (0.4-1.6) 0.9 (0.4-2.0)
Probable 1 0 4 8.0 (0.9-72.1) 6.0 (0.6-64.9)
wXylene
Possible 30 14 1.5 (0.8-2.8) 1.5 (0.7-3.0) 14 1.1 (0.6-2 .o)d 1.2 (0.6-2.4)d
Probable 0 0 - - 2
Alkylphenolic compounds - as a group
Possible 47 23 1.5 (0.9-2.6) 2.0 (1.I-3.5) V 0.7 (0.4-1.3) 0.9 (0.5-1.8)
Probable 0 0 - - 0 - -
Alkylphenol etholoxylates
Possible 47 23 1.5 (0.9-2.6) 2.0 (1.I-3.5) V 0.7 (0.4-1.3) 0.9 (0.5-1.8)
Probable 0 0 - - 0 - -
Alkylphenols
Possible 31 18 1.8 (1.0-3.3) 2.2 (1.2-4.3) 9 0.6 (0.3-1.2) 0.7 (0.3-1.6)
Probable 0 0 - - 0 - -
Metals - as a group
Possible 26 12 1.4 (0.7-2.9) 1.9 (0.9-4.1) 12 0.9 (0.5-1.9) i.i (0.5-2.5)
Probable 6 2 i.o (0.2-5.2) 0.8 (0.2-4.3) 1 0.3 (0.04-2.8) 0.1 (0.02-1.3)
Copper
Possible 23 11 1.5 (0.7-3.1) 1.9 (0.9-4.3) n 1.1 (0.5-2 .i)d 1.3 (o.6-2.9)d
Probable 0 0 - - 1
Lead
Possible 5 1 0.6 (0.1-5.4) 1.1 (0.1-11.2) 3 1.2 (0.3-5.1) 0.9 (0 .2-5.5)
Probable 0 0 - - 0 - -
Mercury
Possible 0 0 - - 1 0.3 (0.04-2.8)d 0.2 (0.02-1.6)d
Probable 6 2 1.0 (0.2-5.2) 0.8 (0.2-4.4) 0
Benzophenones
Possible 11 7 2.0 (0.8-5.2) 2.9 (1.0-8.7) 0 - -
Probable 0 0 - - 0 - -
Parabens
Possible 0 0 - - 0 - -
Probable 10 7 2.2 (0.8-5.8) 2.6 (0.9-7.0) 0 - -
Siloxanes
Possible 13 8 1.9 (0.8-4.7) 2.2 (0.9-5.4) 0 - -
Probable 0 0 - - 0 - -
a Adjusted fo r maternal non-European ethnic origin, maternal obesity, maternal smoking and use o f  oral contraceptives and anti-emetic drugs during pregnancy, gestational preeclampsia, 
twinning, low birth weight, duration o f gestation, and year o f birth. 
b Adjusted fo r maternal non-European ethnic origin, maternal obesity, maternal smoking during pregnancy, gestational preeclampsia, twinning, low birth weight, duration o f gestation, and 
year o f  birth.
c Treated as reference categories in all further analyses 
d Exposure categories 'possible' and ‘probable’ were grouped
t a b l e  7.3 A ssociations between paternal occupational exposure to potential EDs according to the JEM and the risks o f undescended testis and hypospadias
Referents Undescended testis Hypospadias
n n
Crude 
O R (95°/oCI)
Adjusted3 
O R (95°/oCI) n
Crude 
OR (95°/oCI)
Adjusted6 
OR (95°/oCI)
Summary JEM score for all chemical 
groups
Unlikely 322e 7 09e ref ref 754e ref ref
Possible 157 46 0.9 (0.61.3) 0.9 (0.6-1.4) 80 1.1 (0.8-1.5) 1.0 (0.7-1.4)
Probable 88 27 0.9 (0.61.5) 0.9 (0.5-1.6) 41 1.0 (0.6-1.5) 1.3 (0.8-2.0)
Polycyclic aromatic hydrocarbons
Possible 81 22 0.8 (0.51.3) 0.8 (0.1-1.4) H 1.1 (0.7-1.6) 0.8 (0.5-1.4)
Probable 3 2 2.0 (0.3-11.8) 2.6 (0.4-16.5) 1 0.7 (0.1-6.8) 1.1 (0.1-11.2)
Polychlorinated organic compounds
Possible 3 1 0.6 (o.i-5.i)d 0.7 (o.i-7.i)d 2 0.8 (o.2-44)d 0.6 (o.i-5.8)d
Probable 2 0 0
Pesticides - as a group
Possible 33 5 0.5 (0.2-1.2) 0.3 (0.1-1.0) 11 0.7 (0.63-1.4) 0.5 (0.2-1.1)
Probable 29 12 1.2 (0.6-2.5) 1.6 (0.7-3.5) 13 0.9 (0.5-1.9) 1.4 (0.7-3.0)
Organoch brines
Possible 6 1 0.5 (0.1-4.1) 0.5 (0.1-4.5) 2 0.7 (0.1-3.5) 0.3 (0.03-2.5)
Probable 28 12 1.3 (0.6-2.6) 1.7 (0.8-3.8) 13 1.0 (0.5-1.9) 1.5 (0.7-3.3)
Carbamates
Possible 33 5 0.5 (0.21.2 ) 0.3 (0.1-1.0) 11 0.7 (0.3-1.4) 0.5 (0.2-1.1)
Probable 29 12 1.2 (0.6-2.5) 1.6 (0.7-3.5) 13 0.9 (0.5-1.9) 1.4 (0.7-3.0)
Organoph os pates
Possible 6 1 O.5 (O.l-4.1) 0.5 (0.1-4.5) 2 0.7 (0.1-3.5) 0.3 (0.03-2.5)
Probable 29 12 1.2 (0.6-2.5) 1.6 (0.7-3.5) 13 0.9 (0.5-1.9) 1.4 (0.7-3.0)
Pyrethroids
Possible 33 5 O.5 (0.2I.2) 0.3 (0.1-1.0) 11 0.7 (0.3-1.4) 0.5 (0.2-1.1)
Probable 29 12 1.2 (0.6-2.5) 1.6 (0.7-3.5) 13 0.9 (0.5-1.9) 1.4 (0.7-3.0)
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Other pesticides
Possible 33 5 0.5 (0.2-1.2)
Probable 29 12 1.2 (0.6-2.5)
Phtalates - as a group
Possible 69 20 0.8 (o.5-i.4)d
Probable 4 0
Di-2-ethylhexyl phthalate, di-isononyl 
phthalate, di-n-hexyl phthalate
Possible 34 12 i.o (0.5-2.1)
Probable 0 0 -
Butyl benzyl phthalate
Possible 35 7 0.5 (o.2-1.2)d
Probable 4 0
Dibutyl phthalate
Possible 72 19 0.8 (o.4-i.3)d
Probable 1 0
Diethyl phthalate
Possible 33 12 1.0 (o.5-2.l)d
Probable 1 0
Organic solvents - as a group
Possible 88 29 1.0 (0.6-1.6)
Probable 41 9 0.7 (0.3-1.4)
Ethylene glycol ethers
Possible 90 28 0.9 (0.6-1.5)
Probable 0 0 -
Toluene
Possible 47 17 1.1 (0.6-1.9)
Probable 41 9 0.7 (0.3-1.4)
Xylene
Possible 45 16 1.1 (0.6-1.9)
Probable 38 9 0.7 (0.3-1.5)
0.3 (o.i-i.o) 
1.6 (0.7-3.5)
11
13
0.7 (0.3-1.4) 
0.9 (0.5-1.9)
0.5 (0.2-1.1) 
1.4 (0.7-3.0)
0.8 (o.4-i.5)d 31
3
0.9 (0.6-1.5) 
1.6 (0.4-7.1)
1.1 (0.7-1.9) 
3.0 (0.6-15.7)
1.3 (0.6-2.8) H
1
0.9 (o.5-i.7)d 1.4 (o.7-2.7)d
0.3 (o.i-i.o)d 16
3
1.0 (1.5-1.8) 
1.6 (0.4-7.1)
0.9 (0.5-1.8) 
3.0 (0.6-15.2)
0.8 (o.4-i.4)d 32
1
0.9 (0.6-1.5) 
2.1 (0.1-33.7)
1.1 (0.7-1.9) 
3.0 (0.2-53.3)
1.3 (o.6-2.8)d H
1
0.9 (0.5-1.7) 
2.1 (0.1-33.7)
1.3 (0.6-2.6) 
3.0 (0.2-53.2)
1.0 (0.6-1.8) 
0.5 (0.2-1.2)
44
20
1.1 (0.7-1.6) 
1.0 (0.6-1.8)
1.3 (0.8-2.0) 
1.1 (0.6-2.0)
1.0 (0.6-1.7) 45
0
1.1 (0.7-1.6) 1.2 (0.8-I.9)
1.2 (0.6-2.3) 
0.5 (0.2-1.2)
18
20
0.8 (0.5-1.4) 
1.0 (0.6-1.8)
1.2 (0.7-2.3) 
1.1 (0.6-2.0)
1.2 (0.6-2.3) 
0.5 (0.2-1.3)
20
17
0.9 (0.5-1.6) 
0.9 (0.5-1.7)
1.5 (0.8-2.7) 
O.9 (0.5-I.7)
t a b l e  7.3 Continued
Referents
n
Undescended testis 
Crude 
n OR (95 °/oCI)
Adjusted8 
OR (95 °/oCI)
Hypospadias 
Crude 
n OR (95°/oCI)
Adjusted6 
OR (95°/oCI)
Trichloroethylene
Possible 40 9 0.7 (0.3-1.4) 0.7 (0.3-1.6) 27 1.4 (0.8-2.4) 1.3 (0.7-2.3)
Probable 0 0 - - 0 - -
Perch loroethylene
Possible 40 9 0.7 (0.3-1.4) 0.7 (0.3-1.6) 26 1.4 (0.8-2.3) 1.2 (0.7-2.2)
Probable 0 0 - - 0 - -
Alkylphenolic compounds - as a group
Possible 38 16 1.2 (0.7-2.3) 1.5 (0.8-3.1) 17 0.9 (0.5-1.7) 1.3 (0.7-2.6)
Probable 0 0 - - 0 - -
Alkylphenol etholoxylates
Possible 38 16 1.2 (0.7-2.3) 1.5 (0.8-3.1) 17 0.9 (0.5-1.7) 1.3 (0.7-2.6)
Probable 0 0 - - 0 - -
Alkylphenols
Possible 30 12 1.2 (0.6-2.4) 1.5 (0.7-3.4) 13 0.9 (0.5-1.8) 1.4 (0.7-3.0)
Probable 0 0 - - 0 - -
Metals - as a group
Possible 119 33 0.8 (0.5-1.3) 0.8 (0.5-1.3) 61 1.1 (0.8-1.5) 1.1 (0.7-1.6)
Probable 16 4 0.7 (0.2-2.2) 0.7 (0.2-2.5) 8 1.1(04-2.5) 1.5 (0.6-3.9)
Copper
Possible 85 26 0.9 (0.6-1.5) 1.0 (0.6-1.7) 40 1.0 (0.7-1.5) 1.1 (0.7-1.7)
Probable 8 4 1.5 (0.4-5.0) 1.8 (0.4-7.8) 7 1.8 (0.7-5.1) 2.5 (0.8-7.9)
Lead
Possible 76 17 0.7 (0.4-1.2) 0.6 (0.3-1.2) 42 1.2 (0.8-1.8) 1.1 (0.7-1.8)
Probable 6 1 0.5 (0.1-4.1) 0.7 (0.1-6.4) 1 0.4 (0.04-2.9) 0.8 (0.1-7.5)
a Adjusted fo r paternal non-European ethnic origin, paternal obesity, paternal smoking, maternal use o f oral contraceptives and anti-emetic drugs during pregnancy, gestational preeclamp­
sia, twinning, low birth weight, duration o f gestation, and year o f birth. 
b Adjusted fo r paternal non-European ethnic origin, paternal obesity, paternal smoking, gestational preeclampsia, twinning, low birth weight, duration o f gestation, and year o f birth. 
c Treated as reference categories in all further analyses 
d Exposure categories 'possible' and ‘probable’ were grouped
#ciations between case-referent status and the final exposure probability scores for moth­
ers and fathers are displayed in Tables 7.2 and 7.3, respectively. The tables do not include 
chemical groups and subgroups with very small numbers of exposed cases and referents, 
such as brominated flame retardants, bisphenol A, styrene, arsenic, and cadmium.
Compared to referents, mothers of UDT cases were somewhat more likely to be 
exposed to any chemical group in the JEM : OR 1.6 (95%CI 0.9-2.8) (Table7.2). More specifi­
cally, associations were observed between UDT and probable exposure to pesticides: OR
2.0 (95%CI 0.9-4.6) and phthalates: OR 2.0 (95%CI 0.8-5.4) (as a group and individually), 
possible exposure to organic solvents: OR 1.7 (95%CI 1.0-2.8) (as a group), ethylene glycol 
ethers (EGEs): OR 1.9 (1.1-3.4), alkylphenolic compounds: OR 2.0 (95%CI 1.1-3.5), copper: OR  
1.9 (95%CI 0.9-4.3), benzophenones: OR 2.9 (95%CI 1.0-8.7), and siloxanes: OR 2.2 (95%CI 
0.9-5.4), and probable exposure to parabens: OR 2.6 (95%CI 0.9-7.0). Albeit based on small 
numbers, a strong association was observed between hypospadias and maternal solvent 
exposure (probable): OR 10.3 (95%CI 1.0-101.8), which mainly involved exposure to tolu­
ene: 6.0 (95%CI 0.6-64.9). Very few mothers of cases with hypospadias were exposed to 
mercury, benzophenones, parabens, and siloxanes at time of pregnancy, whereas several 
mothers of referents and UDT cases were. Odds ratios for the remaining chemical groups 
centered around one.
Looking at the exposure scenarios for mothers, we saw that all pesticide exposures 
occurred in agricultural settings. Exposure to phthalates, organic solvents, and alkylphe­
nolic compounds, however, involved a wider variety of exposure scenarios, including the 
use of printing ink, adhesives, industrial cleaning agents, and solvents at laboratories, in 
addition to exposure from agricultural pesticides and cosmetics, which were two common 
exposure scenarios for all three chemical groups. Agricultural pesticides also explained 
nearly all exposure to copper, whereas exposure to benzophenones, parabens, and silox­
anes almost exclusively involved working with cosmetic products. When exposure due to 
agricultural pesticides and/or cosmetics was excluded from the analyses for phthalates, 
organic solvents, and alkylphenolic compounds, the risk estimates for UDT were much 
weaker. The association between hypospadias and organic solvents, however, remained 
unaltered: OR 9.9 (95%CI 1.0-97.8).
Overall, the associations between paternal exposure and UDT or hypospadias were less 
evident (Table7.3). Only weak indications were seen for increased risks of UDT and hypo­
spadias due to pesticide exposure (probable): OR 1.6 (95%CI 0.7-3.5) and OR 1.4 (95%CI 
0.7-3.0), respectively, with similar effect estimates for possible exposure to alkylphenolic 
compounds. In addition, hypospadias seemed to be associated with probable exposure to 
copper: OR 2.5 (95%CI 0.8-7.9) and perhaps phthalates: OR: 3.0 (95%CI 0.6-15.7). Among 
fathers, pesticide exposure involved agricultural uses as well as pesticides used for wood 
treatment. Paternal exposures to phthalates, organic solvents, and alkylphenolic com­
pounds concerned chemical exposure in plastics, metal, paper, and textile industries, next 
to using paints, adhesives, industrial cleaning agents, and pesticides. Exposure to copper
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#table 7.4 Effect estimates for UDT and hypospadias before and after modification of exposure 
probability scores based on parental job descriptions
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#table 7.4 Continued
N.B. Comparison o f effect estimates before and after modification o f  JEM exposure probability scores was restric­
ted to exposure groups with an OR > 1.5 and/or lower bound o f the 95%CI > 0.7. The exposure probability 
scores fo r  benzophenones, parabens, and siloxanes were not modified based on parental job  descriptions, so these 
exposure groups are omitted from  the table.
a Effect estimates presented in this column are copied from  Tables 7.2 and 7.3
b Adjusted fo r  maternal/paternal non-European ethnic origin, obesity, and smoking, maternal use o f oral contra­
ceptives and anti-emetic drugs during pregnancy, gestational preeclampsia, twinning, low birth weight, duration 
o f gestation, and year o f birth. 
c Adjusted fo r  maternal/paternal non-European ethnic origin, obesity, and smoking, gestational preeclampsia, 
twinning, low birth weight, duration o f gestation, and year o f birth.
involved use of pesticides as well as exposure to copper fumes released during manufac­
turing or processing of metals, which was often accompanied by exposure to lead. Addi­
tional exposure scenarios for lead included working with heavy vehicle storage batteries, 
ammunition for fire arms, and lead solder. When exposure from pesticides was excluded 
from the analyses, the ORs for alkylphenolic compounds were reduced to 1, while the 
associations between hypospadias and copper or phthalates remained unaltered: OR 2.6 
(95%CI 0.8-8.4) and OR 3.2 (95%CI 0.6-16.9), respectively.
When differentiating between subgroups of UDT, the crude effect estimate for mater­
nal pesticide exposure was stronger for cases without inguinal hernia (n=103): OR 2.7 
(95%CI 1.2-6.0) compared to cases with inguinal hernia (n=92): OR 0.6 (95%CI 0.1-2.7).
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#Similar differences in effect estimates were seen for EGEs: OR 1.7 (95%CI 0.9-3.3) vs. OR
1.1 (95%CI 0.5-2.4), alkylphenolic compounds: OR 1.7 (95%CI 0.9-3.3) vs. OR 1.1 (95%CI 0.5­
2.4), and copper: OR 2.4 (95%CI 1.1-5.5) vs. OR 0.6 (95%CI 0.1-2.4). The effect estimates for 
benzophenones did not differ between the two subgroups of UDT: OR 1.7 (95%CI 0.5-6.2) 
vs. OR 1.8 (95%CI 0.5-6.5), with similar findings for parabens and siloxanes. For cases with 
anterior (n=195), middle (n=67), and posterior (n=43) hypospadias, the effect estimates for 
maternal exposure to organic solvents were: OR 9.4 (95%CI 1.0-90.9), OR 8.7 (95%CI 0.5­
141.2), and OR 15.4 (95%CI 0.9-251.3), respectively. The effect estimates for paternal expo­
sure to pesticides and copper did not differ substantially between subgroups of cases. 
Excluding cases with birth defects (n=55) did not change any of the effect estimates in 
Tables 7.2 a n d 7.3 either.
Table 7.4 displays the increased effect estimates before and after modification of the 
exposure probability scores based on parental job descriptions. The findings with modi­
fied scores, presented in the right column, correspond with the effect estimates in Tables
7.2 a n d 7.3. The modifications generally resulted in slightly stronger effect estimates, with 
a large difference in effect estimates for the association between maternal solvent expo­
sure and hypospadias: OR 10.3 (95%CI 1.0-101.8) after modification vs. OR 3.6 (95%CI 0.6­
23.2) before modification. The effect estimates for paternal exposure to copper changed 
in the opposite direction: OR 2.5 (95%CI 0.8-7.9) after vs. OR 3.3 (95%CI 1.1-10.0) before 
modification.
Discussion
We observed associations between UDT and several maternal occupational exposures 
to potential EDs, including pesticides, phthalates, organic solvents, alkylphenolic com­
pounds, copper, benzophenones, parabens, and siloxanes. These exposures could mainly 
be ascribed to working in agriculture and with cosmetic products. In addition, a strong 
association was found between hypospadias and maternal organic solvent exposure at 
time of pregnancy, which did not result from pesticides or cosmetics. Only some weak 
indications for increased risks of UDT and hypospadias were seen when fathers were 
occupationally exposed to pesticides, phthalates, or copper. Before interpreting these 
findings, we will reflect on some methodological issues.
With the study population recruitment strategy, we obtained three comparable groups 
of boys of similar age and from the same geographical area. The referent population con­
sisted of boys treated for persistent middle ear effusion, which is unlikely to be associ­
ated with prenatal ED exposure21. Parents were not informed about the study hypotheses, 
resulting in high response rates for both cases and referents. Yet, the population size did 
not allow us to assess the effects of very rare exposures. Therefore, exposures to poly­
chlorinated organic compounds, bisphenol A, brominated flame retardants, and several
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#organic solvents and metals could not be analyzed separately. In addition, the ORs for 
some other chemical groups were based on very small numbers, but we decided not to 
calculate exact confidence intervals as the ORs for these agents were all close to unity. All 
elevated risk estimates, however, concerned relatively common exposures and involved 
sufficient cell counts.
Studies of rare exposures are extra sensitive to exposure misclassification. Even 
small differences in the proportions of false-positives between cases and referents may 
strongly bias an association towards or away from the null22. In the present case-referent 
study, this would favor using a JEM  over self-reported exposure estimates, as the latter 
may be more susceptible to recall bias. The JEM  also enabled us to study a large variety of 
potential EDs, several of which are difficult to capture with questionnaires. In addition, 
the JEM  facilitated the selection of a reference category with no exposure to any potential 
ED, in order to make similar comparisons between exposed and non-exposed for each 
chemical group. Exposure assessment with a JEM  is, however, limited by the inability to 
account for differences in exposure between workers within the same job title. This type 
of misclassification, when fully non-differential, usually results in underestimated ORs23. 
Therefore, we tried to make the exposure assessment more specific by modifying the JEM  
exposure probability scores based on the original job descriptions of the parents. This 
resulted in slightly stronger risk estimates for most exposure variables, which may indi­
cate an overall reduction in non-differential misclassification. Our exposure assessment 
strategy shows many similarities with the strategy applied by Kennedy et al. in a study on 
occupational asthma24. They also incorporated an ‘expert re-evaluation step' in which sev­
eral exposure estimates were adjusted based on the original job description, leading to 
an increase of their OR for high-risk jobs according to the JEM  from 1.4 (95%CI 0.8-2.3) to
1.7 (95%CI 1.1-2.7). Both their and our results provide support for the value of such efforts 
to obtain more accurate exposure estimates.
Despite the extra exposure assessment step, our JEM  generally provided only crude 
measures of exposure. Therefore, the findings of our study should be interpreted with 
caution. Our findings regarding maternal and paternal pesticide exposure and increased 
risks of UDT and hypospadias in offspring, however, find support in several previous 
studies. In 1998, Weidner and colleagues reported an increased occurrence of UDT, but 
not hypospadias, in sons of women employed in gardening, including workers in green­
houses, orchards, and nurseries, based on a large registry based case-referent study1.
More recently, Carbone et al. linked a potentially increased risk of UDT (OR 2.7, 95%CI 0.7­
10.4) to maternal pesticide exposure based on the original JEM  for endocrine disrupting 
agents developed by van Tongeren et al (2002), using a small study population4. Pierik and 
colleagues reported an association between paternal exposure to pesticides according 
to the van Tongeren JEM  and UDT (OR 3.8, 95%CI 1.8-8.2), with inconclusive findings for 
maternal exposure due to small numbers2. In both of these studies, and a third study in 
which the van Tongeren JEM  was used3, no associations were found between hypospadias 
and maternal or paternal pesticide exposure.
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#For maternal pesticide exposure, as well as for the associated chemical groups, stronger 
ORs were observed for cases with UDT only compared to cases in which UDT was accom­
panied by inguinal hernia or hydrocele. For most other potential risk factors, an opposite 
pattern in effect estimates was seen for these two subgroups of cases19. These findings 
suggest etiological heterogeneity within cases of UDT, but are yet difficult to interpret.
The increased risk of UDT when mothers were occupationally exposure to cosmetic 
products has, to our knowledge, not been described previously. In the present popula­
tion, a similar association was found using self-reported data (OR 3.0 (95%CI 0.9-10.0))19, 
although only little overlap existed between these data and cosmetics exposure accord­
ing to the JEM. Hypospadias was recently linked to self-reported occupational exposure 
to hairsprays6 and to maternal phthalate exposure according to the van Tongeren JEM , in 
which hairdressers formed the largest group3. In contrast, mothers of cases with hypospa­
dias in our study were less often exposed to potential endocrine disruptors from working 
with cosmetic products according to the JEM.
Regarding hypospadias, however, a large, although imprecise, effect estimate was 
calculated for maternal organic solvent exposure. More specifically, mothers of hypo­
spadias cases more often worked with adhesives, paints, printing ink, and dry cleaning 
agents, which involve ‘probable' exposure to organic solvents according to the JEM. Using 
self-reported exposure, Pierik et al. found some indication for an association between 
hypospadias and maternal organic solvent exposure as well, although this factor dropped 
out of their multivariable model2. They also observed a more robust association between 
hypospadias and paternal organic solvent exposure, which was not reflected in our study.
A role of ED exposure in the etiologies of UDT and hypospadias has, among others, 
been proposed by Skakkebaek et al., who hypothesized that in early gestation, EDs may 
cause testicular dysgenesis, leading to UDT, hypospadias, and reduced fertility or testicu­
lar cancer in adult life25. Testicular descent occurs in two phases, in which transabdomi­
nal descent takes place between gestational weeks 8 to 15, followed by inguinoscrotal 
descent in weeks 26 to 3526,27. Endocrine regulation seems to be a key factor in both of 
these phases27,28. Therefore, the time window during which EDs may interfere with testic­
ular descent is relatively wide, ranging from the development of the fetal testis within the 
first trimester of pregnancy to only a few weeks before delivery, when the descent is sup­
posed to be complete. The development of the penis involves a much shorter time period 
and is complete around 16 weeks of gestation29,30. Therefore, an association between 
occupational ED exposure and hypospadias may be more difficult to detect than an asso­
ciation between occupational EDs and UDT. This seems consistent with our findings, but 
there may be more causal explanations for the differences in associations found between 
ED exposure and the two disorders.
In conclusion, our findings indicate that several potential EDs that involve working 
with pesticides, cosmetic products, or organic solvents may interfere with prenatal devel­
opment of the male reproductive organs, thereby increasing the risks of UDT and/or
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#hypospadias. For pesticides, exposed mothers described many activities that may involve 
indirect exposure, such as taking care of farm animals, cleaning, or harvesting. Environ­
mental or biological monitoring could possibly give more insight in the exposure risks 
during such activities, as well as in the risks of ED exposure in hairdressers or beauti­
cians working with cosmetics. Larger epidemiological studies could elucidate the effects 
of rare exposure to potential EDs and provide the required support for the associations 
identified in this study. W e believe that the 2009 JEM  is a valuable exposure assessment 
method for such additional epidemiological studies, especially when data on tasks and 
working environment are incorporated.
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Estrogenic and androgenic 
activities in total plasma 
measured with reporter-gene 
bioassays:
relevant exposure measures 
for endocrine disruptors 
in epidemiologic studies?
#
#Abstract
M e asurem en ts o f estro gen ic and an drogenic activities in total plasm a w ith 
C h e m ically  A ctivated LU ciferase gene eX pression (CA LU X®) bioassays could 
provide biolo gically  relevant m easures for e xpo sure to e n d o crin e  d isrup to rs in 
e pidem iolog ic studies. The objective o f this study was to explore the effects o f a 
variety o f sources o f potential e nd ocrine  d isru pto rs on estro gen ic and androgenic 
activities in total plasm a m easured by CALUX®. Plasm a sam ples and interview  
data on sources o f potential e n d o crin e  d isru pto rs w ere collected from  108 men 
w ith different expo sures profiles. CA LU X® m easurem ents (B ioD etectio n Ser­
vices) involved hum an U2-O S cell lines con trolled  by the estrogen receptor alpha 
and the androgen receptor. M ean differences (beta) in v ^ -e s tra d io l equivalen ts 
(EEQ s) and d ihydrotestostero ne equivalen ts (A EQ s) betw een expo sure groups 
w ere estim ated using general linear m odels. M ean plasm a A EQ s and EEQs w ere 
9.1 x io -1ng/m l and 12.0 pg/m l, respectively. Elevated A EQ s w ere found in sm ok­
ers (beta 1.9 (95%CI 0.1-3.6) x10-1ng/m l) and heavy d rinkers (1.4 (0.2-3.1) x10-1n g / 
ml), and in men o ccup a tio n ally  exposed to d isinfectants (1.6 (0.3-3.5) x10-1ng/m l) 
or w e ld in g /so ld e rin g  fum es (1.4 (-0.2-2.9) x10-1ng/m l). O ccup atio n al expo sure 
to pesticides, disinfectants, and exh aust fum es seem ed to be associated with 
increased plasm a EEQs: 1.5 (-0.2-3.2) pg/m l, 2.1 (0.2-3.9) pg/m l, and 2.9 (0.6-5.2) p g / 
ml, respectively. M o d erate to high plasm a dioxin levels, m easured in a subgroup 
by the d io xin-re spo nsive  CALU X®, w ere accom panied by a 20%  increase in AEQs. 
This is the first stud y in w hich CA LU X® was used to assess horm one activities in 
total plasm a. A ltho ugh the results are not yet readily interpretable, they indicate 
that these m easurem ents can be valu able  for e pidem iolog ic studies on e nd ocrine  
d isru pto rs and give direction for fu rth e r research.
#Introduction
Endocrine disru pto rs are described as exogenous substances that alter fu n ctio n s o f the 
endo crine system  and co nsequently cause adverse health effects in o rganism s and/or 
th e ir progeny1. A  grow ing list o f  substances are now suspected o f  such endocrine d isru p ­
ting properties, including industrial chem icals, such as polycyclic arom atic hydrocarbons 
(PA H s)2, d io xin s3, brom inated flam e retardants4, several p esticid es5, bisphenol A6, phthal- 
ates7, parabens8, organic solvents9, and som e m etals10, as w ell as the naturally o ccurrin g  
p hyto-estrogens11. Exposure to these substances o ccurs in everyday life and involves 
very different sources, such as diet, personal care products, tobacco smoke, and e xp o ­
sures at the w orkplace. Endocrine disru pto rs may interfere w ith the end o crine  system  
through activating or blocking horm one receptors, but they can also alter the synthesis, 
m etabolism , and clearance o f  endogenous horm ones and thereby influence horm one 
bio availab ility1. Endocrine disru pto rs are hypothesized to play a role in the pathogenesis 
o f  vario us disorders, including urogenital birth defects, endom etriosis, m ale and fem ale 
subfertility, and m alignancies12-15. How ever, epidem iological evidence fo r health risks o f 
curre nt exposure levels is scarce.
In the past few  years, a num ber o f  receptor-based assays have been developed that 
o ffe r new p o ssibilities fo r epidem iologic research into endocrine disruption, am ong 
w hich the C hem ically Activated LU ciferase gene e x p re ssio n  (CA LUX®) bioassays16,17.
CALUX® bioassays co nstitu te o f  a genetically m odified cell line in w hich specific recep ­
tor responsive D N A elem ents are linked to a so-called repo rter gene that tra n scrib es to 
the easily m easurable firefly (P hotinus pyralis) protein luciferase. In essence, CALUX® 
bioassays m easure receptor induced gene-expression, w hich gives inform ation about the 
expected biological response to chem icals in hum ans. For exam ple, elevated or reduced 
gene-expression m easured w ith a C A LU X ® bioassay indicates w h eth er specific sub­
stances w ould exert agonistic o r antagonistic effects on the target cell level.
In epidem iological investigations, CALUX® technology has mostly been used to assess 
internal exp osu re to d ioxin-like  substances18-25. For that purpose, d ioxin-respo nsive cell 
lines (D R  CALUX®) w ere developed in w hich exp ression o f luciferase is mediated by acti­
vation o f the aryl hydrocarbon receptor (AhR). CALUX® bioassays that are responsive to 
estrogens (ER CALUX®) o r androgens (AR CA LUX®) seem  particularly interesting  w ith 
respect to end o crine  disru ption o f  reproductive horm ones. So far, the ER CALUX® and AR 
CALUX® have predom inantly been used to study recep to r activating ab ilities o f  individual 
chem icals26-28 o r m ixtures o f  chem icals in e.g. environm ental sam ples29-31. In tw o e p id e ­
m iologic studies, the ER CALUX® and AR CALUX® w ere used to determ ine estrogenic and 
androgenic activities o f  p ersistent organic pollutants (P O P s) extracted from  male serum  
sam ples32,33. In addition, a recent publication by Pederson and colleagues, d escrib es ER 
CALUX® and AR CALUX® m easurem ents o f  m aternal and fetal plasm a sam ples after 
m ethyl tert-butyl e th er (M TBE) extraction, and th e ir associations w ith internal levels o f 
d ioxin-like substances34.
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#To o u r know ledge, the ER CALUX® and A R  CALUX® bioassays have not previously been 
used to study estro genic and androgenic activities in total hum an plasm a, containing all 
prevalent xe no b io tics and endogenous horm ones (see Figure 8.1). In this model, an e le ­
vated o r reduced estro genic o r androgenic activity  could result from  interference o f  xe n o ­
biotics w ith the bioavailability o f  endogenous horm ones an d/o r th e ir ab ility to activate or 
block horm one receptors w ithin the cell. Such m easurem ents could provide biologically 
relevant sum m ary estim ates for endocrine disruption.
Therefore, the objective o f this study was to explore the effects o f  a variety o f  sources 
o f potential end o crine  disruptors, including occupational exposures, sm oking, personal 
care products, living environm ent, and diet, as w ell as the effects o f  potential determ i­
nants such as age and w eight on the estrogenic and androgenic activities in total plasma 
m easured by CALUX® bioassays, w hich w ould provide ideas about the ap p lica b ility  o f 
these m easurem ents fo r epidem iologic studies.
fig u re  8.1 Graphic illustration of ER CALUX® and AR CALUX® measurements in total plasma, 
as performed in the present study
CALUX U2-OS cells are exposed to total 
plasma, which would contain a mixture of 
xenobiotics (X) and endogenous hormones 
(H). Depending on their specific chemical 
properties, xenobiotics can remain bound 
to proteins (X-PB) or lipids (X-LB). A large 
amount of the endogenous hormones 
normally remain protein bound (H-PB) and 
are therefore biologically inactive. After 
uptake, both endogenous hormones and 
xenobiotics may bind to hormone recep­
tors (HR). These receptor-ligand complexes 
may (or may not) activate transcription of 
hormone-responsive elements (HRE) and the 
luciferase gene-construct (Luc.), leading to 
the release of luciferase, which is quantified 
by luminescence. In this model, elevated or 
reduced luminescence may indicate interfer­
ence of xenobiotics with the bioavailability of 
endogenous hormones on a plasma level (1) 
and their ability to activate or block hormone 
receptors within the target cell (2).
Materials and methods
Population
Subjects w ere selected from a population o f men w ho participated in a case-referent study 
on risk factors for hypospadias and cryptorchidism . Cases with hypospadias and cryptorchi­
dism were compared to a referent population o f  boys w ith persistent middle ear effusion, 
for w hich they received ear ventilation tubes. In 2005, the fathers o f cases and referents
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#com pleted postal questionnaires covering a wide range o f  potential risk factors, including 
exposure to potential endocrine disruptors through diet, work, or leisure tim e activities. 
Based on these questionnaire data, 135 fathers w ere selected for the present study. Included 
w ere fathers w ho reported specific occupational exposures (pesticides, paint, adhesives, 
thinners, industrial cleaning agents, dry cleaning agents, metals, exhaust fum es, fum es 
from plastics), regular use o f personal care products, or o besity at tim e o f  the index preg­
nancy. W ith respect to dietary habits, we selected fathers with a high intake o f  fish (>  3 
tim es per week), as a major source o f  persistent endocrine disrupting chem icals. D ue to 
small numbers, we could not select a group o f  fathers w ith regular intake o f  soy replace­
ments for meat or dairy, which are rich sources o f phytoestrogens. A num ber o f fathers who 
did not report occupational exposures, had a low or average dietary intake o f fish, were not 
obese, and did not frequently use personal care products was selected as well. The aim o f 
this selection strategy was to obtain a sufficient exposure gradient in the study population 
to assess differences between low and high exposure groups, expecting that the exposures 
at time o f pregnancy (4 to 11 years ago) w ould partly correspond w ith current exposures 
o f the fathers. The selected fathers received an invitation letter and study inform ation by 
regular mail and were contacted by telephone to ask for their consent, w hich was later co n­
firm ed in w riting. We chose to restrict the study population to men, because the menstrual 
cycle in women w ould bring about many methodological difficulties.
Data collection
From February until A pril 2007, all study participants w ere visited at home or at w ork for a 
single blood draw  and interview. Participants w ere asked to abstain from alcohol and drinks 
or foodstuffs that contained soy in the 24 hours before the blood draw, because these could 
lead to tem porarily elevated levels o f plasma phytoestrogens. Blood (i0 c c ) w as collected 
in glass heparin coated vacutainers and was cooled in a closed box during transportation. 
After spinning, plasma was stored in glass collection tubes and frozen at -8 0 °C  until fu r­
ther w ork up. C urrent exposures to and determ inants fo r potential endocrine disruptors 
w ere assessed w ith structured interview s, in w hich we included q uestions on age, weight, 
eth nic origin, living environm ent (urban vs. country side), sm oking, personal care products 
(used w ithin the past tw o days), leisure tim e activities (hom e im provem ents, hobbies), 
and specific occupational exposures (see Table 8.3). Q uestions w ere phrased as: ‘ Do you 
w ork w ith pesticides, e.g. to control weeds, insects, or fungi?' Subjects w ere asked about 
exposure intensities (e.g. num ber o f  hours per w eek) and w hen they w ere last exposed to 
specific agents. G eneral q uestions about tasks and activities at w ork w ere included as well. 
Referring to the past 4 weeks, subjects scored th eir intake frequency o f  food item s such as 
seafood, chicken, beef, pork, or eggs, as sources o f  persistent endocrine disru pting  ch em i­
cals. In order to assess the long-term effects o f  phytoestrogens, we collected data on the 
regular intake o f  soy replacem ents for meat or dairy. Inform ation on alcohol consum ption, 
health status, and prescrip tive drug use w as collected as well.
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#CALUX® measurements
CALUX® m easurem ents w ere perform ed at BioD etection System s BV in Am sterdam , as 
described in detail e lsew here17. Estrogenic and androgenic activities w ere determ ined 
using hum an U2-OS cell lines stably transfected w ith a luciferase gene construct that 
was controlled by the estrogen receptor alpha (E R a CALUX®) and androgen receptor (AR 
CALUX®), respectively. The m icrotiter plates in w hich the cells w ere plated contained ca li­
bration concentration series o f 17^-estradiol (E R a CALUX®) or dihydrotestosterone (D H T) 
(AR CALUX®). C ells w ere exposed to a medium containing hum an plasma w ith co ncentra­
tions o f 5% and 10% vo l/vo l, and w ere incubated for 24 hours under standard conditions.
For a subset o f  50 men w ho w ere selected based on interview  inform ation on weight, 
age, and dietary habits, d ioxine -re sp o nsive  (D R) CALUX® m easurem ents w ere perform ed, 
w hich provide an indicator fo r internal total dioxins. These m easurem ents w ere m eant to 
assess w h eth er the e ffects o f  exp osu re sources that w ould involve p ersistent endocrine 
disru pto rs could indeed be ascribed to a higher body burden o f  such chem icals. A  rat 
hepatoma H 4 IIE  cell line was used, w hich contains a luciferase repo rter gene controlled 
by the A h R 16. The m icro titer plates contained a calibration concentration series o f  23,7,8- 
TCDD. A pproxim ately 1 g o f  hum an plasm a w as extracted by m eans o f  shake-solvent 
extraction (hexane:diethylether, 97:3). The extract was cleaned through oxidation using 
an acid silica colum n topped w ith sodium  sulphate. DR CALUX® cells w ere exposed to the 
cleaned extracts (o.8% D M SO ) fo r 24 hours.
Follow ing the 24 hours o f  incubation, media w ere rem oved and the cells w ere lysed, 
after w hich a luciferin containing solution was added to m easure lum inescence (Lucy2; 
Anthos Labtec Instrum ents, Wals, A ustria). Total estrogenic, androgenic, and dioxin-like 
activity in the sam ples was determ ined by interpolation from  the fitted calibration curves. 
Results w ere expressed as pg ^ S -e stra d io l equ ivalents (EEQ s) and ng DHT e quivalents 
(AEQ s) per ml o f  processed plasma and as pg 2,3,7,8-TCDD toxic e quivalents (TEQ s) per 
g o f  extracted plasm a lipid. Total sam ple lipid contents w ere determ ined gravim etrically. 
The lim its o f  detection w ere fo r EEQs: 7.0 pg/m l plasm a, fo r AEQ s: 0.42 x10-1ng/m l plasma, 
and fo r TEQs: 8.2 pg/g plasm a lipid.
Data analyses
Statistical analyses w ere perform ed in SPPS version 16.0. Plasma EEQs, AEQ s, and TEQs 
w ere norm ally distributed. All exp osu re variables and oth er determ inants w ere c la ssi­
fied into tw o o r three levels, o f  w hich one level w as treated as the reference category 
(see Tables 8.2-85). For the occupational exp osu re variables, the reference category was 
restricted to fathers w ho did not report occupational exp osu re to any o f the exposure 
categories (n=34). M ean diffe re nce s in plasma EEQs and A EQ s betw een variable catego­
ries w ere estim ated using general linear m odels w ith adjustm ent fo r tim e o f  blood draw  
to account fo r diurnal variations in endogenous estradiol and testo stero ne35,36. M u ltivari­
able analyses w ere done to estim ate the effect o f  each exp osu re variable independently
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#from  potential confo und ers if  at least 10 observations per included dum m y variable w ere 
available. All general determ inants and exp osu re variables presented in Table 8.2 and the 
sum m ary variable ‘any occupational exp osure' w ere treated as potential confounders. The 
dietary exp osu re variables presented in Table 8.4 w ere not, in o rd er to prevent ove rco r­
rection. First, each o f  the potential co nfound ers was added to the model separately. S ub­
sequently, confound ers that changed the crude beta w ith at least 10% w ere added to the 
model sim ultaneously. The 10% rule w as not applied w hen the crude effect estim ates o f 
e xp osu re variables w ere very w eak (betas betw een -1.0 and 1.0 pg/m l EEQ, -1.0 and 1.0 x 
10-1ng/m l AEQ s, and -5.0 and 5.0 pg/g lipid TEQ w ere considered w eak effe ct estim ates 
w ith regards to the need to adjust fo r potential confounders); in these cases, w e only 
adjusted fo r confo und ers if this resulted in substantially strong er effect estim ates. A  sim i­
lar data analyses strategy w as used to assess associations betw een specific variables and 
internal dioxin levels m easured by the DR CALUX®.
Results
O ne hundred and eight men (80% ) participated and provided plasm a sam ples and inter­
view  data. The tim e o f  blood draw  varied betw een 8 :0 0  am and 8:30 pm. The mean, m ini­
mum, and m axim um  EEQs, AEQ s, and TEQ s m easured in the total population are shown 
in Table 8.1. Plasma total lipid levels o f  the subset o f  men w ho w ere selected fo r the DR 
CALUX® m easurem ents varied betw een 4.1 and 8.5 g/l.
Effect estim ates fo r plasm a EEQ and AEQ  are displayed in Tables 8.2-84. The regres­
sion co efficients (beta) w ith 95 percent confidence intervals (95% CI) reflect the mean 
d ifferences in EEQs and A EQ s betw een the variable categories. The correspond ing  inter­
cepts varied betw een 12.8 and 16.2 pg/m l EEQ and 9.9 and 12.6 x10-1ng/m l AEQ  and w ere 
som ew hat h igher than the population m eans presented in Table 8.1 due to adjustm ent for 
tim e o f  the blood draw.
table 8.1 Mean, minimum, and maximum estrogenic (EEQ), androgenic (AEQ), 
and dioxin-like (TEQ) activities measured in total plasma of the study participantsa
n Mean (SD) Minimum Maximum
EEQ pg/ml 108 12.1 (3 .0 ) 5.2 21.0
AEQ xio-'ng/ml 108 9-1 (2 .9) 2.1 17-9
TEQ pg/g lipid 50 54.0 (12.9) 31.5 85.0
a Please note that the study population consisted o f  men with specific exposure profiles and that blood was drawn 
at variable times during the day. Therefore, the measured values are not readily generalisable to other men.
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#t a b le  8.2 Estimated effects o f general determ inants and exposure variables on estrogenic (EEQ)
and androgenic (AEQ) activities as measured by CALUX® in total plasma
EEQ pg/ml AEQ x10-1ng/ml
n Betaa Adj. beta (95%CI)b Betaa Adj. beta (95%CI)b
Ethnic origin
European Caucasian 104 ref ref ref ref
Other 4 -2.5 -1.7 (-4 .9 -1.5)c 3.7 3.1 (0.1-6.2)d
Age
25-39 4 0 ref ref ref ref
4 0 -4 4 45 0.1 0.1 (-1.2-1.3) 0.1 0.4 (-0 .8 -1.5)e
45-55 22 0.9 1.0 (-0.7-2.4) 0.8 1.3 (-0.2-2.7)e
BMI
< 25 38 ref ref ref ref
25-30 56 0.8 0.7 (-0.4-1.9Z -0.5 -0 .4 (-1.5-0 .8)e
> 30 14 1.3 0.8 (-1.0-2.7)f -1.9 -1.3 (-3.1-0 .4 )e
Weight loss of >10 kgs
no 82 ref ref ref ref
> 2 years ago 19 -0.8 -0.8 (-2 .3-0 .7) -0.6 -0.6 (-2.0-0.9)
within past 2 years 7 0.5 0.5 (-1.8-2.7) - a 7 -0.7 (-2.9-1.6)
Smoking
no 79 ref ref ref ref
5-6 cigarettes per day 6 1.7 1.7 (-0.7-4.2) 0.1 -0 .4 (-2 .7-1.9)g
10-15 cigarettes per day 15 0.0 0.0 (-1.6-1.7) 2.5 1.9 (0.1-3.6)8
20-30 cigarettes per day 8 -0.4 -0 .4 (-2.6-1.7) 2.4 1.9 (-0.1-4.0)8
Alcohol consumption
0-6 glasses per week 56 ref ref ref ref
7-15 glasses per week 36 0.1 0.1 (-1.1-1.3) 0.4 0.5 (-0 .7-1.7)e
20-50 glasses per week 16 0.3 0.3 (-1.4-2.0) 1.4 1.4 (0.2-3.1)e
Prescriptive drug use
no 82 ref ref ref ref
yes 26 1.5 1.5 (0.2-2.8) -0.6 -0.2 (-1.4 -1.1)h
Use of personal care prod­
ucts
no 24 ref ref ref ref
1-2 products 68 -0 .4 -0.3 (-1.7-1.0)' 0.3 0.3 (-1.0-1.6))
> 3 products 16 -1.4 -1.2 (-3.0-0.7)' -1.0 -1.4 (-3.3-0.4)1
Lives within city centre
no 101 ref ref ref ref
yes 7 -0.7 -0.3 (-2.5-2.0)k 0.3 0.3 (-1.9-2.6)
a Adjusted fo r  time o f  blood draw
b Adjusted fo r  time o f  blood draw and other confounders: c BMI, smoking, prescriptive drug use, personal care 
products, and occupational exposures (any); d smoking and alcohol consumption; e ethnic origin and smoking; 
f  prescriptive drug use; g ethnic origin and alcohol consumption;h ethnic origin, BMI, and smoking;1 ethnic origin; 
j ethnic origin, age, and smoking;k ethnic origin, BMI, and occupational exposures (any).
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#t a b le  8.3 Estimated effects o f occupational exposures on estrogenic (EEQ) and androgenic
(AEQ) activities as measured by CALUX® in total plasma
EEQ pg/ml AEQ x10-1ng/ml
n Betaa Adj. beta (95%CI)b Betaa Adj. beta (95%CI)b
Any self-reported exposures
no 34 ref ref ref ref
yes 74 1.2 1.2 (-0.1-2.4) a 7 0.7 (-0 .5-1.9)
Pesticides
no 34 ref ref ref ref
>4 weeks ago 11 1.0 1.0 (-0.7-2.8) 2.0 1.6 (-0 .5-3.6)c
< 4 weeks ago 12 1.5 1.5 (-0.2-3.2) -0.1 -0.2 (-2.1-1.8)c
Disinfectants
no 34 ref ref ref ref
>1 week ago 18 0.9 0.9 (-0.7-2.4) 0.5 0.5 (-1.1-2.1)d
< 1 week ago 12 2.1 2.1 (0.2-3.9) 1.1 1.6 (0 .3-3.5)d
Industrial cleaning agents, 
solvents, paint, ink, adhesives, 
and thinners
no 34 ref ref ref ref
>1 week ago 13 0.8 0.6 (-1.4-2.6)e 1.1 1.1 (-0 .9 -3.1)
< 1 week ago 24 1.1 1.3 (-0 .3-3.0 )e 1.0 1.0 (-0.7-2.6)
Fumes from welding or soldering
no 34 ref ref ref ref
>1 week ago 6 1.2 1.7 (-0 .9 -4 .2)f 0.3 0.7 (-1.3-2 .7)g
< 1 week ago 11 0.5 0.5 (-1.4 -2 .4 )f 1.1 1.4 (-0.2-2.9)8
Copper or lead
no 34 ref ref ref ref
>4 weeks ago 3 1.4 1.4 (-1.8-4 .5) 0.1 0.1 (-2.7-2.8)
< 4 weeks ago 10 ° 7 0.7 (-1.2-2.6) - a 7 -0.7 (-2.3-1.0)
Fumes from plastics
no 34 ref ref ref ref
yes 8 a 7 0.7 (-1.5-2 .9) 0.5 0.5 (-1.3-2 .3)
Exhaust fumes (indoors for at 
least five hours per week)
no 34 ref ref ref ref
yes 6 2.1 2.9 (0.6-5.2)h 0.1 0.1 (-2.0-2.1)
a Adjusted fo r  time o f  blood draw
b Adjusted fo r  time o f  blood draw and other confounders: c alcohol consumption; d BMI and smoking; e BMI and 
age; f private use o f  personal care products; g ethnic origin; h age and private use o f  personal care products.
N.B. For each o f  the occupational exposure variables, the reference category was restricted to fathers who did not 
report occupational exposure to any o f  the exposure categories (n=34)
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#ta b le  8.4 Estimated effects o f dietary intake variables on the estrogenic (EEQ) and androgenic
(AEQ) activities as measured with CALUX® in total plasma
EEQ pg/ml AEQ x10-1ng/ml
n Betaa Adj. Beta(95%CI)b Betaa Adj. beta (95%CI)b
Beef or pork
< 3x per week 21 ref ref ref ref
3-5X per week 59 0.1 0.1 (-1.3-1.6) 1.2 0.7 (-0.8-2.1)c
6-7X per week 27 -0.2 -0.2 (-1.9-1.5) 1.0 0.8 (-0.8-2.3)c
Chicken
<1x per week 30 ref ref ref ref
1-5X per week 63 -0.8 -0.6 (-1.9-0.6)d -0.1 -0.1 (-1.3-1.1)e
6-7x per week 15 -1.3 -0.8 (-2 .7-1.1)d 0.9 0.6 (-1.2-2.4)e
Fish and seafood
<1x per week 35 ref ref ref ref
1-2x per week 65 -0.3 -0.2 (-1.2-1.2)d 0.4 0 .4 (-0.8-1.6)
3-7x per week 8 -0.2 0 .4 (-1.9 -2 .7)d 1.0 1.0 (-1.3-3.3)
Dutch fried meat snacks
<1x per week 35 ref ref ref ref
1-7x per week 73 -0.3 -0.3 (-1.5-0.9) 0.5 0.5 (-a 7-1.7)
Eggs
<1x per week 14 ref ref ref ref
1-2x per week 80 -0.3 -0.3 (-2.0-1.4) -1.5 -1.1 (-2.7-0.6)f
3-7x per week 12 0.4 0 .4 (-1.9-2.7) - a 7 -0.5 (-2 .7-1.8)f
Dairy (cheese, yoghurt, milk)
1-2x per week (on average) 29 ref ref ref ref
3-5x per week (on average) 41 -0.1 -0.1 (-1.5-1.3) -0.6 -0.6 (-2.0-0.8)
6-7x per week (on average) 38 0.5 0.5 (-0.9-2.0) 0.3 0.3 (-1.7-1.1)
Soy replacements of meat or milk
<1x per week 103 ref ref ref ref
> 1x per week 5 -1.2 -1.2 (-3.9 -1.4 ) -0.2 -1.1 (-3.7-1.4 )g
a Adjusted fo r  time o f  blood draw
b Adjusted fo r  time o f  blood draw and other confounders: c ethnic origin and smoking; d occupational exposures 
(any);e ethnic origin, smoking, and occupational exposures (any);f  ethnic origin, smoking, and alcohol consump­
tion; g ethnic origin, BMI, and smoking.
As shown in Table 8.2, the fo u r men o f  non-European origin (Turkish (n=i), Asian (n=2), and 
Latin-Am erican (n=i)), had 3.1 (95%CI 0.1-6.2) x io -1ng/m l h igher plasm a A EQ s com pared to 
European Caucasian men, indicating an approxim ately 30%  higher total plasma andro­
genic activity. In addition, men o ver 4 4  years o f age seem ed to have som ew hat higher 
plasma A EQ s com pared to men you nger than 40: beta 1.3 (95%CI -0.2-2.7) x io -1ng/m l. 
Sm oking 10 o r more cigarettes per day and drinking  a m inim um  o f 20 glasses o f  alcohol
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#per w eek w ere associated w ith increases in plasm a A EQ s as w ell: beta 1.9 (95%CI 0.1-3.6) 
x i0 -1ng/m l and beta 1.4 (95%CI 0.2-3.1) x i0 -1ng/m l, respectively. M en w ho used p rescrip ­
tive  drugs w ere found to have 1.5 (95% CI 0.2-2.8) pg/m l higher plasma EEQs, but this was 
d ifficult to attribute to a specific type o f drug. For BMI, w eight loss, use o f  personal care 
products, and living w ithin a c ity  centre, no c lea r associations w ith plasm a EEQs and 
A EQ s w ere found.
Table 8.3 presents the effect estim ates fo r occupational exposures. R eporting o f  any 
occupational exp osu re seem ed to be associated w ith an increase in plasm a EEQs o f 1.2 
(95%CI -0.1-2.4) pg/m l. Exposure to p esticid es appeared to be associated w ith an increase 
in plasma EEQ o f 1.5 (95%CI -0.2-3.2) pg/m l. For the associations betw een recent use o f  d is­
infectants and plasm a EEQs and AEQ s, m ore convincing  effect estim ates w ere calculated: 
beta 2.1 (95%CI 0.2-3.9) pg/m l and beta 1.6 (95%CI 0.3-3.5) x10-1ng/m l, respectively. D isin­
fectants m ostly involved cleaning  hands o r e quipm ent w ith alcohol, w hich was reported 
by men w ith very diverse jo b  titles. O ccupational exp osu re to org anic solvents, including 
industrial cleaning  agents, paint, ink, adhesives and thinners, seem ed to be linked w ith 
a slightly increased plasma EEQ: beta 1.3 (95% CI -0.3-3.0) pg/m l, w hereas no elevated o f 
reduced EEQs or A EQ s w ere noted in 31 men w ith exp osu res to th ese products from  lei­
sure tim e activities (e.g. hom e im provem ents o r hobbies). M en w ho reported exposure 
to w eld ing  o r soldering fum es seem ed to have som ew hat higher plasma AEQ s: beta 1.4 
(95%CI -0.2-2.9) x10-1ng/m l. W orking w ith co pp e r o r lead o r exp osu re to fum es from  plas­
tics could not be associated w ith EEQs o r A EQ s in plasm a. An approxim ately 30%  higher 
plasm a EEQ was found in six men w ith indoor exp osu re to ve h icle  exh aust fum es fo r at 
least 5 hours per week: beta 2.9 (95%CI 0.6-5.2) pg/m l.
Effect estim ates o f dietary intake variab les are presented in Table 8.4. Plasma EEQs 
and A EQ s could not be associated w ith the curre nt intake fre qu ency o f  any food item. The 
DR CALUX® m easurem ents, how ever, revealed that men w ith TEQ s o ver 60 pg/g lipids, 
w hich represent m oderate to high internal levels o f total dioxins, had approxim ately 20%  
higher plasma A EQ s com pared to men w ith TEQ s below 50 pg/g lipids (Table 8.5).
table 8.5 Estimated effects of internal dioxin levels (TEQ) on total estrogenic (EEQ) and 
androgenic (AEQ) activities measured with CALUX® in total plasma
n
EEQ pg/ml AEQ x10-1ng/ml I
Betaa Betaa Adj. beta (95%CI)b
Internal dioxin level
32.5 - 50.0 TEQ pg/g lipid 22 ref ref ref
50.1- 60.0 TEQ pg/g lipid 13 -0.4 (-2.5-1.6) 0.3 0.7 (-1.3-2.8)
60.1 - 85.0 TEQ pg/g lipid 15 0.2 (-1.7-2.2) 2.1 2.4 (0.5-4.3)
a Adjusted fo r  time o f  the blood draw  
b Adjusted fo r  time o f  the blood draw and age
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#Discussion
In this observational study, we explored the effects o f  exp osu re to a variety o f  sources o f 
potential end o crine  disru pto rs on total estrogenic and androgenic plasm a activities mea­
sured by CALUX® bioassays. To o u r know ledge, this is the first study in w hich the CALUX® 
technology was used to assess horm one activities in total plasm a, in contrast to previous 
reports in w hich m easurem ents w ere perform ed on plasma extracts o f  specific lipop h ilic 
pollutants. The total estrogenic and androgenic activities in plasm a w ould reflect recep ­
tor activation by any prevalent xenobiotics, as w ell as by endogenous horm ones (Figure 
8.1), also detecting  certain ‘indirect' effects o f  xenobiotics, such as interference w ith the 
bioavailability o f endogenous horm ones o r com petitive receptor binding. Therefore, we 
hypothesized that the CALUX® m easurem ents in total plasma w ould represent biologi­
cally relevant sum m ary estim ates fo r internal exp osu res to endo crine disruptors.
In summary, w e detected diffe re nce s in the estro genic an d /o r androgenic activi­
ties betw een categories o f  eth nic origin (crudely classified as ‘ European C aucasian' vs. 
‘other'), age, sm oking, alcohol consum ption, and p rescrip tive drug use. The data also indi­
cated associations betw een several occupational exp osu re s and increased plasm a estro- 
genicity an d/o r androgenicity, w hereas no associations w ith the intake o f  specific food 
item s w ere found. Finally, positive associations w ere found betw een internal dioxin levels 
(TEQ s) and androgenic plasm a activity. Before interpreting  these results, we return to 
som e m ethodological issues concerning  the study design, methods, and analyses that 
may have influenced o u r findings.
The study population was recruited am ong fathers w ho participated in a case-referen t 
study on hypospadias and cryptorchidism , so approxim ately 50% had a son w ith a uro­
genital birth d e fe c t Theoretically, a problem  could arise if  in these fathers, the effects o f 
chem ical exp osu res on plasma horm one activity w ould substantially d iffe r from  o ther 
men, but this seem s unlikely. H ow ever, the fact that all men had fathered children could 
im ply that men w ith reduced fe rtility  (possibly associated w ith exposure to endocrine 
disru pto rs) w ere som ew hat u nderrepresented in o u r population.
W ith the population re cruitm ent strategy, w e aim ed to obtain a sufficient exposure 
gradient to identify d ifferences in plasm a horm one activities betw een high and low e xp o ­
sure categories fo r d iffe re n t sources o f  potential end o crine  disruptors. A s a consequence, 
the reference category o f  a particular exp osu re variable may include m any subjects that 
reported o th e r sources o f  potential endocrine d isrupto rs, w hich could bias the effect e sti­
mate. Although we tried to adjust fo r confound ing  by o th e r exp osu re so urces w ith m ulti­
variable analyses, residual confound ing  cannot be ruled out, esp ecially  w hen the popula­
tion size did not allow  adjustm ent fo r m ultiple variables sim ultaneously. This may have led 
to both underestim ated and overestim ated effe ct estim ates. The effect estim ates may 
also be affected by exp osu re m isclassification, w hich most likely resulted in bias tow ards
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#the null. O verall, the findings o f  this explorative study should be interpreted w ith caution 
and require confirm ation by futu re research.
The elevated plasma androgenic activity associated w ith increased age was unex­
pected. Increasing age is known to be accom panied by a d ecline in endogenous free te s­
tosterone37-40. Therefore, it seem s that o u r findings result from  d ifferences in e n viro n ­
mental factors, rather than in endogenous horm one levels, betw een different ages. We 
speculate that life-long exposure to p ersistent endocrine disru ptors in o lder men could 
explain the association, because w e found a p ositive association betw een internal dioxin 
levels and plasma androgenic activity. W e could not link age w ith internal dioxin levels, 
but o ther investigators have done so23,25.
A  relatively strong association was found betw een sm oking and plasm a androgenic 
activity, w hich increased w ith approxim ately 20%. Sm oking has been reported to increase 
serum  Sex H orm one Binding G lobulin  (S H B G ) and total testo sterone levels, but no clear 
d ifferences in bioavailable testosterone w ere seen41. Tobacco sm oke consists o f  a m ixture 
o f  end o crine  disru pting  toxicants, such as PAHs2 and cad m ium 42. Possibly, these ch em i­
cals are able to directly activate androgen receptors w ithou t altering the level o f  e n do g ­
enous bioavailable testosterone. The increased androgenic activity  associated w ith alco­
hol consum ption also seem s unlikely to result from  elevated endogenous testosterone39 
and could reflect a receptor-activating potential o f e.g. ethanol, phytoestrogens, o r other 
constituents. Based on the curre nt data, however, w e can only speculate about the exp la­
nations fo r the increased androgenic plasm a activities in sm okers and heavy drinkers.
The effect estim ates for the use o f  personal care products w ere inconclusive. M any 
personal care products contain a m ixture o f  phthalates, parabens, solvents, and UV 
screens, for w hich d iffe re n t endocrine disru p tin g  properties have been re ported8,43,44. In 
o rd er to draw  co nclu sion s about the effects o f  personal care products on the total plasma 
androgenic and estro genic activities, a more detailed exp osu re assessm ent m ethod is 
required. A different population recruitm ent strategy that w ould cap ture men w ith higher 
exp osu re levels could give more insight into the effects o f  personal care products as well.
D ue to sm all num bers, we could not reliably assess the effects o f regular co nsu m p ­
tion o f  phytoestrogens in soy. For the intake o f  anim al fats, w hich are sources o f  per­
sistent endo crine disru p tin g  ch em ica ls45, no associations w ith estrogenic o r androgenic 
activities w ere found. Com paring the data on curre nt dietary habits w ith the DR CALUX® 
m easurem ents provided som e indications fo r increased internal dioxin levels am ong men 
w ith high intakes o f chicken and eggs (Supplemental Table 1). But the intake o f  beef, pork, 
and dairy products seem ed to be inversely associated w ith plasma TEQs, w hich w as unex­
pected. W e exam ined confound ing  by oth e r determ inants including the other dietary 
intake variables and hypothesized that a high intake o f  chicken o r eggs could be asso ci­
ated w ith a low intake o f  beef and pork o r dairy, resulting in the inverse associations. 
A fte r adjustm ent fo r intake o f chicken and eggs, how ever, even sm aller betas w ere found. 
These findings w ere probably affected by exp osu re m isclassification, as the q uestio nnaire
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supplem en tal table 1 Associations between dietary intake variables and internal dioxin levels 
(TEQ) measured by the DR CALUX®
TEQpg/g lipid
n Betaa Adj. Beta(s) (95%CI)b
Beef or pork
< 3X per week 9 ref ref ref
3-5X per week 30 -8.5 -9.6 (-19.1- -0.2)c -10.3 (-19.8- -0.8)d
6-7X per week 11 -10.3 -7.9 (-19.2-3.4 )c -14.6 (-26.5- -2.8)d
Chicken
<1x per week 18 ref ref ref
1-5X per week 25 4.2 3.5 (-4 .5-11.4 )d 4.2 (-3.6-12.0)e
6-7x per week 7 12.7 9.2 (-3.0-21.3)d 9.5 (-4 .5-23.5)e
Seafood
<ix per week 22 ref ref
1-2X per week 20 0.2 0.2 (-8.0-8.4)
3-7X per week 8 2.4 2.4 (-8.6-13.3)
Dutch fried meat snacks
<1X per week 31 ref ref
1-7X per week 19 -2.6 -2.6 (-10.2-5.0)
Eggs
<1X per week 7 ref ref ref
1-2X per week 35 4.7 4 .0  (-6 .5-14.5)c 4.1 (-6 .3-14.3)e
3-7X per week 6 15.5 11.7 (-3.4 -26 .8)c 13.5 (-0 .6 -27.7)e
Dairy (cheese, yoghurt, milk)
1-2X per week (on average) 7 ref ref ref ref
3-5X per week (on average) 20 -9.0 -7.3 (-18.7-4 .1)c -7.8 (-19.0 -3.4 )d -6.1 (-17.9 -5.8)e
6-7X per week (on average) 23 -5.6 2.8 (-14.0-8.3)c -6.8 (-17.9 -4 .3)d -2.0 (-14.0-10.0)e
a Crude beta
b For some determinants, several adjusted betas are shown, because the population size did not allow to estimate the 
effect o f  adjusting fo r  two or more cofactors simultaneously. 
c Adjusted fo r  intake o f chicken 
d Adjusted fo r  intake o f eggs 
e Adjusted fo r  living w ithin a city centre
provided only crude estim ates fo r dietary intake. For exam ple, w e could not account fo r d if­
ferences in chem ical exp osu re betw een different typ es o f fish and betw een fish captured 
from  w ild fish eries o r harvested in fish farms. In addition, only cu rre n t dietary habits w ere 
assessed, w hich could d iffe r from  dietary habits in the past that w ould also have contributed 
to the body burden at tim e o f  study. Due to these lim itations, we may not have been able to
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#s u p p l e m e n t a l  ta b le  2 A ssociations between age, BMI, w eight loss, and living environm ent and
internal dioxin levels (TEQ) measured by the DR CALUX®
TEQpg/g lipid
n Betaa Adj. Beta (95%CI)
Age
25-39 17 ref ref
40-44 23 3-3 3-3 (-5-1-11-7)
45-55 9 -3-1 -3-1 (-14-0-7-7)
BMI
< 25 19 ref ref
25-30 26 1-3 1-3 (-6 -6 -9-3)
V 3 0 5 -3-3 -3-3 (-16-5-10-0)
Weight loss of > 10 kgs
no 4 0 ref ref
> 2 years ago 3 3-0 3-8 (-12-1-18-7)b
within past 2 years 7 6-9 3-8 (-7-6 -15-2)b
Lives within city centre
no 47 ref ref
yes 3 14-0 12-0 (-4-6-28-7)°
a Crude beta
b Adjusted for living within a city centre 
c Adjusted for weight loss
d etect endocrine disru p tin g  effects o f  dietary sources o f p ersistent chem ical eXposures. 
W e also assessed associations betw een the DR CALUX® m easurem ents and other poten­
tial determ inants fo r internal eXposure to p ersistent end o crine  disru p tin g  chem icals, 
including age, BMI, w eight loss, and living w ithin a city  centre, but the effect estim ates 
w ere inconclusive (Supplemental Table 2). W e did, how ever, identify a positive association 
betw een plasm a androgenic activity and the internal dioXin TEQ values o ve r a sm all range 
(Table 8.5). An inverse association betw een CALUX® TEQ s and total and free testosterone 
in male serum  has been reported25, as w ell as betw een CALUX® TEQ s and A EQ s in fetal 
plasm a after MTBE eXtraction (R=-o.7)34. Pliskova and colleagues m easured a reduced 
estro genic activity in male serum  eXtracts containing high levels o f  PCBs, w hich seem ed 
to be associated w ith a d ecline in endogenous e strad io l32. In o u r study, plasma TEQ s w ere 
not associated w ith reduced estrogenic activity  in total plasma, but this could also be due 
to the low er eXposure levels.
Estrogenic an d /o r androgenic plasm a activities seem ed to be increased in men o ccu ­
pationally eXposed to disinfectants, pesticides, w elding o r soldering, and veh icle  eXhaust
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#fum es. These eXposures occurred in very divers occupational settings and often involved 
m iXtures o f  different substances. A s co-eXposure to other chem ical groups w as very com ­
mon, it was difficult to attribute d ifferences in estro genic or androgenic activities to sp e ­
cific eXposures. In general, m ultivariable analyses w ith adjustm ent fo r co-eXposures did 
not d rastically change the effe ct estim ates. H ow ever, reliable estim ation o f  the indepen­
dent effects o f  disinfectants, pesticides, w elding o r soldering, eXhaust fum es, and other 
occupational eXposures, re quires a larger population size that allow s more specific eXpo­
sure classification. W e interpret the present fin dings as indications that various occupa­
tional eXposures can alter estrogenic o r androgenic activities and are therefore poten­
tially relevant sources o f  endocrine disruptors.
As pointed out, fu rth e r research is needed to elucidate the effects o f  d iffe re n t sources 
o f end o crine  disru pto rs on the estrogenic and androgenic plasma activities in men. 
Including internal m easurem ents o f  certain groups o f chem icals such as dioXins in future 
research, could clarify  th e ir specific role in the estrogenic and androgenic activities found, 
especially if  th ese chem icals have long half-lives o f  eXcretion. In addition, m easurem ents 
o f endogenous estradiol and testo sterone levels could give m ore insight into the m echa­
nism s through w hich estro g e n icity  o r an dro g enicity  in total plasma are influenced by 
chem ical eXposures. An eXperim ental study design could clarify  the rapid effects o f phy­
toestrogens on estrogenic and androgenic plasma activities. Research also needs to be 
eXtended to both m ales and fem ales o f d ifferent age groups, w ho have specific horm one 
profiles and may therefore respond differently to chem ical eXposures.
Conclusions
The results o f this eXplorative study are not yet readily interpretable. H ow ever, they 
dem onstrate that it is possible to identify associations betw een sources o f potential 
endocrine disru pto rs and m easurem ents o f  estrogenic and androgenic activities in total 
plasma am ong a reasonably sized group o f  men. Because the total estrogenic and an dro ­
genic plasm a activities reflect receptor activation by any X enobiotics present as well as 
by endogenous horm ones, th ey also cap ture indirect effects such as interference with 
the bioavailability o f  endogenous horm ones or com p etitive  receptor binding. Com par­
ing these m easurem ents w ith fin dings regarding the levels o f  endogenous horm ones or 
with internal m easurem ents o f  specific chem icals o r chem ical de rivatives could clarify  the 
endocrine disru p tin g  potential o f  certain chem icals as w ell as th e ir behavior w ithin the 
hum an body. M easurem en ts o f  total estrogenic and androgenic plasma activities could 
thereby help to better understand associations betw een potential eXposure sources o f 
endocrine disru pto rs and specific health outcom es in epidem iological studies.
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General discussion and 
future perspectives

#General discussion
This th esis represents a research project in w hich w e aim ed to provide more insight into 
the etiology o f hypospadias and UDT, and specifically  into the role o f prenatal exposure 
to EDs therein. Several case-referen t stud ies w ere conducted in w hich risk factor data 
w ere collected w ith postal q uestio nnaires. For the assessm ent o f  occupational exposure 
to EDs, a JEM  w as incorporated in the study. The main findings regarding risk factors for 
hypospadias and UDT are sum m arised in Figure 9.1.
fig u re  9.1 Risk factors for hypospadias and UDT according to case-referent studies 
performed in the Netherlands in 2002 and 2005
familial clustering of 
testicular cancer
mother is 
DES-daughter
maternal smoking
paternal obesity
familial clustering of 
hypospadias/UDT
factors associated with 
placental insufficiency 
(LBW, twinning, preeclampsia)
paternal subfertility, IVF/ICSI 
treatment
oral contraceptives used 
after conception
prescription drug use 
(iron supplements, 
anti-emetics)
occupational exposure to EDs 
(cosmetics, pesticides, organic 
solvents, copper)
N.B. The question marks indicate associations with questionable validity due to méthodologie issues or because 
the findings fro m  the two studies on hypospadias were inconsistent
Both disorders show ed fam ilial clustering  and associations w ith factors that reflect s itu ­
ations in w hich the placenta may be insufficient in providing the foetus w ith adequate 
am ounts o f  nu trien ts and gonadotropins. O th e r sim ilarities in risk factors include pater­
nal subfertility, IV F /IC S I treatm ent, and p rescrip tio n drug use in general, although asso ­
ciations w ith specific typ es o f  drugs seem ed to differ. Increased risks o f  hypospadias w ere 
also found in case o f fam ilial o ccurrence o f  te sticu la r cancer, m aternal intra-uterine DES­
exposure, and possibly m aternal sm oking and paternal obe sity  (Chapters 2-5).
Regarding EDs, no c lea r associations w ere identified w ith parental leisure tim e e xp o ­
sures, intake o f  soy o r seafood, and private use o f  cosm etics at tim e o f  the index preg­
nancy (Chapters 2, 4, a n d 5). O ccupational exp osu re to cosm etics, how ever, did seem  to 
increase the risk o f  UDT, w hich was reflected in both the q ue stio n n a ire  data and the expo-
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sure p robabilities according to the JEM. The association w ith m aternal ED exp osu re to 
agricultural p esticid es found w ith the JEM  was not identified using q uestio n n a ire s only. 
Furtherm ore, the JEM  revealed indications fo r an increased risk o f  hypospadias w hen 
m others w orked w ith organic solvents (Chapters 2, 4,5, and 7).
In addition to the case-referen t studies, a cross-sectional study was perform ed am ong 
the fathers o f  a subset o f  cases and referents to assess the ap p lica b ility  o f  CALUX® bio­
assays for biological m onitoring purposes. Several exp osu re factors w ere found to be 
associated w ith an increased androgenic or estro genic plasma activity as m easured w ith 
CA LU X ®, w hich indicates that these m easurem ents can indeed be valuable for exposure 
assessm ent o f  EDs in e pidem iologic research (Chapter 8).
Potential pitfalls in the case-referent studies
To identify risk factors fo r hypospadias and UDT, we used a case-referen t design, w hich is 
very com m on fo r etiologic stud ies on birth defects, because o f  the generally low preva­
lences o f  these disorders. The e fficiency o f  this retrospective design may, how ever, be 
counterbalanced by the introduction o f  bias w hen risk factor data are influenced by case- 
referent status. Furtherm ore, bias may result from  the selection o f  an inappropriate refer­
ent population. Therefore, the recruitm ent strategy and the m ethods o f  data collection 
are im portant issues to account for in the interpretation o f  the study findings.
For the referent population in the 2 00 2  study on hypospadias, w e chose friend s o f 
cases, w hereas the cases in the 2005 study on hypospadias and UDT w ere com pared to 
a hospital population o f  boys w ith o titis  m edia w ith effusion (O M E) w ho received ear 
ventilation tubes. Both typ es o f  populations have several advantages and disadvantages, 
w hich are sum m arized in Box 9.1.
box 9.1 Advantages and disadvantages of friend and hospital referents
Advantages Disadvantages
Friend
referents
- Represent the source population of cases 
with respect to age and geographical 
origin
- Motivated population ^  minimizes selec­
tive non-response
- Readily available and easy to approach
- Boys/parents with social or physical 
problems are less likely labelled as 
friends ^  risk of ‘friendly control 
bias'1,2
- Friends may share a certain life style, 
living environment, and profession 
^  risk of overmatching on the expo­
sures under study2,3
Hospital
referents
- Represent the source population of cases 
with respect to age and geographical 
origin if chosen wisely
- Motivated population ^  minimizes selec­
tive non-response
- Readily available and easy to approach
- Unaware of case-referent status ^  mini­
mizes recall bias
- Could easily be non-representative of 
the source population with respect to 
geographical origin and life style
- Referent disorder may be associated 
with exposures under study ^  risk of 
selection bias2,3
162 c h a p t e r  9
#In general, a referent population should reflect the exp osu re distribu tion o f the source 
population o f  case s4, w hich in o u r stud ies com prises all boys w ho w ould have been 
included as cases had th ey developed hypospadias or p ersistent UDT. Due to o u r selec­
tion strategies, w e exp ect both referent populations to match the age and geographical 
backgrounds o f  the source populations. This is im portant as e.g. life styles, m edical prac­
tices, and occupations may d iffe r betw een geographical areas and o ver time. How ever, by 
including friend s as referents, w e may have ended up w ith a selection o f referent parents 
w ith a more favourable social status and physical health. Also, overm atching may have 
occurred if parents tended to invite referent coup les w ith e.g. sim ilar life styles and o ccu ­
pations. That is w hy we co n sid er the selection o f  hospital referents in the 2005 study to 
be a more sup e rio r recruitm ent strategy. O u r ch oice fo r boys treated fo r O M E was based 
on the high prevalence o f  this d isease and an appropriate age d istributio n. O M E was also 
considered to be a suitable referent d iso rd e r fo r hypospadias and UDT because o f the d if­
ferent etio lo g ic/path olog ic m echanism s (infection vs. d isturbed foetal developm ent) and 
the lack o f  em pirical evidence fo r shared risk factors5. N evertheless, the possibility  o f  an 
association betw een O M E and som e exp osu res under study (e.g. m aternal use o f an tib i­
otics) could not be ruled o u t and had to be taken into consideration in the interpretation 
o f  o u r findings (Chapters 4 a n d 5).
An advantage o f including hospital referents is that it reduces the risk o f  recall bias, 
w hich w e found im portant because we collected data using self-adm inistered q u e stio n ­
naires. Reports on the im pact o f recall bias are very inco nsistent and som e argue that the 
use o f  affected referents, in an attem pt to reduce recall bias, may not w eigh up against 
the potential bias introduced by an association betw een exp osu re and referent d iso rd e r3,6. 
Several specific studies, how ever, indicate that o u r co ncerns about recall bias w ere ju s t i­
fied. Recall bias was dem onstrated in a large study on the potential teratogenic effects 
o f  p rescription drug use du ring  pregnancy7 and indications fo r recall bias w ere found in a 
study on the role o f  parental occupational exposure in the aetiology o f ch ildhood cance r8.
In summary, both the 2 002  and the 2 005 case-referen t stud ies have m ethodological 
lim itations, although esp ecially  in the 2 005 studies, the potential fo r selection and recall 
bias w ere reduced to a m inim um . Correspondingly, the results did not show  indications 
fo r system atic bias and w ere mostly consistent w ith the fin dings o f  previous studies. The 
e ffect estim ates fo r som e specific factors (e.g. parental life style, p rescription drug use, 
dietary intake, and self-reported occupational exposure), how ever, should be interpreted 
w ith caution, because the sub jective nature o f  the data raise concerns about th e ir valid ity  
(see Chapters 2, 4 and 5).
Limitations o f the cross-sectional study with CALUX® bioassays
W hen w e conducted the study w ith CALUX® bioassays, no previous stud ies w ere avail­
able in w hich estrogenic and androgenic activities in total plasm a w ere m easured and 
com pared to exposure data. Therefore, p rior inform ation on e.g. the variances o f  these
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#effect m easures was lacking and the sam ple size used was m erely based on assum ptions 
and practical feasibility. In addition, we only obtained crude inform ation on the d iffe r­
ent exp osu re variables in the interview s. For th ese reasons, we may have been unable 
to detect associations betw een estrogenic and androgenic plasm a activities and som e 
o f the exp osu re s o f interest. In general, the findings o f  this explorative study should be 
interpreted very carefully and are m ainly to be valued as a basis for furth e r research, in 
w hich the concept o f  total horm onal activity  instead o f m easuring separate endocrine 
disru pting  com pounds should be explored more thoroughly (Chapter 8).
Which inferences can be made from  our studies?
Now that w e have sum m arized the findings and reflected on som e general m ethodologi­
cal issues, w e can review  o u r results in light o f  the o bjectives o f  this thesis.
1 To add know ledge on risk factors fo r hypospadias and UDT
Focusing on: (a) fam ilial occurrence o f  TDS component disorders, (b) parental intra-uterine 
exposure to DES, (c) parental reproductive health, pregnancy complications, and obstetric 
factors, and (d) exogenous factors related to parental life style, prescription drug use, and 
occupation.
O u r results confirm  the e xiste n ce  o f  several previously reported risk factors for hypospa­
dias and UDT, such as fam ilial clustering, low birth weight, tw inning, and preeclam psia, 
and the increased risks o f  hypospadias found after IV F /IC S I treatm ent and m aternal DES­
e xposure (see fig u re  9.1). The results also include som e novel findings, such as fam ilial 
occurrence o f te sticu la r can ce r am ong cases w ith hypospadias and increased risks o f  UDT 
after IV F /IC S I treatm ent o r use o f  oral contracep tives after conception, w hich seem  plau­
sible in light o f  the TDS hypothesis and the presum ed role o f endocrine disru ption in the 
etiology o f  TDS com ponent disorders. In addition, o u r fin dings provide new and co nvinc­
ing indications fo r d ifferences in risk factor patterns betw een subgroups o f  cases w ith 
hypospadias (anterior, m iddle, p osterior) and possibly betw een subgroups o f  cases with 
UDT (w ith and w ithou t inguinal hernia) (Chapters3, 4 a n d 7).
Several previously suggested risk factors for hypospadias (increased m aternal age and 
paternal sm oking) and UDT (gestational diabetes, m aternal sm oking, and m aternal alcohol 
consum ption), w ere not identified in o u r study. Som e o f these previous fin dings rely on 
larger study populations w ith more pow er to identify w eak o r m oderate asso ciatio ns9-12. 
The results on gestational diabetes and m aternal sm oking and alcohol consum ption, how­
ever, are not supported by tw o oth e r large stud ie s13,14. These inco nsistencies require c la ri­
fication by fu rth e r research, w hich is also needed to confirm  som e o f  o u r results (e.g. on 
p rescription drug use and occupational exposure to dusts o r gasoline fum es) that w ere 
difficult to interpret due to the m ethodological lim itations m entioned earlier.
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#2 To identify w h eth er prenatal exp osu re to EDs increases the risks o f  hypospadias and 
UDT
Focusing on: (a) parental ED exposure at the workplace, (b) parental ED exposure fro m  
dietary intake o f  specific foodstuffs, and (c) parental ED exposure during home improve­
ments or leisure time activities.
O u r results point tow ards increased risks o f  UDT w hen m others are occupationally 
e xposed to potential EDs in cosm etics o r agricultural p esticid es and tow ards an increased 
risk o f hypospadias w hen m others w ork w ith organic solvents. Paternal ED exp osu re at 
the w orkplace seem s unlikely to increase the risks o f  hypospadias and UDT in offspring 
substantially, although slightly increased risks after paternal exp osu re to p esticid es or 
copp er cannot be ruled out. W e did not observe increased risks o f  hypospadias o r UDT 
fo r parental exposures, such as painting, gluing, o r applying p esticid es in o r around the 
house. Exposure assessm ent w ith the JEM o r based on the self-adm inistered q u e stio n ­
naires did not allow  us to reliably assess the effects o f  som e additional ED exp osu re s o r to 
identify w eak associations w ith hypospadias o r UDT (Chapters 2, 4,5, a n d 7).
O u r fin dings on pesticide exp osu re correspond w ith several previous studies (see 
Chapter7). Pierik et al., how ever, reported an increased risk o f UDT due to paternal e xp o ­
sure to p esticid es w ith inconclusive findings fo r m aternal exposure, possibly due to the 
relatively small sam ple size15. In futu re research, it w ould be interesting  to try to d ise n ­
tangle the role o f m aternal and paternal exp osu re to p esticid es in the etiology o f  UDT, o f 
w hich the latter seem s to be much less relevant according to o u r findings. The associa­
tio ns found w ith m aternal occupational exp osu re to solvents (hypospadias) and cosm et­
ics (UDT) have not been reported before and require confirm ation by additional studies, 
e sp ecially  since they w ere based on sm all num bers. On the o th e r hand, w e could not 
confirm  previously suggested associations betw een hypospadias and self-reported o ccu ­
pational exp osu re to hairsprays16 or exp osu re to phthalates according to the van Tongeren 
JEM 17. These inconsistencies could result from  d ifferences in exp osu re assessm ent fo r EDs 
betw een the e arlie r studies and o u r study, in w hich we used the presum ably more accu­
rate new  JEM  (see below).
W ith respect to exposure to EDs through dietary intake, m any q ue stio n s rem ain u nan­
swered. No c lea r associations have been described betw een dietary sources o f  EDs and 
the risks o f  hypospadias and UDT, apart from  an increased risk o f  hypospadias w hen m oth­
ers had a vegetarian diet (presum ably w ith a high soy intake)18, w hich we could not rep­
licate in o u r case-referen t studies. O u r study w ith CALUX® bioassays did not clarify  the 
endocrine disru p tin g  potential o f specific food item s either, probably due to the exp lor­
ative nature o f  that study. Findings from  o th e r stud ies do indicate that dietary intake 
may lead to relevant exp osu res to EDs. Am ong Flem ish men, for exam ple, fre q u en cie s o f 
fish and egg consum ption w ere positively associated w ith serum  TEQ s assessed w ith the
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#DR CALUX® bioassay. In turn, this sum m ary m easure fo r internal exp osu re to dioxin-like 
chem icals w as associated w ith reduced sem en volum e and reduced total and free te s­
tosterone levels19. Furtherm ore, m easurem ents o f  PCBs, flam e retardants, and p ersistent 
p esticid es in breast milk and placenta tissu e  w ere associated w ith increased risks o f  hypo­
spadias an d/o r UDT20-23. Although diet is probably an im portant so urce o f  these p ersistent 
EDs, a link betw een parental dietary intake o f these chem icals and hypospadias and UDT 
in o ffsp ring  has not been established y e t
3 To contribu te to the developm ent and evaluation o f  exp osu re assessm ent m ethods for 
EDs in epidem iologic studies
Specifically: (a) a jo b  exposure matrix f o r  EDs and (b) measurements o f  estrogenic and 
androgenic activities with a reporter-gene bioassay
W e adjusted and updated the 2 00 2  JEM  for exposure assessm ent o f  EDs in com m unity- 
based stud ies (Chapter 6). This JEM  provides a pragm atic and relatively objective method 
to assess occupational exp osu re to EDs in large study populations, but an im portant lim i­
tation is that it provides only crude exp osu re estim ates that are prone to m isclassifica- 
tion on the individual level. W e dem onstrated that exp osu re assessm ent w ith the JEM 
may im prove w hen subject-specific inform ation on tasks and activities is incorporated 
(Chapter 7). H ow ever, fu rth e r developm ent o f  exposure assessm ent methods, including 
m ethods for biological m onitoring o f  EDs, is o f  great im portance.
W e hypothesized that estro genic and androgenic activities in total blood plasm a, mea­
sured w ith CALUX® bioassays, w ould be suitable fo r biological m onitoring purposes. In 
an exp lorative study, w e show ed that it is possible to identify associations betw een some 
life style factors and occupational exp osu res and th ese m easurem ents o f  estrogenic and 
androgenic plasm a activities (Chapter 8). At this point, it is d ifficult to interpret these 
findings, as the biological sig nificance o f  d iffe re nce s in total estro genic and androgenic 
activities is yet unclear. How ever, we believe that in time, CALUX® bioassays can be very 
valuable for exposure assessm ent o f  EDs, because they provide a sum m ary m easure o f 
e xposure to different substances w ith end o crine  disru p tin g  properties, in contrast to 
other com m on m ethods that rely on the detection o f  individual chem icals o r chem ical 
derivatives.
4  Evaluation o f  the TDS hypothesis through the recognition o f  sim ila rities an d /o r d iffe r­
ences in risk factor patterns for hypospadias and UDT
In the 2 005 study, risk factors fo r hypospadias and UDT w ere explored using the same 
referent population and data collection m ethods (Chapters 4 a n d 5). This is an im portant 
strength o f o u r study, since it enables us to com pare the findings fo r the tw o disorders in
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#o rd er to see w h eth e r a sim ilar etiologic pathway is involved, such as te sticu la r dysgenesis 
in early gestation as proposed by the TDS hypothesis. Several sim ilarities in risk factor 
patterns w ere found (see Figure 9.1), w hich w ould sup p ort this hypothesis. How ever, alter­
native etiologic m echanism s, such as placental insufficiency in providing the fetus with 
gonadotropins, can also explain the sim ilarities in risk factors fo r hypospadias and UDT.
A s illustrated in Figure 1.3, the TDS hypothesis suggests that com m on causes fo r the 
fo u r com ponent disorders should be sought in both genetic and environm ental factors, 
and esp ecially  in exposure to EDs. The association betw een hypospadias and fam ilial 
o ccurrence o f  te sticu la r can ce r and the increased risks o f  hypospadias and UDT in case 
o f  paternal su b fe rtility  provide som e sup p ort for a shared genetic su scep tib ility  am ong 
these TDS com ponent disorders. O verall, how ever, no strong evidence for fam ilial c lu s­
tering  o f  TDS w as found.
O u r findings on the role o f  EDs in the etiologies o f  hypospadias and UDT w ere hardly 
com parable w ith one another. This indicates that the associations found may involve 
o th e r etiologic m echanism s than te sticu la r dysgenesis in early gestation. As the associa­
tio ns betw een exp osu re to EDs and UDT seem  to be the m ost convincing, we hypothesize 
that te sticu la r descent involves a relatively large w indow  o f su scep tib ility  to EDs (Chapter 
7). This w ould favor adverse effects o f  EDs later in pregnancy, w hen the testes are already 
form ed.
This ties in w ith S harpe's suggestion that endocrine d isruption is m ore likely a co n se ­
q uence o f  te sticu la r dysgenesis rather than a cause o f dysgenesis itself24. As te sticu la r 
developm ent precedes the production o f  horm ones by the testes, th is process is thought 
to be mostly horm one-independent, although Sharpe de scrib es som e research findings 
suggesting that androgens do play a role in testis form ation and, m ore specifically, in 
the proliferation o f  Sertoli cells. Furtherm ore, te sticu la r dysgenesis and the associated 
dow nstream  e ffects w ere dem onstrated to o ccu r in rats prenatally exposed to high levels 
o f  dibutyl phthalate (DBP). Therefore, DBP has been suggested to provide a model to 
study the c ellu la r aspects o f  the TDS hypothesis25. The m echanism  through w hich DBP 
causes te sticu la r m aldevelopm ent in rats is unclear, how ever24, so these fin dings can ­
not be extrapolated to EDs in general, esp ecially  w hen you co nsid er the uncertain role 
o f  androgens in early te sticu la r developm ent. The com parison o f the risk factor patterns 
fo r hypospadias and UDT in o u r studies indicates that, on a population level, te sticu la r 
dysgenesis is not a probable o r com m on cause fo r the tw o disorders and a rather unlikely 
causal pathway fo r the potentially adverse effects o f  EDs. Interference o f  EDs w ith the 
m etabolism  and production o f  endogenous horm ones du ring  penile developm ent and 
te sticu la r descent is considered to be a m ore likely e tiologic pathway w ith respect to the 
increased risks o f  hypospadias and UDT24.
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#Future perspectives
Based on o u r findings and the fin dings o f  oth er e tiologic stud ies on hypospadias and UDT, 
several sug gestions fo r futu re  research can be put forward.
Studies on fam ilial clustering, placental insufficiency, fertility treatment, and DES
For hypospadias, the relatively strong fam ilial clustering  may indicate im portant genetic 
factors in its etiology. A lthough experim ental stud ies have indicated several candidate 
genes, th e ir link w ith hypospadias in hum ans rem ains to be established26. O u r fin dings for 
UDT do not clearly indicate a need fo r genetic research. UDT does not show  such a strong 
fam ilial com ponent as hypospadias, indicating a less prom inent role fo r genetic risk fac­
tors. Furtherm ore, according to a large cohort study, fam ilial o ccurrence o f UDT is more 
likely explained by shared m aternal factors than by inheritable genetic factors, since UDT 
show s a strong er aggregation am ong brothers com pared to fathers and sons, and also 
am ong m aternal half-brothers com pared to paternal half-brothers27. Familial hypospadias, 
in contrast, show s a sim ilar aggregation am ong first degree relatives (brothers vs. fathers 
and sons) and is equally transm itted through the paternal and m aternal sides o f  fam ilies28, 
indicating a m ajor genetic com ponent.
In 2005, the A G O R A  (A etiologic research into G e n e tic  and O ccu p a tio n al/E n viro n m en ­
tal Risk Factors fo r A nom alies in C h ild re n) project was initiated, in w hich environm ental 
and genetic data are routinely collected from  several pediatric target populations in the 
Radboud U niversity  Nijm egen M edical Centre, including boys w ith hypospadias. In a p re ­
lim inary genetic study, previously suggested associations betw een hypospadias and tw o 
single nucleotide polym orphism s (SNPs) could not be confirm ed29. A  w hole-genom e asso­
ciation study that is currently being perform ed, may provide more insight into the genes 
that are involved in the etiology o f  hypospadias.
The role o f  placental insufficiency in the etiologies o f hypospadias and UDT requires 
clarification as w ell. This etiologic m echanism  finds additional support by the low er mean 
placental w eight for boys w ith hypospadias reported by Boisen et al.30 and observations 
o f placental pathology in all o f  the grow th retarded boys w ith hypospadias (n=30) studied 
by Yinon et al.31. Several horm onal factors could be involved in the associations between 
placental insufficiency and the risks o f hypospadias and UDT, such as e strio l32,33, a w eak 
estrogen prim arily produced by the placenta, A lpha-Fetoprotein (A FP)34, w hich plays a 
role in fetal m etabolism  and tra n sp o rt o f  estrogens and is treated as a m arker fo r pla­
cental dysfunction, and Hum an C h o rio n ic G o nadotro p in (H C G ). H CG  could be the major 
link betw een placental insufficiency and the tw o disorders, as it regulates the produc­
tion o f  testosterone by the fetal Leydig cells in early gestation35. The link betw een low 
m aternal H C G  levels around gestational w eeks 9-10 and being sm all fo r gestational age 
is w ell docum ented and poses the po ssibility  to develop a screening  tool fo r early detec­
tion o f  grow th re strictio n 36-38. Later on in pregnancy, how ever, placental dysfunction may
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#be accom panied by a high m aternal H C G 39. Therefore, m easurem ents at m ultiple tim e 
points th ro ugh out pregnancy w ould be required to understand the potential associations 
betw een H CG  and o ccurrence o f  hypospadias and, especially, UDT. W hen such associa­
tio ns are identified, the next q uestion w ill be w h eth e r the presum ably reduced levels o f 
H C G  in case o f  hypospadias and UDT are prim ary o r secondary to placental dysfunction, 
given the role o f  H C G  in early placentation39.
W ith respect to IV F /IC S I treatm ent, futu re stud ies should try to disentangle the effects 
o f  horm one adm inistration, in vitro  fertilization, and underlying parental su b fe rtility  as 
potential causal factors fo r the increased risks o f  hypospadias and UDT. They should also 
evaluate o u r suggestion that these risks may no longer exist (see Chapter 4)  by com paring 
previously and m ore recently treated couples. How ever, this endeavor w ill require large 
study populations and detailed exp osu re data.
Future stud ies are also needed to clarify  the increased risk o f  hypospadias fo r sons o f 
DES-daughters. Inform ation on m aternal reproductive health, horm one levels, placental 
abnorm alities, and intra-uterine grow th may provide more insight into the etiologic path­
way. Alternatively, an epig enetic m echanism  may be assum ed. Im m ediately after fertiliza­
tion, the germ  cells undergo a phase o f  genetic program m ing, in w hich dem ethylation 
and rem ethylation o f  alm ost the entire  genom e takes place40. Recent fin dings suggest 
that specific endo crine disru p tin g  substances are capable o f  altering the D N A methyla- 
tion process, thereby affecting reproductive health in sub sequ ent generations41-43. This 
may also apply to a synthetic horm one, such as DES, and may explain the o ccurrence o f 
hypospadias in D ES-grandsons. Research into the potential e pig enetic effects o f  chem ical 
exp osu res is still scarce, how ever.
Further evaluation o f the TDS hypothesis
In o rd er to get m ore insight into the assum ed shared etiology o f  hypospadias, UDT, te s­
ticu la r cancer, and reduced sem en quality, the risk factor patterns o f  all fo u r diso rders 
should be com pared. The search fo r sim ilarities in risk factors betw een the fo u r d iso r­
ders could provide valuable inform ation about the m echanism  through w hich these fac­
tors may disturb the developm ent o r the functio n o f m ale reproductive organs. O n the 
oth e r hand, w e should not lose sight o f the potential risk factors and pathogenic pathways 
that are not shared betw een the TDS com ponent disorders. Recently, Akre and Richiardi 
w arned about the extent to w hich the TDS hypothesis has influenced the directio n o f 
research about the etiologies o f  hypospadias, UDT, te sticu la r cancer, and reduced sem en 
quality, as well as the interpretation o f  study fin dings44. They argue that the TDS hypoth­
esis was adopted too easily and that it requires a m ore critical attitude. The lack o f  su p ­
port for the TDS hypothesis in o u r study u nderlines this point o f  view.
Recently, tw o case-referen t stud ies on te sticu la r can ce r and reduced sem en quality  
have been perform ed at the Radboud U n iversity  Nijm egen M edical Centre, in w hich 
cases w ere com pared to a single referent population o f  men w hose partners gave birth at
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#the departm ent o f  O b stetrics and Gynecology. Together w ith o u r findings on hypospadias 
and UDT, the findings o f  these other tw o studies will give a m ore com plete p icture o f  the 
sim ilarities and d ifferences in risk factors fo r the fo u r TDS com ponent disorders.
Studies into the role o f EDs in the etiologies o f hypospadias and UDT
The developm ent o f  a food exp osu re index to estim ate the intake o f  p ersistent EDs as w ell 
as naturally occurrin g  phyto-estrogens through the consum ption o f d iffe re n t food item s 
could shed more light on the role o f  dietary ED exposure in the etiologies o f hypospadias 
and UDT. Regarding occupational exposure to EDs, we recom m end to fu rth e r investigate 
the exp osu res that o ccu r am ong w om en in agriculture and those handling cosm etics, as 
well as th e ir potential to increase the risks o f UDT and hypospadias in offspring. For other 
occupational exp osu re s to potential EDs, the findings o f  o u r study and other epid e m io ­
logic stud ies are much less convincing. As m entioned earlier, this could be due to e xp o ­
sure m isclassification, as m ost stud ies rely on job titles o r q u e stio n n a ire  data only. There­
fore, futu re studies should focus on the developm ent o f  exp osu re assessm ent strategies 
fo r EDs, and especially  m ethods fo r biological m onitoring. It w ould be interesting and 
feasible to com bine CALUX® m easurem ents o f total estrogenic and androgenic plasma 
activities w ith internal m easurem ents o f  specific chem icals or chem ical derivatives (e.g. 
phthalates, org anic solvents) and w ith m easurem ents o f  endogenous estradiol o r testos­
terone. Such stud ies could help to better understand the health risks o f  these EDs as w ell 
as th e ir behavior w ithin the hum an body.
Additional opportunities fo r  epidemiologic studies
In the past few  years, several case-referen t stud ies on hypospadias an d /o r UDT w ere per­
form ed, w hich offers the possibility  to pool data in o rd er to furth e r explore the effects 
o f rare exp osu re factors, such as p rescription drugs and specific w orkplace exposures. 
Regarding the latter, the JEM  fo r ED exposure could be a useful instrum ent, because it 
only re quires data on jo b  title, w hich w ill often be available. The results o f  pooled analyses 
o f case-referen ts studies should be interpreted w ith caution, however, as th e ir valid ity 
depends on the hom ogeneity in study populations and data co llection m ethods across 
different stud ie s45.
A  prospective study design could clarify  the effects o f  risk factors that are difficult 
to recall. It offers the po ssibility  to collect exp osu re data, obtained w ith q uestio n n a ire s 
or from  environm ental o r biological m easurem ents, w ithin the relevant tim e w indow s. 
Furtherm ore, the aforem entioned problem s w ith selecting  suitable referents are avoided. 
Currently, the PRegnancy and Infant DEvelopm ent (PRID E) study is being set up at the 
Radboud U niversity  Nijm egen M edical Centre. In th is study, w om en are enrolled at pre- 
conceptional or early prenatal care visits and follow ed up until at least 6 m onths after 
delivery. A w ide spectrum  o f potential risk factors w ill be addressed using w eb-based 
q uestionnaires, pharm acy records, and serum  sam ples from  a subset o f  participants. A im ­
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#ing to include as m any as 150,000 to 2 0 0 ,0 0 0  pregnancies nationw ide, the PRIDE study 
w ill have enough pow er to zoom in on hypospadias and UDT and offers a unique setting 
to study th e ir etiologies.
Implications fo r clinical practice
Increased know ledge on the etiologies o f  hypospadias and UDT as pursued in this thesis, 
is necessary fo r the developm ent o f  p reventive m easures fo r these tw o disorders. These 
may include education o f  coup les that are planning a pregnancy or, w hen it com es to 
EDs, regulatory actions regarding the chem ical content o f  pesticides, paints, o r personal 
care products. The fin dings in o u r study do not form  a strong foundation for such p reven­
tive m easures yet, but are a basis fo r fu rth e r research. W hen associations betw een ED 
exp osu re and hypospadias o r UDT are dem onstrated in futu re  studies, an educational 
approach to prevention may still be challenging, esp ecially  w hen several sources o f  e xp o ­
sure e xist and risk estim ates are weak. Education about these risks may cause unnec­
essary distre ss o r feelings o f  guilt. Am ong the exp ecting  parents, com pliance w ith the 
advice given may suffer from  the fact that so m any do's and don'ts already e xist fo r preg­
nant w om en. Therefore, research into the effective application o f  the acquired know ledge 
w ill probably be an im portant next step.
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#Summary
i_

#Introduction and objectives
Hypospadias and undescended te stis are tw o com m on birth defects in boys. In hypospa­
dias, the urethral m eatus is not found at the tip o f the glans, but som ew here along the 
ventral surface o f  the penis. U ndescended te stis (UDT), also called cryptorchidism , m eans 
that one or both testes did not fully descend into the scrotum , but rem ained w ithin the 
abdom inal cavity  o r the inguinal canal, or are found in a high scrotal o r ectopic p o si­
tion. A lthough previous research identified som e risk factors for hypospadias and UDT, 
th e ir etiologies rem ain largely unknow n. A ccording to the Testicular D ysgenesis Syn­
drom e (TDS) hypothesis, hypospadias and UDT, but also te sticu la r cance r and reduced 
sem en quality, may originate from  te sticu la r dysgenesis in early fetal life. N ext to a shared 
genetic predisposition, the TDS hypothesis indicates prenatal exp osu re to endocrine dis- 
ruptors as a com m on cause for these fo u r disorders.
Endocrine disru pto rs (EDs) are defined as exogenous substances that alter functio ns 
o f  the end o crine  system , thereby causing adverse health effects. This broad defin ition 
cap tures a grow ing num ber o f substances w ith very different chem ical properties and 
m echanism s o f  effect. Potential EDs include industrial chem icals, such as pesticides, 
dioxins, and phthalates, but also naturally occurrin g  phyto-estrogens. Exposure to these 
substances may o ccu r at the w orkplace, du ring  leisure tim e activities (e.g. home im prove­
m ents o r hobbies), through the use o f  personal care products, and through dietary intake.
O nly a few  associations have been reported betw een prenatal exp osu re to EDs and the 
risks o f  hypospadias and UDT. This could partly be due to difficulties in accurately assess­
ing these exposures, esp ecially  in retrospective studies.
The objectives o f  the research described in this thesis, w hich are form ulated in more 
detail in Chapter 7, w ere the follow ing: i)  to add know ledge on risk factors fo r hypospadias 
and UDT, 2) to identify w h eth e r prenatal exp osu re to EDs increases the risks o f  hypospa­
dias and UDT, 3) to contribu te to the developm ent and evaluation o f  exp osu re assessm ent 
m ethods fo r EDs in e pidem iologic studies, and 4 ) to evaluate the TDS hypothesis through 
the recognition o f  sim ila rities an d/o r d iffe re nce s in risk factor patterns for hypospadias 
and UDT.
Methods, results, and interpretation
Explorative case-referent study on hypospadias (2002)
In 2002, we first conducted an explorative case-referen t study on hypospadias, in w hich 
w e assessed a w ide range o f potential risk factors. C ases w ere boys w ho w ere treated for 
hypospadias at the Pediatric U rology C entre o f the Radboud U niversity  Nijm egen M e d i­
cal C entre and w ere born in 1987-1997. A s referents, we included friend s o f  sim ila r age 
w hose parents w ere recruited via the parents o f  cases. Data w ere collected w ith postal 
q ue stio n n a ire s fo r both parents o f  cases and referents.
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As described in Chapter 2, fam ilial clustering  w as found to be a strong risk factor fo r hypo­
spadias, w hich indicates an im portant genetic com ponent in its etiology. H ypospadias 
also occurred more often in children w ith low birth w eight and in tw in s o r trip let; s itu ­
ations that are suggested to involve placental insufficiency in providing the fo etus with 
nu trien ts and gonadotropins. Paternal su b fe rtility  an d /o r fertility  treatm ent seem ed to 
increase the risk o f  hypospadias as w ell. Som e indications w ere found fo r associations 
betw een hypospadias and m aternal use o f  iron supplem ents, m aternal sm oking, paternal 
p rescrip tive drug use, and paternal exp osu re to pesticides, w hich should be interpreted 
carefully due to the sub jective nature o f the data on these topics.
O u r data also reflected an increased risk o f  hypospadias w hen m others w ere prenatally 
exposed to D iethylstilbestrol (DES) (see Chapter3). The increased occurrence o f  hypospa­
dias am ong sons o f  DES-daughters was first reported by Klip et al. in 2002, w ho studied 
a cohort o f  wom en diagnosed w ith fe rtility  problem s. Although o u r results provide sup ­
port fo r these e arlie r findings, they also point out that the tru e excess risk is probably o f 
a much sm aller m agnitude. H ow ever, this does not discard the fact that the occurrence 
o f hypospadias am ong grandsons may indicate a transgenerational effect o f  DES, w hich 
w arrants fu rth e r research.
Case-referent studies on hypospadias and UDT (2005)
The 2 002  study form ed the basis fo r tw o subsequent stud ies on hypospadias and UDT 
that w ere set up in 2 005 and are described in Chapters 4 and 5. These stud ies involved 
more e xtensive data collection, especially w ith respect to prenatal exp osu re to potential 
EDs. Cases w ere boys w ho had surgery fo r hypospadias o r UDT at the departm ents o f 
U rology and Pediatric Surgery o f  five hospitals in the Eastern part o f The N etherlands. 
Referents w ere boys w ho received ear ventilation tubes at the departm ents o f  O to rh in o ­
laryngology o f the sam e hospitals. C ases and referents w ere born in 1996-2004.
The risk factor patterns fo r hypospadias and UDT in the 2 005 studies show ed several 
sim ilarities and w ere mostly in line w ith the results o f  the 2 0 0 2  study on hypospadias. 
Again, increased risks o f  hypospadias in case o f  paternal su b fe rtility  o r IV F /IC S I treatm ent 
w ere observed, w ith sim ila r findings fo r UDT. A sso ciation s found w ith low birth weight, 
tw inning, and gestational preeclam psia provide fu rth e r sup p ort fo r the role o f  placental 
insufficiency in the etiologies o f both hypospadias and UDT. In addition, fam ilial c luster­
ing o f  the tw o disorders was observed, w hich in case o f UDT probably results from  shared 
environm ental factors rather than inheritable genetic factors (see Chapter 9). A s in the 
2 002  study, som e associations w ere found betw een parental p rescrip tive drug use and 
hypospadias o r UDT, w hich w ere difficult to explain.
Novel findings in 2005 include increased risks o f  hypospadias in case o f  fam ilial o ccur­
rence o f  te sticu la r cance r and possibly paternal o be sity  and the association betw een 
UDT and m aternal use o f oral contracep tives until after conception. Furtherm ore, the 
2005 stud ies provide new and co nvincing  evidence for d iffe re nce s in risk factor patterns
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#betw een subgroups o f  cases w ith hypospadias (distal, middle, and proxim al) and possibly 
betw een subgroups o f  cases w ith UDT (w ith and w itho u t inguinal hernia).
W ith respect to prenatal ED exposure, an association was found betw een maternal 
self-reported occupational exp osu re to cosm etics and UDT. H ow ever, the q uestio nnaire  
data did not reveal additional associations betw een hypospadias o r UDT and occupational 
ED exposures. Also, w e did not identify increased risks o f  hypospadias o r UDT due to 
private use o f  cosm etics, dietary intake o f  seafood o r soy replacem ents fo r meat o r dairy, 
o r activities, such as painting, gluing, o r applying p esticid es in o r around the house. These 
‘null-findings' fo r EDs, how ever, could partly be due to exp osu re m isclassification by the 
retrospective q uestionnaires.
Exposure assessment using a Job Exposure Matrix fo r  potential EDs
A im ing to obtain a m ore reliable exp osu re classification, w e decided to use a Job Exposure 
M atrix (JEM ) fo r the assessm ent o f  occupational exp osu re to EDs. Based on a JEM pub­
lished by Van Tongeren et al. in 2002, we developed a new  and more up-to-date JEM for
10 groups and 33 subgroups o f  potential EDs, w hich is described in Chapter 6. For a total 
o f  353 jo b  titles, the p robability o f  exp osu re to these chem ical groups and subgroups was 
classified as ‘unlikely', ‘possible', o r ‘probable' by m eans o f  e xpert assessm ents, focusing 
on the years 1996-2006.
U sing the JEM, associations w ere found betw een UDT and m aternal occupational 
e xp osu re to pesticides, phthalates, org anic solvents, alkylphenolic com pounds, cop­
per, benzophenones, parabens, and siloxanes, w hich m ainly involved job s in agriculture 
and w orking w ith cosm etic products (Chapter 7). M aternal exp osu re to org anic solvents 
seem ed to increase the risk o f  hypospadias in offspring. Paternal ED exp osu re is unlikely 
to substantially increase the risks o f  hypospadias and UDT in o ffsp ring  according to our 
findings w ith the JEM, although slightly increased risks after paternal exp osu re to p esti­
c ides o r co pp e r cannot be ruled out.
The JEM is a pragm atic and relatively objective method to assess occupational e xp o ­
sure to EDs in large study populations. But an im portant lim itation is that it provides 
only crude exp osu re estim ates that are prone to m isclassification on the individual level. 
Therefore, we system atically m odified som e o f the JEM exposure p robability scores based 
on inform ation on tasks and w orking environm ents obtained from  the self-adm inistered 
q ue stio n n a ire s w hen we applied the JEM to o u r study population. This resulted in slightly 
strong er risk estim ates fo r most exp osu re groups, w hich indicates an overall reduction in 
exp osu re m isclassification (see Chapter 7).
The applicability o f reporter-gene bioassays in epidemiologic studies on EDs 
In addition to these case-referen t studies, a cross-sectional study was perform ed to assess 
the ap p lica b ility  o f  Chem ically Activated LU ciferase gene eX p resssion (CA LU X ) bioassays 
fo r biological m onitoring o f  EDs. Plasma sam ples and interview  data w ere collected from
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#108 men w ith different exp osu re profiles, aim ing to explore the effects o f  several sources 
o f potential EDs, including occupational exposure, sm oking, personal care products, liv­
ing environm ent, and diet, as w ell as the effects o f  potential determ inants such as age and 
w eight on the estro genic and androgenic activities in total plasma m easured by CALUX® 
bioassays. As described in Chapter 8, several o f  these factors w ere found to be associated 
w ith an increased androgenic or estro genic plasma activity. These results indicate that 
m easurem ents o f  androgenic and estrogenic plasma activities can be valuable fo r e p id e ­
m iologic stud ies on endo crine disru pto rs and give direction fo r fu rth e r research.
Evaluation o f the Testicular Dysgenesis Syndrome hypothesis
Several sim ilarities in the risk factor patterns fo r hypospadias and UDT w ere found, w hich 
is in line w ith a com m on etiologic pathway, such as te sticu la r dysgenesis in early gesta­
tion as proposed by the TDS hypothesis. This hypothesis specifically  indicates genetic 
factors and environm ental factors, especially  prenatal ED exposure, as com m on causes 
fo r the fo u r com ponent disorders. In o u r studies, however, no convincing  evidence fo r a 
shared genetic su scep tib ility  am ong TDS com ponent diso rders w as found. Furtherm ore, 
ou r findings on the role o f  EDs in the etiologies o f  hypospadias and UDT w ere hardly 
com parable w ith one another and indicated o ther target points fo r EDs than te sticu la r 
developm ent in early gestation. Therefore, o u r findings provide little support fo r the TDS 
hypothesis. The sim ilarities in risk factors found are m ore likely explained by alternative 
etiologic m echanism s, such as placental insufficiency in providing the foetus w ith n u tri­
ents and g onadotropins an d /o r interference o f  EDs w ith endogenous horm ones during  
penile developm ent and te sticu la r descent (Chapter 9).
Future perspectives
The fin dings in o u r stud ies do not yet form  a strong foundation fo r p reventive m easures 
fo r hypospadias o r UDT, but are a good basis fo r furth e r research (C h ap ter9). The strong 
fam ilial clustering  o f  hypospadias dem onstrates the need fo r genetic research. Future 
studies should also try to clarify  the role o f  placental insufficiency in the etiologies o f 
hypospadias and UDT and disentangle the effects o f  horm one adm inistration, in vitro  fer­
tilization, and underlying parental su b fe rtility  as potential causal factors for the increased 
risks o f  hypospadias and UDT after IV F /IC S I treatm ent. The increased risk o f hypospadias 
in sons o f  D ES-daughters re quires clarification as w ell. The developm ent o f  a food e xp o ­
sure index to estim ate the intake o f  p ersistent EDs as w ell as naturally occurrin g  phyto­
estrogens could shed more light on the role o f  dietary intake o f  EDs in the etiologies o f 
hypospadias and UDT. For occupational exposure, the focus should be on w om en w ork­
ing in agriculture o r handling cosm etic products. Furtherm ore, futu re  research should 
focus on the developm ent and ap p lica b ility  o f  biological m onitoring o f  EDs, am ong others
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#by m eans o f  reporter-gene bioassays. These studies could help to better understand the 
health risks o f  EDs as w ell as th e ir behavior w ithin the hum an body, esp ecially  in com bina­
tion w ith p rospective epidem iologic studies.
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#Inleiding en doelstellingen
Hypospadie en niet-scrotale testis zijn tw ee veelvoorkom ende aangeboren afw ijkingen 
bij jongens. Bij hypospadie bevindt de m eatus van de urethra zich niet op de top van 
de glans, m aar ergens aan de ventrale  zijde van de penis. Bij niet-scrotale te stis (NST), 
ook wel cryptorchism e genoem d, zijn één o f  beide testes niet volledig ingedaald in het 
scrotum , m aar liggen in de buikholte o f  in het lieskanaal o f  bevinden zich in een hoog 
scrotale o f  ectop isch e positie. H oew el in voorgaand onderzoek enkele risicofactoren voor 
hypospadie en NST gevonden zijn, blijft de etiologie van beide aandoeningen grotendeels 
onbekend. Volgens de ‘Testicular D ysgenesis Syndrom e' hypothese kunnen hypospadie 
en NST, alsook teelbalkanker en verm ind erde sperm akw aliteit, ontstaan uit een testicu- 
laire dysgenese tijdens de vroege foetale ontw ikkeling. N aast een gedeelde genetische 
predispositie, w ijst de TDS hypothese naar prenatale blootstelling aan horm oonversto- 
rende stoffen als een gezam enlijke oorzaak vo o r deze v ie r aandoeningen.
H orm o onverstoren de stoffen zijn gedefinieerd als exogene substanties die de hor­
m oo nh uish o uding  veranderen en daardoor nadelige effecten hebben vo or de gezondheid. 
Deze brede defin itie  omvat een toenem end aantal stoffen met zeer diverse chem ische 
eigenschappen en w erkingsm echanism en. Zo zijn versch illen d e  industriële  chem icaliën 
zoals pesticiden, dio xines en ftalaten potentieel h orm oonverstorende stoffen, m aar ook 
plantaardige fyto-oestrogenen. Blootstelling aan dit soort stoffen kan plaatsvinden op 
het werk, in en rond het huis (bijvoorbeeld tijdens klussen o f  hobbies), d oo r het gebruik 
van co sm etische producten en via het dieet. Er zijn slechts enkele verbanden beschreven 
tussen prenatale blootstelling aan h o rm oonverstorende stoffen en de kans op het krijgen 
van hypospadie en NST. Dit kan gedeeltelijk komen doordat het lastig is om  blootstel­
ling aan horm oonverstorende stoffen goed in kaart te brengen, vooral in re tro sp e ctief 
onderzoek.
De doelstellingen van het onderzoek beschreven in dit proefschrift, die in detail 
geform uleerd zijn in Hoofdstuk 7, w aren de volgende: i)  m eer kennis vergaren o ver de 
risicofactoren voo r hypospadie en NST, 2) vaststellen o f  prenatale blootstelling aan hor­
m oonverstorende stoffen het risico op hypospadie en NST verhoogt, 3) bijdragen aan het 
o ntw ikkelen en evalueren van m eetm ethoden voor horm oonverstorende stoffen in e p i­
dem iologisch onderzoek en 4 ) evalueren van de TDS hypothese d oo r het herkennen van 
overeenkom sten e n /o f verschillen  in de risicofactoren voo r hypospadie en NST.
Methode, resultaten en interpretatie
Exploratief patiënt-controle onderzoek naar hypospadie (2002)
In 2 0 0 2  startten w e met een e xp lo ratief onderzoek naar hypospadie, w aarin we een breed 
spectrum  van m ogelijke risicofactoren in kaart brachten. De patiëntengroep bestond uit
s a m e n v a t t i n g  187
#jo ng ens die in het Kinderurologisch C entrum  van het U niversita ir M edisch C entrum  St 
Radboud geopereerd waren aan hypospadie en geboren waren in de periode 1987-1997. De 
controlegroep bestond uit vriendjes van de patiënten van dezelfde leeftijd, w iens o uders 
via de ou ders van de patiënten w erden uitgenodigd om aan het onderzoek deel te nemen. 
De data w erden verzam eld met behulp van sch riftelijke vragenlijsten vo or beide ouders 
van patiënten en controles.
Zoals beschreven in Hoofdstuk 2, bleek het vóórkom en van hypospadie in de fam i­
lie een sterke risicofactor vo o r de aandoening te zijn, hetgeen duidt op een belangrijke 
genetisch com ponent in het ontstaan van hypospadie. Hypospadie kwam ook vaker voor 
bij kinderen met een laag g eboortegew icht en bij m eerlingen; situaties w aarin p lacen­
taire insufficiëntie  m ogelijk een rol speelt en de foetus van onvoldoend e voedingsstoffen 
en horm onen w ordt voorzien. Daarnaast leken een verm ind erde vruchtbaarheid van de 
vader e n /o f  vruch tbaarh eidsbehandelingen het risico op hypospadie te verhogen. V erder 
w erden er aanw ijzingen gevonden voor verbanden tussen hypospadie en het gebruik van 
ijzersupplem enten d o or de m oeder, roken van de moeder, m edicijngebruik van de vader 
en blootstelling aan pesticiden van de vader, die met de nodige voorzichtigheid geïnter­
preteerd moeten w orden vanw ege het subjectieve karakter van deze data.
O nze gegevens lieten ook een verhoogd risico op hypospadie zien als de m oeder pre­
nataal was blootgesteld aan D iethylstilbestrol (DES) (zie Hoofdstuk3). In 2 00 2  rapporteer­
den Klip et al. als eersten dat hypospadie vaker vóórkom t bij de zonen van DES-dochters. 
Zij deden deze bevinding in een cohort van vrouw en met vruchtbaarheidsproblem en. 
Hoew el onze resultaten deze eerdere observatie bevestigen, laten ze ook zien dat het 
w erkelijke extra risico op hypospadie voo r DES-kleinzonen w aarsch ijn lijk  veel m inder 
groot is. M aar dit doet niets a f aan het feit dat het vóórkom en van hypospadie bij DES­
kleinzonen kan w ijzen op een transgenerationeel effe ct van DES, dat ve rd er onderzocht 
zou moeten worden.
Patiënt-controle onderzoeken naar hypospadie en NST (2005)
Het onderzoek in 2 00 2  vorm de de basis voo r tw ee studies naar hypospadie en NST die in 
2 005 zijn opgezet en zijn beschreven in Hoofdstuk4 en 5. De gegevensverzam eling in deze 
studies w as veel uitgebreider, met name wat betreft de blootstelling aan m ogelijk hor- 
m oonverstorende stoffen. De patiënten w aren jo ng e ns die vanw ege hypospadie o f  NST 
een operatie ondergingen op de afdelingen U rologie en K inderchirurgie van v ijf  z ieken­
huizen in O ost-N ederland. De co ntroles w aren jo ng e ns die trom m elvliesb uisjes kregen op 
de afdelingen Keel-, Neus-, en O o rh eelkund e van dezelfde ziekenhuizen. A lle patiënten 
en contro les waren geboren in de periode 1996-2004.
De gevonden risicofactoren vo o r hypospadie en NST vertoonden diverse o ve re en ­
komsten en w aren verg elijkb aar met de resultaten van het patiënt-controle onderzoek in 
2002. O pnie uw  vonden w e een verhoogd risico op hypospadie als de vader verm inderd 
vruch tbaar was en na een IV F /IC S I behandeling, met overeenkom stige odds ratio's vo or
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#NST. De gevonden associaties met een laag geboortegew icht, m eerlingzw angerschappen 
en pre-eclam psie onderbouw den de rol van placentaire insufficiëntie  in de etiologie van 
zowel hypospadie als NST. Bovendien vonden we du idelijk  verhoogde risico's op hypo­
spadie en NST als deze aandoeningen in de fam ilie voorkwam en. M a ar het fam iliair vó ó r­
komen van NST is w aarsch ijn lijk  m eer een gevolg van gedeelde om gevingsfactoren dan 
van overerfbare g enetische factoren (zie H oofdstuk9). Net zoals in het onderzoek in 2 002 
vonden we enkele verbanden tussen voorgeschreven m e dicijngeb ruik d oo r de vader en 
hypospadie en NST, die lastig te verklaren waren.
N ieuw e bevindingen in de stud ies in 2 005 w aren een verhoogd risico op hypospadie 
bij het fam iliair vóórkom en van te stiskan ke r en w ellicht bij obesitas van de vader en een 
verband tussen NST en pilgebruik d o or de m oeder na de conceptie. Bovendien leverden 
de studies nieuw  en overtuigend bew ijs vo o r verschillen  in risicofactoren tussen sub gro e­
pen van patiënten met hypospadie (distaal, m idden, en proxim aal) en m ogelijk tussen 
subgroepen van patiënten met NST (m et en zonder liesbreuk).
Wat betreft prenatale blootstelling aan h o rm oonverstorende stoffen vonden w e uit­
sluitend een verband tussen NST en zelfgerapporteerde beroepsm atige blootstelling aan 
cosm etica van de m oeder. De vrag enlijstgegevens gaven geen du idelijke  aanw ijzingen 
v o o r een rol van andere beroepsblootstellingen aan h o rm oonverstorende stoffen in de 
etiologie van hypospadie o f  NST. O ok vonden w e geen verhoogde risico 's vo or hypo­
spadie o f  NST bij p rivégebruik van cosm etica, bij innam e van vis en schaaldieren o f  op 
soja gebaseerde vlees- en zuivelvervangers en bij het gebruik van bijvoorbeeld verf, lijm 
o f  ch em isch e bestrijdingsm iddelen in en rond het huis. Deze ‘nulbevinding en' kunnen 
ech te r gedeeltelijk een gevolg zijn van m isclassificatie van de blootstelling, die gebaseerd 
was op retrospectieve vragenlijsten.
Blootstellingsclassificatie met een Job Exposure Matrix voor potentieel hormoon­
verstorende stoffen
Om  tot een m eer betrouw bare b lootstelling sclassificatie  van horm oonverstorende sto f­
fen te komen, besloten we om  de beroepsm atige blootstellingen in kaart te brengen met 
behulp van een Job Exposure M atrix (JEM ). D aarvoor o ntw ikkeld en we, gebaseerd op de 
do or Van Tongeren et al. in 2 002  gep ub liceerde JEM, een nieuw e en actuele JEM vo o r 10 
groepen en 33 subgroepen van potentieel h orm oonverstorende stoffen, die beschreven 
is in Hoofdstuk 6. Een panel van exp erts classificeerde vo or in totaal 353 beroepsgroepen 
de w aarschijnlijkheid van blootstelling aan deze groepen en subgroepen van stoffen als 
‘onw aarschijnlijk ', ‘m ogelijk' o f  ‘w aarschijnlijk '. Hierbij richtten ze zich op de periode 1996­
2006.
Bij toepassing van de JEM vonden we associaties tussen NST en blootstelling van de 
m oeder aan pesticiden, ftalaten, org anische oplosm iddelen, alkylfenol verbindingen, 
koper, benzofenonen, parabenen en siloxanen. Deze blootstellingen kwam en vooral voor 
in agrarische beroepen en bij het w erken met cosm etische producten. Blootstelling van
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#de m oeder aan org anische oplosm iddelen leek het risico op hypospadie te verhogen. Het 
is onw aarsch ijn lijk  dat paternale beroepsblootstelling aan horm oonverstorende stoffen 
het risico op hypospadie en NST substantieel verhoogt, hoew el licht verhoogde risico 's na 
paternale blootstelling aan pesticiden o f  koper niet kunnen w orden uitgesloten.
De JEM  is een pragm atische en relatief o bjectieve m ethode om  beroepsm atige bloot­
stelling aan h o rm oonverstorende stoffen in kaart te brengen, vooral voor grote onder­
zoekspopulaties. M aar een belangrijke beperking van de JEM  is dat deze slechts een zeer 
grove indicatie van de blootstelling geeft, w aardoor m isclassificatie op individueel niveau 
onverm ijdelijk  is. Bij het toepassen van de JEM  op onze o nderzoekspopulatie hebben we 
daarom  op een system atische w ijze som m ige blootstellingscores van de JEM  aangepast 
op basis van de zelfgerapporteerde inform atie o ver taken en w erkom geving uit de vra­
genlijsten. De odds ratio's voor de m eeste groepen van potentieel horm oonverstorende 
stoffen w erden daardoor iets sterker, hetgeen w ijst op een algehele afnam e van m isclas­
sificatie (zie Hoofdstuk 7).
De toepasbaarheid van reporter-gen bioassays voor epidemiologisch onderzoek naar 
hormoonverstoring
Naast deze patiënt-controle onderzoeken, voerden we een dw arsdoorsnede onderzoek 
uit naar de toepasbaarheid van de zogenaam de Chem isch g eA ctiveerde LU ciferase gen 
eX pressie (CA LU X ) bioassays vo o r biologische m onitoring van h orm oonverstorende stof­
fen. H iervo or verzam elden we bloedplasm a en interview gegevens van 108 m annen met 
verschillen de blootstellingsprofielen. Het doel w as om het effect van versch illen d e  bron­
nen van m ogelijk h o rm oonverstorende stoffen, zoals beroep, roken, cosm etica, leefom ge­
ving en voeding, alsook het effe ct van m ogelijke determ inanten zoals leeftijd en gewicht, 
op de totale oestrogene en androgene plasm a-activiteit gem eten met CALUX® bioass- 
says te onderzoeken. Zoals beschreven in Hoofdstuk 8 vonden w e voo r verscheidene van 
deze factoren associaties met een verhoogde androgene o f oestrogene plasm a-activiteit. 
Deze bevindingen w ijzen erop dat het m eten van de androgene en o estrogene activiteit 
in plasma een w aardevolle m ethode kan zijn vo or epidem iologisch onderzoek naar hor- 
m oonverstoring en geven richting aan ve rd er onderzoek.
Evaluatie van de Testicular Dysgenesis Syndrome hypothese
Er w erden diverse overeenkom sten in risicofactoren gevonden tussen hypospadie en NST, 
hetgeen w ijst op een gedeelde etiologie, bijvoorbeeld een aanlegstoornis in de te stis  tij­
dens de vroege foetale ontw ikkeling  zoals verondersteld in de TDS hypothese. Deze hypo­
these noem t specifiek g enetische factoren en om gevingsfactoren, met name prenatale 
blootstelling aan h o rm oonverstorende stoffen, als gem eenschappelijke oorzaken voo r 
de v ie r TDS aandoeningen. In onze studies vonden w e ech te r geen overtuigend bew ijs 
voo r een genetische p red isp o sitie  vo o r TDS. Bovendien kwamen onze bevindingen ten 
aanzien van prenatale blootstelling aan h orm oonverstorende stoffen nauw elijks overeen
1 9 0
vo or hypospadie en NST en w ijzen ze op andere aang rijpingspunten vo o r horm oonversto- 
ring dan de aanleg van de testis. Daarmee geven onze resultaten m aar w einig  steun aan 
de TDS hypothese. Andere e tiologische m echanism en, zoals placentaire insufficiëntie  e n / 
o f  h o rm oonverstoring tijdens de o ntw ikkeling  van de penis en de indaling van de testes, 
zijn m eer w aarsch ijnlijke verklaringen voor de gevonden overeenkom sten in risicofacto­
ren tussen hypospadie en NST (Hoofdstuk 9).
Toekomstperspectieven
De resultaten van onze stud ies vorm en nog geen sterke basis voo r m aatregelen om 
hypospadie en NST te voorkom en, m aar zijn wel een goed uitgangspunt vo o r toekom stig 
onderzoek (Hoofdstuk9). Zo geeft het fam iliair vóórkom en van hypospadie het belang aan 
van g enetische stud ies naar deze aandoening. O ok zou in toekom stig  onderzoek g ep ro­
beerd moeten w orden de rol van placentaire insufficiëntie  in de etiologie van hypospadie 
en NST op te helderen. Ten aanzien van de verhoogde kans op hypospadie en NST na 
een IV F /IC S I behandeling, d ie n t toekom stig onderzoek de afzonderlijke effecten van de 
toegediende horm onen, de in vitro bevruchting en de onderlig gende sub fe rtilite it van de 
ou ders te ontrafelen. D aarnaast is het belangrijk om  m eer inzicht te krijgen in het o n d e r­
liggende etiologisch m echanism e vo o r de verhoogde kans op hypospadie bij de zonen 
van D ES-dochters. Het ontw ikkelen van een blootstellingsindex vo o r het schatten van 
de innam e van persistente chem icaliën en plantaardige fyto-oestrogenen kan de rol van 
blootstelling aan horm oonverstorende stoffen via de voeding in de etiologie van hypos­
padie en NST verduidelijken. Wat betreft beroepsblootstelling aan horm oonverstorende 
stoffen moeten onderzoekers zich met name gaan richten op vrouw en die in de agrari­
sche sector o f  met cosm etica w erken. Daarnaast is de verd ere ontw ikkeling  en toepassing 
van biologische m onitoring vo o r h orm oonverstorende stoffen, o n d e r andere d oo r middel 
van reporter-gen bioassays, van groot belang. Daarm ee kunnen toekom stige stud ies m eer 
inzicht geven in de g ezo ndh eidsrisico 's en w erkingsm echanism en van horm o onversto ­
rende stoffen, vooral in com binatie met p ro sp ectief epidem iologisch onderzoek.
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Dankwoord

#En toen was het proefschrift opeens af! Weliswaar ‘iets' later dan de bedoeling was. Maar 
nu is het toch echt zover en kijk ik terug op een mooie promotietijd. De volgende mensen 
wil ik graag ontzettend bedanken.
Op de eerste plaats natuurlijk copromotor Nel Roeleveld. Nel, ik vond het erg bijzonder 
om zo nauw met je samen te werken al die jaren. Ik ga het missen! Met heel veel plezier 
kijk ik terug naar onze vaak urenlange besprekingen (waarvoor ik wel eerst even een 
plekje moest zien te veroveren tussen de torenhoge stapels papier op jouw kamer..). Je 
enthousiasme voor het onderzoek en de grote betrokkenheid die je toonde, ook buiten 
het werk, heb ik ontzettend gewaardeerd. Bedankt!
Ook bedank ik promotores Gerhard Zielhuis en Wout Feitz. Beste Gerhard, ik heb veel 
geleerd van onze besprekingen, waarin je me met een heel andere blik naar het onder­
zoek liet kijken. Ook bedankt dat je, ondanks je volle agenda, de tijd vrijmaakte om snel 
en uitgebreid te reageren op de stukken die ik je stuurde. Je opbouwende feedback heb ik 
erg gewaardeerd. Beste Wout, jij stond aan het allereerste begin van dit promotieonder­
zoek. Samen met Bart Kiemeney en later ook Nel liet je mij als student ‘even' een onder­
zoek naar hypospadie opzetten en uitvoeren; voor mij een superstage. Bedankt voor de 
fijne samenwerking; ik hoop dat deze op het gebied van de prenatale screening een ver­
volg krijgt!
Beste Bart, jou bedank ik ook voor je rol bij het afronden van mijn studie en de start van 
dit promotieonderzoek. Ik vind het erg leuk dat je bij de verdediging van dit proefschrift 
wilt opponeren. Robert de Gier, jij en Wout hebben me wegwijs gemaakt in de klinische 
aspecten van hypospadie en niet-scrotale testis, waarbij we onder andere stapels patiën­
tendossiers doornamen. Bedankt! André Verbeek, bedankt voor de goede coaching bij 
mijn onderwijsactiviteiten.
M et het afronden van mijn promotie sluit ik voor mijn gevoel ook pas echt mijn tijd 
op de afdeling Epidemiologie, Biostatistiek en HTA af. Ik heb me hier ontzettend thuis 
gevoeld. Een heleboel collega's hebben geholpen door bijvoorbeeld mee te denken over 
de opzet van het onderzoek of door advies te geven bij de statistische analyses, maar 
ook met praktische dingen zoals het inpakken van de stapels brieven en vragenlijsten. En 
daarnaast hebben die collega's ervoor gezorgd dat ik nu op zo'n leuke tijd terugkijk; in de 
kroeg, bij het bowlingcentrum en aan de koffietafel met de befaamde cake-van-de-week. 
Daar wil ik iedereen erg voor bedanken!
Een paar collega's wil ik even apart noemen. Op de eerste plaats Reini, van wie ik aan 
het begin van het promotieonderzoek de kunst kon afkijken. Reini, ontzettend bedankt 
voor al je hulp. Samen hebben we een heleboel stoer ‘veldwerk' gedaan en voor mij waren 
dat hoogtepunten van mijn promotietijd. Een ander hoogtepunt was voor mij het epide­
miologie congres in Chicago; Iris, bedankt voor de fantastische ‘vakantie', maar ook voor 
je betrokkenheid bij mijn onderzoek. Mariëtte, het was fijn dat ik in het begin van mijn 
promotieonderzoek voor van alles en nog wat bij jou terecht kon. Ook bedankt voor de
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#leuke tijd in Finland. Sita, met jou heb ik op en na het werk veel gesproken over onderzoek 
en onderwijs, maar vooral ook over veel interessantere dingen! Ik ben blij dat ik je heb 
leren kennen. Loes en Marleen, ik vond het ontzettend gezellig om met jullie een kamer 
te delen. Ik heb er bewondering voor hoe jullie met je promotieonderzoek bezig zijn. Heel 
veel succes met het afronden daarvan. Tot slot ben ik in het trotse bezit van een SoA- 
erelidmaatschap; Hans en Judith, bedankt voor de leuke tijd!
Ook de contacten met promovendi op andere afdelingen vond ik erg leuk en waarde­
vol. Bijvoorbeeld met de leden van de PhD council van het NCEBP en met de promovendi 
die deelnamen aan de wekelijkse refereerbijeenkomsten. Beste Marion, met jou had ik 
nog lange tijd een soort ‘lotgenotencontact'. Eindelijk kan ik je nu ook voor mijn promotie 
uitnodigen!
Tijdens mijn promotieonderzoek heb ik drie maanden bij het Centre for Occupational 
and Environmental Health (COEH) in Manchester gewerkt. Professor Raymond Agius, 
thank you for your hospitality. I very much appreciated the opportunity to learn about 
the research that is conducted at COEH and I felt very welcome at the department. Thanks 
to everyone at COEH for making my time in Manchester so worthwhile. Together with 
Martie van Tongeren and Adrian Hirst, I worked on the job exposure matrix for endocrine 
disruptors, which is an important part of this thesis. Dear Adrian, thank you for the long 
hours spent on scoring exposures, which got quite mind-numbing at the end! Beste Mar­
tie, ik vond het ontzettend leuk en leerzaam om met je samen te werken in Manchester,
Graag wil ik Bram Brouwer en Harrie Besselink van Biodetection Services in Amster­
dam bedanken voor de fijne samenwerking bij het bloedonderzoek. W e hebben intensief 
overlegd over wat te meten en bij wie, waar ik erg veel van heb geleerd. Paul Scheepers 
en Rob Anzion, jullie bedank ik ook voor je belangrijke input bij de opzet en uitvoering 
van het bloedonderzoek. Heidi Neisingh, bedankt voor je hulp bij de bloedafnames en 
interviews.
En dan zijn er nog een aantal andere mensen die een belangrijke bijdrage hadden aan 
het onderzoek en die ik daar erg voor wil bedanken. Op de eerste plaats denk ik dan aan de 
ouders van de patiënten en controles die in groten getale bereid waren om deel te nemen 
aan het onderzoek. Het uitnodigen van deze ouders voor het onderzoek was mogelijk 
door de medewerking van professor Graamans, Dr. Rieu, Dr. Corten, Dhr. Van Leeuwen, 
Dr. Barten, Dr. Theunissen, Dhr. Meier en Dr. Hinderink van de afdelingen Keel-, Neus-, 
en Oorheelkunde, Urologie en Kinderchirurgie van het UMC St Radboud in Nijmegen, 
het Canisius Wilhelmina Ziekenhuis in Nijmegen, de Alysis Zorggroep locatie Rijnstate 
in Arnhem, het VieCuri Medisch Centrum Noord Limburg en het regionaal Streekziek­
enhuis Koningin Beatrix in Winterswijk. Ook bedank ik Luc Roelofs, die het eerste hypo- 
spadie-onderzoek voor een deel heeft uitgevoerd. Annelies Pellegrino, Maartje Loeffen 
en Martijn van de Leur voerden de vragenlijstgegevens van ‘de grote' studie in, waar in de 
vakanties ook Anne Verbeek en Danique en Marènne Kiemeney mee hebben geholpen.
bedankt!
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#Hans Groenewoud, Erik Brummelkamp en Wim Lemmens hielpen bij het verwerken van 
de gegevens en Nelly Peer en Ton Feuth gaven statistische ondersteuning. Tot slot heb ik 
met veel plezier samengewerkt met Leonie, Marja, Sandra en Loes, die als stagiaires een 
hoop werk voor het onderzoek hebben verzet. Bedankt allemaal!
Ik wil ook graag een aantal mensen buiten het onderzoek bedanken, omdat zij de 
afgelopen jaren zo met me hebben meegeleefd. Mijn collega's bij de Stichting Prenatale 
screening regio Nijmegen, waar ik sinds september 2008 met veel plezier werkzaam ben 
en waar ik de ruimte kreeg om verder te werken aan mijn proefschrift. Annette, Akosua, 
Riet en Marion, bedankt voor jullie steun en belangstelling! Alle vrienden en vriendinnen, 
ik heb ontzettend veel zin om met jullie een feestje te gaan vieren op 4 april! Martijn, 
wat grappig dat je even bij mij ‘in dienst' bent geweest, en leuk dat ik je nu dan eindelijk 
het eindresultaat van het onderzoek kan geven. Monique en Alma, we hebben heel wat 
uren samen in de bieb aan onze boekjes zitten werken. Ik vond het erg gezellig! Ivon en 
Janneke, bedankt dat jullie er gewoon altijd voor me zijn. Een geruststellend idee dat jullie 
op 4 april als paranimfen naast me staan! Susanne en Freek, ik ben ontzettend blij met 
zulke leuke en goede vrienden. Ik heb heel veel zin in wat ons de komende tijd allemaal 
te wachten staat. Pap, mam, Arnout, Thalitha, Bouke, Ellen, Iris, Wim, Toos, Peter, Ivonne 
en kleine Luc, wat fijn om het afronden van mijn promotieonderzoek met jullie te kunnen 
delen. Een lievere (schoon)familie kan ik niet wensen!
Tot slot Ruud. Je hebt me zoveel geholpen bij mijn promotieonderzoek! Die laatste 
alinea van je dankwoord zal wel erg lang worden, zei je vaak. Dat klopt, en daarom krijg jij 
een extra bijlage bij jouw boekje! Lieve Ruud, ik ben blij dat ik alles in het leven samen met 
jou kan doen. W e gaan genieten op 4 april, en vooral ook daarna met Eefje!
Marijn
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